Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,24966,0.184864986519585,0.0046268428031455,0.17579637462542,0.19393359841375,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,29786,-0.141725927074208,0.00363190189811267,-0.148844454794509,-0.134607399353908,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,24951,0.0746967587404369,0.00170637582668479,0.0713522621201347,0.078041255360739,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,29545,0.0774330042145575,0.00190378627247252,0.0737015831205113,0.0811644253086036,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0800950029335728,0.00204394259382865,-0.0841011304174769,-0.0760888754496686,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,24951,0.143296422295246,0.00365259387274609,0.136137338304663,0.150455506285828,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.155572530774581,0.0021263456413339,0.151404893317567,0.159740168231596,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,28797,-0.443754695008888,0.0083709536390574,-0.46016176414144,-0.427347625876335,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.351714715049507,0.00834002053798352,0.335368274795059,0.368061155303954,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,24922,-0.262241729683433,0.0056169118785661,-0.273250876965422,-0.251232582401443,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,29443,-0.167892714585338,0.0029277204790144,-0.173631046724206,-0.16215438244647,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,29725,-0.186981197517797,0.00450740350997167,-0.195815708397341,-0.178146686638252,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.139382390554978,0.00208915468026661,0.135287647381655,0.1434771337283,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.0960273513890155,0.00191766108717678,0.092268735658149,0.099785967119882,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.14161782998053,0.00274067135999587,-0.146989545846122,-0.136246114114938,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,29347,-0.137523767705669,0.00277670842887118,-0.142966116226257,-0.132081419185082,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,24111,-0.275358143388741,0.00664123408724493,-0.288374962199741,-0.262341324577741,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,29349,-0.236659768480154,0.0062171226095065,-0.248845328794786,-0.224474208165521,1.19330863091783e-308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.362932620216919,0.00956281601941443,-0.381675739614971,-0.344189500818866,8.0991554726648e-308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,29478,0.121888476508851,0.00323506011477374,0.115547758683894,0.128229194333807,1.87558673428837e-303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,29443,-0.100596033338029,0.00284761292581041,-0.106177354672617,-0.0950147120034402,9.12661362901985e-268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.128368412103008,0.00363781090252994,-0.135498521471966,-0.121238302734049,3.36159386149673e-267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0743417448412156,0.00211358599732894,0.0701991162864509,0.0784843733959804,2.0788356694215e-264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,29454,-0.131814045619902,0.00376950132339484,-0.139202268213756,-0.124425823026048,1.60437374671181e-262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.133444368761097,0.00383223682649042,-0.140955552941019,-0.125933184581176,2.04160973940116e-259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,29702,0.0845688802537831,0.0024797329449749,0.0797086036816323,0.0894291568259339,4.34726942744334e-250
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.152992696282181,0.00457873202785857,-0.161967011056784,-0.144018381507578,3.2420491157696e-240
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,29725,0.0816805544011494,0.00246384179038655,0.0768514244919918,0.0865096843103071,1.10779981229589e-236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0774189417903791,0.00233942981119363,-0.0820042242203186,-0.0728336593604396,7.21855431963543e-236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0494821464210451,0.00149959700184909,0.0465429362974209,0.0524213565446693,1.5649989875779e-234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,29489,-0.18397766003913,0.00558555033786332,-0.194925338701342,-0.173029981376917,1.08705865673761e-233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.116772141215305,0.00369460498162119,-0.124013566979283,-0.109530715451328,1.23536145649262e-215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0722341954164836,0.00230656697831177,-0.0767550666939746,-0.0677133241389925,8.10906409989055e-212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.254504452267191,0.00821195455576351,-0.270599883196487,-0.238409021337894,1.42242421746892e-207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,29435,0.0964173760803565,0.00312828054717055,0.0902859462079023,0.102548805952811,2.52000929280833e-205
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,28931,-0.170087700246765,0.00551794780041138,-0.180902877935571,-0.159272522557958,2.60042569310212e-205
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.113628075313033,0.00371921868112019,0.106338406698037,0.120917743928028,8.49923854958321e-202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,23787,0.0920815071901972,0.00301467699698518,0.0861727402761063,0.0979902741042882,5.12072778629619e-201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0793347310606148,0.00260260816179435,0.0742336190634979,0.0844358430577317,5.90066891231133e-201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.07003678445783,0.002310284581227,0.0655086266786251,0.0745649422370349,7.99306193392848e-199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0690468312312377,0.00227903419475678,-0.073513738252961,-0.0645799242095144,1.51296731009171e-198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,29584,-0.0718596921976086,0.00237568427559192,-0.0765160333777688,-0.0672033510174484,5.78243815953811e-198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,29478,-0.127220579601864,0.00427974280110668,-0.135608875492033,-0.118832283711695,2.36608168261177e-191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.0967709056965368,0.0032786356956209,-0.103197031659954,-0.0903447797331199,9.87317559861182e-189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.111651254977391,0.00383237930310285,-0.119162718411473,-0.104139791543309,6.1413683505089e-184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0547399221058365,0.00188668148050555,0.0510420264040457,0.0584378178076274,1.6294098294521e-182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,24922,-0.184188100809032,0.00635928710025014,-0.196652303525522,-0.171723898092541,1.92307023899381e-181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,29400,-0.204300263325619,0.0070690670579842,-0.218155634759268,-0.19044489189197,4.02993392517888e-181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0698638405823135,0.00242501313424407,-0.0746168663254319,-0.0651108148391952,5.02144259888065e-180
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,29507,0.039637530156101,0.00137672757222827,0.0369391441145336,0.0423359161976684,8.54505285069986e-180
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0631869194282213,0.00220134381766398,0.0588722855455999,0.0675015533108426,9.98740099646854e-179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,29820,-0.103971486152285,0.0036333266174299,-0.111092806322448,-0.0968501659821225,1.07700760471506e-177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0578270702762892,0.00204775115001074,0.0538134780222682,0.0618406625303103,3.86613992098729e-173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.104522839789273,0.00375188263292343,-0.111876529749803,-0.0971691498287428,1.31923770296827e-168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.0986939874433485,0.00356457262909801,-0.105680549796381,-0.0917074250903164,3.81208958366094e-166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.0619339894440155,0.00223694627502147,-0.0663184041430576,-0.0575495747449735,4.29071039385519e-166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.132624762611975,0.00481231179956413,-0.142056893739121,-0.12319263148483,4.33496345115624e-165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,29566,-0.064095566570098,0.00232989566789549,-0.0686621620791731,-0.0595289710610228,1.57993472264988e-164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,24951,0.0990394681374876,0.00359812365466956,0.0919871457743352,0.10609179050064,2.49956564494458e-164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.159335259947845,0.00581988521517247,-0.170742234969583,-0.147928284926107,6.07629651327328e-163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,24914,0.0703145426209621,0.00260996128072025,0.0651990185107504,0.0754300667311738,1.32790205692998e-157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,27442,-0.076233928046351,0.00283276147500082,-0.0817861405373526,-0.0706817155553494,1.79025737485344e-157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0631075893196315,0.00237506736223324,0.0584524572896544,0.0677627213496087,9.14613942723101e-154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0484055403928661,0.00182122748501321,-0.051975146263492,-0.0448359345222402,1.78015751549335e-153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,29443,0.0498287895925785,0.00187867761120034,0.0461465814746259,0.0535109977105312,3.30964860672161e-153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,29301,-0.13903399502421,0.0052591815530873,-0.149341990868261,-0.128725999180159,3.20449013767788e-152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.0948713413269888,0.00360017960187879,-0.101927693346671,-0.0878149893073064,3.00219060247994e-151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,24195,-0.148537365701609,0.00564800119697243,-0.159607448047675,-0.137467283355543,2.5524819612126e-150
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.0963738941179693,0.00368323906801211,-0.103593042691273,-0.0891547455446656,3.66469242859294e-149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0889321741356456,0.00341193930644887,0.0822447730950059,0.0956195751762854,8.78024425060019e-148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,28774,-0.0929895742519904,0.00358991255919303,-0.100025802868009,-0.0859533456359721,2.93783164657089e-146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.114207822285849,0.00441476097211462,-0.122860753791194,-0.105554890780504,6.840788534361e-146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0538315045159346,0.00208226757481441,-0.0579127489625708,-0.0497502600692984,9.80283465596392e-146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,29786,-0.0500617337559434,0.00197651850959113,-0.053935710034742,-0.0461877574771447,4.7608191408769e-140
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.1043745142746,0.00412511441890936,-0.112459738535663,-0.096289290013538,1.01930828368068e-139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,29559,-0.0574158599448928,0.00227376444824558,-0.0618724382634541,-0.0529592816263315,3.27856793192382e-139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,29786,-0.0599715062726433,0.00239794335967218,-0.0646714752576008,-0.0552715372876858,1.24129130140281e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.14676713639919,0.0058701882155019,-0.158272705301574,-0.135261567496806,1.54941681056701e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,29683,-0.0350384941700523,0.00140247065967486,-0.0377873366630151,-0.0322896516770896,2.38345145778996e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,24381,-0.0501226163089956,0.00200743181024249,-0.0540571826570709,-0.0461880499609203,6.86443336709981e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.254640082055422,0.0102741369746778,-0.27477739052579,-0.234502773585053,3.27724560529674e-134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,24381,-0.0698056636855651,0.00281716654597849,-0.0753273101156829,-0.0642840172554472,6.91643700809503e-134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,29545,-0.0312565628641964,0.00126840632292011,-0.0337426392571198,-0.028770486471273,9.75686727213277e-133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.0561614709237671,0.00228928633385449,-0.0606484721381219,-0.0516744697094123,1.36535823285169e-131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.105946815286257,0.00434006005340423,0.0974402975815845,0.114453332990929,2.48812447406137e-130
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.122853337724063,0.00503131010224218,-0.132714705524457,-0.112991969923668,3.8189078995318e-130
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.144827770847531,0.00594586354121934,-0.15648166338832,-0.133173878306741,1.59928066110314e-129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,24329,-0.0631154065074758,0.00263027676568459,-0.0682707489682176,-0.057960064046734,8.93925978564369e-126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0508780103518249,0.00212588833564413,-0.0550447514896873,-0.0467112692139624,2.21142331042326e-125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,29786,-0.0438157571900124,0.00183095883610788,-0.0474044365087839,-0.040227077871241,2.25833477535688e-125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,29725,0.0276430797584381,0.00115984703892397,0.0253697795621472,0.0299163799547291,2.21919471673369e-124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.13214896003936,0.0055524527407086,-0.143031767411149,-0.121266152667571,5.00335182271546e-124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.0726182181848661,0.00306291872846922,-0.0786215388926658,-0.0666148974770664,4.36371301061932e-123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,29581,0.0713639881290442,0.00301384482145212,0.065456852278998,0.0772711239790903,8.32485467690369e-123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,29577,-0.107800901497232,0.00455484711441118,-0.116728401841478,-0.0988734011529863,1.08650455110877e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,24966,-0.032182079466103,0.00136170782139441,-0.0348510267960361,-0.02951313213617,3.82737707469561e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.129867784257817,0.00550326833839207,-0.140654190201066,-0.119081378314569,5.71463357138914e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0590549084811932,0.00250439878584712,-0.0639635301014535,-0.0541462868609328,8.17052018345373e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,24938,0.0975630086682008,0.00413395107160778,0.0894604645678496,0.105665552768552,8.27835630383412e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.0731780531223337,0.00310429479135588,-0.0792624709133913,-0.0670936353312762,9.47033844569324e-122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.0514882502274926,0.0021921754262579,-0.055784914062958,-0.0471915863920271,7.00744287631551e-121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.064146541959572,0.00273302626087744,0.0587898104882522,0.0695032734308918,1.04285666138427e-120
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,29750,0.0880245438172241,0.00376889368356706,0.0806375121974326,0.0954115754370155,1.4463885763486e-119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0630943166428278,0.00271195987959935,-0.0684097580068425,-0.0577788752788131,1.14473437276347e-118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.131524640180163,0.00567746257667091,-0.142652466830438,-0.120396813529888,1.14129958952995e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,29349,-0.0898576249279804,0.00392141991457025,-0.0975436079605381,-0.0821716418954228,3.42139938287734e-115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.108857556453555,0.00475393918520203,-0.118175277256551,-0.0995398356505593,4.9268026841909e-115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0374154495815032,0.00163446863855638,-0.0406190081130737,-0.0342118910499327,5.66053655852301e-115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0600469314963627,0.00262657535509916,-0.065195019192357,-0.0548988438003683,1.80694872540704e-114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.122149017168399,0.00534785544061758,-0.13263081383201,-0.111667220504789,1.88391958840271e-114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0505185486191668,0.00222155968452126,-0.0548728056008284,-0.0461642916375051,1.72423853645543e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,29434,0.0543837487804644,0.00239526836148123,0.0496890227919612,0.0590784747689676,3.78819913901651e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,29349,-0.127304697253233,0.00560915390096174,-0.138298638899118,-0.116310755607348,4.63879764614037e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,29478,-0.120701854157273,0.00531849244055986,-0.13112609934077,-0.110277608973775,4.71175522655273e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.0750122358150393,0.00330887215240729,-0.0814976252337576,-0.068526846396321,8.42108821120437e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0579594887704665,0.0025785358997233,0.0529055584070088,0.0630134191339242,8.75462296981417e-111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,29527,0.0607198163050354,0.00272202096269097,0.0553846552181611,0.0660549773919097,2.54197911054062e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0591336297163284,0.0026549942480977,-0.0643374184425999,-0.0539298409900569,5.30269328589477e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,29480,0.0814122546385274,0.00366952041390538,0.0742199946272728,0.0886045146497819,3.60466619394556e-108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.050987549442024,0.00229944645192787,-0.0554944644878026,-0.0464806343962453,6.79466444065168e-108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,29786,-0.0467781614926907,0.00212021982880859,-0.0509337923571556,-0.0426225306282259,5.18526519276637e-107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0676949036554585,0.00307881681531757,-0.0737293846134809,-0.061660422697436,2.67027369563283e-106
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0251997859589658,0.00114695089539813,0.0229517622039855,0.0274478097139461,3.79347871435266e-106
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0413163367258937,0.00188447429435948,0.0376227671089491,0.0450099063428383,1.0638172492366e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0397011959386992,0.00181846493472455,0.0361370046666391,0.0432653872107593,7.62936332037099e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,29632,-0.0734293964686173,0.00338508189851762,-0.0800641569897118,-0.0667946359475227,1.56192161978255e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,29478,-0.092902828367973,0.00428392002189448,-0.101299311610886,-0.0845063451250599,1.77973376239016e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.115472964010394,0.00533587404625009,-0.125931277141044,-0.105014650879743,6.62131735126472e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,29349,-0.0691492893710656,0.00319906976978274,-0.0754194661198398,-0.0628791126222914,8.16761102624518e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0846571189988591,0.00392229129014863,-0.0923448099275504,-0.0769694280701678,1.60058675705055e-102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,29192,0.0427575417021796,0.00198207721478538,0.0388726703612003,0.046642413043159,2.07665926429003e-102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,24805,-0.167037219951973,0.00777331546585855,-0.182272918265055,-0.15180152163889,1.68195975330559e-101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,29604,-0.0893621954114006,0.00417331729080283,-0.0975418973013742,-0.0811824935214271,5.9414421013089e-101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,24938,0.0565464830648637,0.00265325372053258,0.0513461057726198,0.0617468603571076,6.83049987110945e-100
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.121703140010457,0.00574479605054291,-0.132962940269521,-0.110443339751393,7.48651806002235e-99
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.156351043169303,0.00739765583628288,-0.170850448608417,-0.141851637730188,2.04772465761864e-98
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.0826075442103136,0.0039310102254384,-0.0903123242521729,-0.0749027641684544,2.55164125492093e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.0844897274726737,0.00401885710724075,-0.0923666874028656,-0.0766127675424818,2.96762317657842e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.126473718494044,0.00607843636130126,-0.138387453762194,-0.114559983225893,1.83438987688866e-95
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,24867,-0.0643907513210927,0.00310328943237401,-0.0704731986085458,-0.0583083040336397,7.94312929361312e-95
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,29820,-0.0725738707075283,0.00352269129438038,-0.0794783456445138,-0.0656693957705427,1.18904108554245e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,29697,-0.038286641139683,0.0018590147467023,-0.0419303100432195,-0.0346429722361465,1.37123269584682e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0409253192700921,0.00198747957390684,-0.0448207792349495,-0.0370298593052347,1.96166248933848e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.0789557421044866,0.00384710626766258,-0.0864960703891053,-0.071415413819868,6.12654716478449e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0685496228990631,0.00334642633825041,-0.0751086185220339,-0.0619906272760923,1.31436542630461e-92
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.13090225806501,0.00642487169744639,-0.143495006592005,-0.118309509538015,1.24643669764095e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0493921235661573,0.00242646128776174,-0.0541479876901703,-0.0446362594421443,1.74686061979794e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.143525794895769,0.00707103389865255,-0.157385021337128,-0.12966656845441,5.91767909783817e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0856323094103362,0.00427291896873588,0.0772573882316139,0.0940072305890585,1.27273110768182e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,29349,-0.0500321062415847,0.00249858885469813,-0.0549293403967931,-0.0451348720863764,1.3279794365727e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.101455448897183,0.00508476753578109,-0.111421593267314,-0.0914893045270522,6.89161128354033e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,24381,0.0317730274187317,0.001592440366724,0.0286518442999527,0.0348942105375108,7.19263381297282e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0431458190593019,0.00216841220336701,0.0388957311407026,0.0473959069779013,1.60677262344457e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0456087651457892,0.00229558257997653,-0.0501081070025432,-0.0411094232890352,2.83262870835636e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0608705613096333,0.00307106405117111,-0.0668898468499286,-0.0548512757693379,7.45870878911326e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,29544,-0.0424352266686,0.0021448464676419,-0.0466391257451782,-0.0382313275920219,1.46746303059603e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,24240,-0.074821017915271,0.00378940313756135,-0.0822482480648912,-0.0673937877656507,4.23024132409908e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,29820,-0.0815176096456698,0.00413332816807616,-0.0896189328550991,-0.0734162864362406,4.94090110574274e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,24240,-0.0885390315326948,0.0044994341337434,-0.0973579224348319,-0.0797201406305578,1.55672061926258e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0497601675901308,0.00253952003680574,-0.05473762686227,-0.0447827083179915,6.07925610414954e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,24845,0.0262024567824948,0.00134030346236437,0.0235754619962606,0.0288294515687289,1.7946740012055e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,29478,-0.0868953386132464,0.00444756143392931,-0.0956125590237479,-0.078178118202745,1.79823378241148e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,29218,0.0463734514959027,0.00238284947074901,0.0417030665332347,0.0510438364585708,7.94271648283437e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,24938,0.0547586462458119,0.00282034544765892,0.0492307691684004,0.0602865233232234,2.35444420555265e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,28764,-0.0807463715761044,0.00416621467161078,-0.0889121523324616,-0.0725805908197473,3.77576260010549e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,29433,-0.0404553664987611,0.00208917292381321,-0.044550145429435,-0.0363605875680872,5.08253853672275e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0299053594888253,0.00154490718165314,-0.0329333775648654,-0.0268773414127851,5.77218292808681e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,24707,-0.0344453822427079,0.00177941396833994,-0.0379330336206542,-0.0309577308647616,7.22428316017424e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0671934718263675,0.00347364589281952,-0.0740018177762938,-0.0603851258764413,9.60450554248082e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0560723103489245,0.00290985817284543,-0.0617756323677015,-0.0503689883301474,3.08106294867773e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.0921537421353827,0.00478364538283951,-0.101529687085748,-0.0827777971850173,4.43697313364804e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,29434,0.0586572063009605,0.00305067227602855,0.0526778886399445,0.0646365239619765,6.9189649343966e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,29628,0.0372805909374105,0.00194740743017504,0.0334636723742675,0.0410975095005536,3.38353273220195e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,24922,0.0369842712515143,0.00193357930780709,0.0331944558082124,0.0407740866948162,5.69448281934609e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.0812657194659958,0.00425600685895036,-0.0896074929095386,-0.0729239460224531,8.59278858400977e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0467658296204651,0.00244926964134348,0.0419652611234319,0.0515663981174983,8.77177177508794e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0341595869286381,0.00178918149544926,0.0306527911975576,0.0376663826597187,9.0398521322905e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.0971899417832361,0.00509204359282013,-0.107170347225164,-0.0872095363413087,1.01477003610772e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.0882920104036974,0.00462592946966692,-0.0973588321642446,-0.0792251886431503,1.23578712919849e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.0840817877651994,0.00441555998277502,0.0754272901989603,0.0927362853314384,2.33462588770971e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0631075969617228,0.00331864139576658,-0.0696121340974253,-0.0566030598260203,4.77677277761414e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0616156730181882,0.00324466245007439,0.0552561346160424,0.067975211420334,6.22909051040286e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,29468,0.0510962917309631,0.00270654527989496,0.045791462982369,0.0564011204795573,4.99718785762659e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.0751470756742533,0.00398169814527371,-0.0829512040389897,-0.0673429473095168,5.51096600912867e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0448412038702809,0.00237792927144322,-0.0495019452423096,-0.0401804624982522,7.47202313938209e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,29478,-0.0887507571989965,0.00470645776166241,-0.0979754144118549,-0.0795260999861382,7.47462568179534e-79
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,29426,-0.0609854805516916,0.00325075865358862,-0.0673569675127253,-0.0546139935906579,4.55295559232943e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.034881727202273,0.00185993556691498,0.0312362534911196,0.0385272009134263,6.14729658202737e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.068927491858066,0.00367863486679584,-0.0761376161969858,-0.0617173675191461,8.49332444318175e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,0.050025190264681,0.002672121688264,0.0447878317556835,0.0552625487736784,9.37987033275855e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0587221302332792,0.00313654696565661,-0.0648697622859662,-0.0525744981805923,1.16109046863563e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.036998877429347,0.00197956076223047,-0.0408788165233187,-0.0331189383353752,2.00738784462936e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,29443,-0.0418712593402363,0.00225816270206571,-0.0462972582362851,-0.0374452604441875,2.56956598653941e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0954591919976461,0.00514688943290408,0.0853712887091541,0.105547095286138,2.82237774233235e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0438394914298887,0.00236540198142839,0.039203303546289,0.0484756793134883,3.00114262006565e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.166163473649417,0.00896612188682076,-0.183737072547586,-0.148589874751249,3.04840670991901e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,29443,-0.0304919539528171,0.00164628986496303,-0.0337186820881446,-0.0272652258174896,3.74890330087355e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,24845,-0.169408056735352,0.00914207748089344,-0.187326528597903,-0.1514895848728,3.81985220124587e-76
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0503460235872144,0.00272777843017862,-0.0556924693103645,-0.0449995778640643,1.23960270707752e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0475247324947026,0.00258815846294944,-0.0525975230820835,-0.0424519419073217,6.83144482691793e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0369819281297064,0.00203603467769073,-0.0409725560979802,-0.0329913001614326,2.50813008430604e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0649577370149051,0.00359479675802814,-0.0720035386606402,-0.0579119353691699,1.35887533636531e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,29530,-0.0359186022037073,0.00198815586312693,-0.0398153876954361,-0.0320218167119785,1.44631945306334e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.037791074151112,0.00210438356860904,0.0336664823566383,0.0419156659455857,1.01336801401998e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.071869494484307,0.00400224604926991,-0.0797138967408761,-0.064025092227738,1.19851710679067e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0656062629637756,0.00365548321067671,-0.072771010056702,-0.0584415158708493,1.20497764582832e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,29594,-0.0673038782464401,0.00375397446726833,-0.074661668202286,-0.0599460882905941,1.68455923748777e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0431743859264183,0.00241073175114138,-0.0478994201586554,-0.0384493516941812,2.37461122028511e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0496619105940707,0.00277707853608033,-0.0551049845247882,-0.0442188366633533,3.83594462000277e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0576622133309775,0.00323043748984577,-0.0639938708110752,-0.0513305558508798,6.82703498622553e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0463585460250888,0.00259869673697406,-0.0514519916295579,-0.0412651004206196,8.35153845818758e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,29433,0.221835150164449,0.0124385664003624,0.197455560019739,0.246214740309159,9.01056596487393e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0381336806357824,0.00214169321610082,-0.04233139933934,-0.0339359619322248,1.50401773338877e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,29694,0.0465905343191243,0.00262079466445231,0.0414537767767978,0.0517272918614508,2.45799286134166e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,29433,-0.0373431252246523,0.00210498840439833,-0.041468902497273,-0.0332173479520316,4.74983921093102e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,24966,0.0342485658934458,0.00193106859166287,0.0304636714537866,0.038033460333105,5.99467207378635e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,29545,-0.0408965584958669,0.00231576782759441,-0.045435463437952,-0.0363576535537819,1.93957454819517e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,29581,-0.0423596378757724,0.00241289060320192,-0.0470889034580481,-0.0376303722934966,1.20369765915417e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0676085440680905,0.00386334517402747,-0.0751807006091843,-0.0600363875269966,3.2480688893586e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,28477,-0.0492595390925186,0.00281873010141823,-0.0547842500912983,-0.0437348280937388,4.96808788544506e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.0731554618686397,0.00418701156714342,-0.0813620045402408,-0.0649489191970386,5.14418729092587e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.0614796933507147,0.00352085445548078,-0.068380568083457,-0.0545788186179723,6.1414577174162e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.051491761638432,0.00296545204274701,0.0456794756346478,0.0573040476422161,3.36041992346664e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0466201397878999,0.00268544907624934,-0.0518836199773486,-0.0413566595984512,3.53819170064546e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0520250050333215,0.00300014521383444,-0.057905289652437,-0.046144720414206,4.98733327393169e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0415243078312233,0.00239789872949428,-0.046224189341032,-0.0368244263214145,7.46750138748912e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0685063620728666,0.00395477371047067,-0.0762577185453891,-0.0607550056003441,8.09411719848863e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,24867,-0.053447079427153,0.00308776740432406,-0.0594991035396282,-0.0473950553146778,9.86276005916657e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.0298707849073671,0.0017284480341808,0.0264830267603727,0.0332585430543614,1.3617989768647e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0336284002419585,0.00194604920511506,-0.0374426566839841,-0.029814143799933,1.41121933893242e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,29434,-0.0917064847691812,0.00532414459378664,-0.102141808173003,-0.0812711613653593,3.66565231313103e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,0.0384582488690477,0.00223309328670531,0.0340813860271053,0.0428351117109901,3.80087519159698e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,29169,-0.0371197831482435,0.00215676756889945,-0.0413470475832865,-0.0328925187132006,4.67291441025001e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,29820,0.0329073069417206,0.0019134286503478,0.0291569867870389,0.0366576270964023,5.71731733246484e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0383088517991892,0.00224023544442243,-0.0426997132702571,-0.0339179903281212,3.51383427791714e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0357204864782499,0.00209397154075222,-0.0398246706981243,-0.0316163022583756,6.1822252181594e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,29478,0.0614599286022957,0.00361130815088281,0.0543817646265654,0.068538092578026,1.21548915993019e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.0914828429273147,0.00538572369473384,-0.102038861368993,-0.0809268244856363,2.0920513102754e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.112061401397692,0.00659704250709535,-0.124991604711599,-0.0991311980837852,2.09299878371109e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,29511,0.0441256996446646,0.00259953672732698,0.0390306076591037,0.0492207916302255,2.56640179117659e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0339855646267186,0.00200532333595723,-0.0379159983651948,-0.0300551308882424,4.00997258764213e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,24905,0.0410426620944383,0.00242164775735642,0.0362962324900197,0.0457890916988569,4.53924293272177e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,29487,-0.0375246374926538,0.00221674007737693,-0.0418694480443125,-0.033179826940995,5.62982292330366e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0476076641105623,0.00281612775198713,-0.0531272745044571,-0.0420880537166675,8.22610697380887e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0804063176990945,0.00475769706510782,-0.0897314039467058,-0.0710812314514831,8.97427030369219e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,29725,-0.0314405371687229,0.00186423843795195,-0.0350944445071087,-0.0277866298303371,1.6063919811736e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.0445883199739963,0.00265177647415419,-0.0497858018633385,-0.0393908380846541,3.77036237000553e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,29218,0.0303268891132185,0.00180672013033244,0.0267857176577669,0.0338680605686701,6.13994114655565e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0495725772593524,0.00295422091008735,-0.0553628502431236,-0.0437823042755812,6.64382205858229e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0799772887970938,0.00477244874256251,-0.0893312883325164,-0.0706232892616713,9.62500653976164e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0677271407584495,0.00404698634232925,-0.0756592339894148,-0.0597950475274842,1.40692630015578e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,29474,0.0253726474472714,0.00152592075037561,0.0223818427765352,0.0283634521180076,8.39735857508681e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0416063647623011,0.00251300597087644,-0.0465318564652189,-0.0366808730593833,2.7658663174942e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0494362129206313,0.00299029749313674,-0.0552971960071794,-0.0435752298340833,4.05761866888127e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.0418600538188325,0.00253670716464604,-0.0468319998615387,-0.0368881077761262,6.74623835266535e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0304923524514159,0.00184839664688153,-0.0341152098793037,-0.0268694950235281,7.27547977282164e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0276926794316267,0.00168079413094373,0.024398322934977,0.0309870359282764,1.01964985034309e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,29820,-0.0702467391496658,0.00426553003711667,-0.0786071780224144,-0.0618863002769171,1.14656264553143e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0605779191150286,0.00367936939487724,0.0533663551010692,0.067789483128988,1.23899547173953e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0315546974939224,0.00191953131216206,-0.0353169788657601,-0.0277924161220848,2.11861608518444e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.0573269176223233,0.00349020388731897,-0.0641677172414685,-0.0504861180031781,2.34664802113829e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0306306632685528,0.00186663267747814,0.0269720632206956,0.0342892633164099,3.03226098107517e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0502895527217281,0.00306979385065763,0.0442727567744391,0.056306348669017,4.72576132483069e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.040945639304114,0.00250063311999056,0.0360443983889326,0.0458468802192955,5.38784657287101e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0461979249937237,0.0028226729968332,0.0406654859199306,0.0517303640675168,6.08515506725764e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,29786,-0.0397752257895618,0.00243167845965172,-0.0445413155704791,-0.0350091360086444,7.06724196842695e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0313558036077527,0.00191827092819631,-0.0351156146270174,-0.0275959925884879,9.68421384021624e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.073031363641769,0.00447312861363662,-0.0817986957244967,-0.0642640315590412,1.16714096759049e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0680665334398709,0.00417728430292032,-0.0762540106735948,-0.0598790562061471,1.97261515989236e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,29786,-0.0517053468769057,0.00318137950054297,-0.0579408506979699,-0.0454698430558415,3.85674732425677e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.0931962708604763,0.00574067746074017,-0.104447998683527,-0.0819445430374256,5.78944624604386e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.0273443643648858,0.00168540886629263,0.0240409629869522,0.0306477657428193,6.14723857137851e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0699971247336222,0.00431488474383302,-0.0784542988315349,-0.0615399506357095,6.33056019786359e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.0937098897472055,0.0057917756732071,-0.105061770066691,-0.0823580094277196,1.27059480901773e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,24922,-0.0300844800011934,0.00185884960288594,-0.0337278252228498,-0.026441134779537,1.29302672631866e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0497526604784544,0.00309331849035085,-0.0558155647195421,-0.0436897562373668,5.85775439618622e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,29435,-0.0379600702523651,0.00236690391890133,-0.0425992019334117,-0.0333209385713185,1.22086797936573e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0749361649565932,0.00467730210278121,-0.0841036770780444,-0.065768652835142,1.58383020758142e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,28774,-0.0579075904623213,0.00361616142536531,-0.0649952668560373,-0.0508199140686053,1.82211602915288e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0525086473687183,0.00327940305236976,-0.058936277351363,-0.0460810173860736,1.85442199027865e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0563591323954124,0.00352457013307969,-0.0632672898562486,-0.0494509749345762,2.6050704894014e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,29701,-0.0267839336476466,0.00167535497854509,-0.0300676294055949,-0.0235002378896982,2.73121141736237e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0473799626885289,0.00296975869493368,0.0415592356464589,0.0532006897305989,4.61727771648779e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,29725,-0.0620313067585463,0.00389368671791128,-0.0696629327256524,-0.0543996807914402,6.62053185627377e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0604333443952063,0.00381020581250927,-0.0679013477877245,-0.0529653410026881,2.02563366277717e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.040207245514449,0.00254086638414311,-0.0451873436273695,-0.0352271474015285,3.63607726502566e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,29478,0.0344460828724223,0.00218161193718341,0.0301701234755428,0.0387220422693018,6.25623268748044e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0286135240981278,0.00181440968347839,-0.0321697670777454,-0.0250572811185101,8.47549981860408e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0602508613209462,0.00382223551026654,-0.0677424429210686,-0.0527592797208238,9.3651245661811e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0523286751196638,0.00332434041600005,-0.0588443823350239,-0.0458129679043037,1.46885787759656e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.030634369416025,0.00195226825033094,-0.0344608151866737,-0.0268079236453764,2.88918129958732e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,29349,-0.0768278354852357,0.0048980220638324,-0.0864279587303472,-0.0672277122401242,3.18878009899554e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,29293,-0.0781705259181044,0.00498787738858218,-0.0879467655997255,-0.0683942862364834,3.93332090893067e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.0854564555483242,0.00545511053143686,-0.0961484721899405,-0.074764438906708,4.36303396072592e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0332226492841213,0.00212369537872001,0.0290602063418301,0.0373850922264125,6.08407178531392e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,24557,-0.0262494666297086,0.00167943599795338,-0.0295411611856972,-0.02295777207372,8.36994279815111e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.054694229031636,0.00350574554377551,-0.061565490297436,-0.047822967765836,1.17374676567992e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,29725,0.0504272582139962,0.00323920110841414,0.0440784240415045,0.0567760923864879,1.97747463167857e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.074010061503588,0.0047582910911043,-0.0833363120421524,-0.0646838109650235,2.4916348667407e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,29694,-0.0404026524120028,0.00259882751915618,-0.045496354349549,-0.0353089504744567,2.75274163663849e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,29218,-0.0965558032733325,0.00621400695980588,-0.108735256914552,-0.084376349632113,3.14451532636748e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,24938,-0.123220643988553,0.00792931569597187,-0.138762102752658,-0.107679185224448,3.3478043354831e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,24194,-0.0301456005391792,0.00194020061928989,-0.0339483937529874,-0.026342807325371,3.54367272242512e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,24828,-0.0335740791743487,0.00216556946147942,-0.0378185953188483,-0.029329563029849,5.87827284354586e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.105912799606681,0.00683456935365019,-0.119308555539835,-0.0925170436735265,5.98437413655633e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.123636614306123,0.0079847774466354,-0.139286778101528,-0.107986450510717,7.26745832072466e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,29443,0.031092727294126,0.0020119928052569,0.0271492213958225,0.0350362331924295,1.15809629052023e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.106105342306703,0.00687717735900925,-0.119584609930361,-0.0926260746830451,1.86314348543342e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0443830667843158,0.00288066505660247,-0.0500291702952567,-0.038736963273375,2.36734691721087e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.0794800618149248,0.005165903315439,-0.0896052323131852,-0.0693548913166644,3.31269975587105e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0367967319732031,0.00239320536411993,0.032106049459528,0.0414874144868782,3.83042214613237e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0707038353120105,0.00460251496405339,-0.0797247646415551,-0.0616829059824658,4.73188277886227e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,24229,-0.0902671481060181,0.0058806687717874,-0.101793258898721,-0.0787410373133148,6.30833696524207e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.0386391506080264,0.00252126591786109,-0.0435808318070341,-0.0336974694090186,8.30377765737784e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,24240,-0.0648849846668437,0.004244675288497,-0.0732045482322979,-0.0565654211013896,1.66201724290767e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0928595202744411,0.0060765973812592,-0.104769651141709,-0.0809493894071731,1.76109928500764e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.13197182590469,0.00866118812370566,-0.148947754627153,-0.114995897182227,3.50081429830617e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,24240,-0.0645589225304545,0.0042398658915852,-0.0728690596779615,-0.0562487853829475,4.10397834021631e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0258669620531946,0.00170330066159841,0.0225284927564618,0.0292054313499275,6.83498048168831e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0305631892576685,0.00201403704026516,-0.0345107018565882,-0.0266156766587488,8.12610471668621e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.13222864964616,0.00871390639746081,-0.149307906185183,-0.115149393107137,8.21795288032194e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.084943511789137,0.00559992667688551,-0.0959193680758326,-0.0739676555024414,9.85996936306615e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.111514010396388,0.00735857471002119,-0.125936816828029,-0.097091203964746,1.11493840624741e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.0968226798022809,0.00640723581289589,-0.109380861995557,-0.084264497609005,2.11889193788385e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.116560576531528,0.00773040579491828,-0.131712171889568,-0.101408981173488,3.53592071266765e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.046192394317313,0.00306666032553385,-0.0522030485553593,-0.0401817400792666,4.42056138460392e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,24966,-0.0211162029614175,0.00140167271961967,-0.023863481491872,-0.0183689244309629,4.61655496305845e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0682114044280045,0.0045536534038629,-0.0771365650995758,-0.0592862437564332,1.52974841166202e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0711761718959497,0.0047540023433209,-0.0804940164888586,-0.0618583273030407,1.72407440496551e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,29566,-0.0437547261606515,0.00292301366564499,-0.0494838329453157,-0.0380256193759873,1.7918973299178e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.0730444132877245,0.00487849156339845,-0.0826062567519854,-0.0634825698234635,1.84003144449202e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,24381,-0.0482837888479987,0.00322549147310484,-0.0546057521352842,-0.0419618255607132,1.94963050439369e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0558358252167657,0.00373311124077542,-0.0631527232486856,-0.0485189271848459,2.15114648788061e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0593135524938822,0.003975522086349,-0.0671055757831262,-0.0515215292046381,4.04144176537726e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0407919778064021,0.00273578356388528,-0.0461541135916172,-0.0354298420211869,4.29052466564587e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.0288794534736841,0.00193710915615021,-0.0326761874197385,-0.0250827195276297,4.78073364519231e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.0700653280048472,0.00470249448567863,-0.0792822171967773,-0.0608484388129171,5.02050695959261e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,29443,0.030440928716832,0.00204318636364105,0.0264362834440955,0.0344455739895685,5.1117100755063e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,29652,-0.0389507245470946,0.00261493750937718,-0.0440760020654739,-0.0338254470287154,5.35128420591578e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,24381,-0.0668605755462144,0.00448721197409332,-0.0756555110154373,-0.0580656400769915,5.45273695225933e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0287192325061342,0.00193179688791102,0.0249329106058286,0.0325055544064399,8.23262631163087e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0326377829889023,0.0021959444757784,0.0283337318163766,0.0369418341614279,9.21533048599092e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.0352441306320748,0.00238111636296213,-0.0399111187034806,-0.030577142560669,2.15521944084932e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,28916,-0.0557053827597148,0.00376425859795364,-0.063083329611704,-0.0483274359077257,2.27175559179204e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0465452586072753,0.00314553011155381,-0.0527104976259207,-0.0403800195886298,2.50632909701206e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.0331724160109963,0.00224269809076606,-0.0375681042688977,-0.0287767277530948,2.51093658635564e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,29400,-0.095220196087363,0.00644425982514655,-0.10785094534465,-0.0825894468300757,3.14531477790771e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.0372894746038213,0.00253550182083138,-0.0422590581726508,-0.0323198910349918,8.66771858996923e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,29434,-0.0916785170198841,0.00624580345268374,-0.103920291787144,-0.079436742252624,1.31723696361006e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0776729587914409,0.00530895869274068,-0.0880785178292126,-0.0672673997536692,2.63959644572504e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0327637431331854,0.00224025542937414,-0.0371546437747587,-0.0283728424916121,3.10056653636615e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.112225269817472,0.00768253697831301,-0.127283042294966,-0.0971674973399788,3.96766381963168e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0312643747632688,0.00214367126927514,-0.0354659704510481,-0.0270627790754896,5.19635628553169e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0290904288470545,0.00199498955242436,-0.0330006083698062,-0.0251802493243027,5.4173154156626e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0357996513524684,0.0024589186724436,-0.0406191319504578,-0.0309801707544789,7.46540689654159e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.0638375992299408,0.00439394171069271,-0.0724497249828985,-0.0552254734769831,1.27054145166005e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.063667186679534,0.00440454583191868,-0.0723000965100946,-0.0550342768489734,3.62929215423788e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00901355962583395,0.000624759017264146,0.00778903195199622,0.0102380872996717,5.02559676188224e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,24922,-0.0356703839249224,0.00247274152039592,-0.0405169573048984,-0.0308238105449464,5.53826486274067e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,28916,0.0236779037069357,0.0016481038432541,0.0204476201741576,0.0269081872397137,1.21156164467222e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0742158158027152,0.00516859288093538,-0.0843462578493485,-0.0640853737560819,1.34525308875253e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0203948229001972,0.00142112258019543,-0.0231802231573803,-0.0176094226430142,1.50528425671779e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.0860749289967433,0.00600798597669044,-0.0978505815110566,-0.0742992764824301,2.30477918500428e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.0848724898829557,0.00593815463992625,-0.0965112729772111,-0.0732337067887002,3.47229152485759e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0511652371010334,0.00358092247651327,-0.0581838451549994,-0.0441466290470674,3.72531090963264e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0703721770244401,0.00492860934043552,-0.0800322513316937,-0.0607121027171865,4.28758128496571e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,29566,0.0402221978890746,0.00281742418289402,0.0347000464906023,0.0457443492875468,4.38207283739354e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0286386828806882,0.00200669898538337,0.0247055528693368,0.0325718128920396,4.69183646496938e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0280481345180382,0.00196564090410723,-0.0319007906900884,-0.0241954783459881,4.89027551514358e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0318600990047163,0.0022340171905002,-0.0362387726980967,-0.0274814253113359,5.46973794720477e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0265594505198433,0.00186410812922556,-0.0302131024531254,-0.0229057985865612,6.56734381948869e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0406461963408598,0.00285338466461162,-0.0462388302834986,-0.0350535623982211,6.84255934501242e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0565331869973885,0.00401027921468668,-0.0643933342581744,-0.0486730397366026,5.54754690602087e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,29453,-0.0315739731026337,0.00223996168840548,-0.0359642980119084,-0.0271836481933589,5.649155915786e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0515076650809385,0.00365963726352899,-0.0586805541174554,-0.0443347760444217,7.63545251203788e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.0904650954046476,0.00642720900487648,-0.103062425054206,-0.0778677657550897,8.00026483744677e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.0338472857205524,0.00240732878792136,0.0291289212962265,0.0385656501448783,9.32503158940443e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.0837218987577767,0.00595723672804396,-0.0953980827447429,-0.0720457147708105,1.09379087741447e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0589208052559192,0.0041951676152571,-0.0671433337818231,-0.0506982767300152,1.22756888081802e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0315787439910377,0.00225259903697395,-0.0359938381035066,-0.0271636498785688,1.78523978811187e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0194498478996224,0.00138976894749054,0.0167259007625409,0.0221737950367039,2.3225731634952e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.0628320031700958,0.00449008724632813,-0.0716325741728989,-0.0540314321672927,2.38768934786003e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,29443,0.0253587147504524,0.00181425652734384,0.0218027719568585,0.0289146575440464,2.96462328763778e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.105070183141125,0.00752351720586929,-0.119816276864628,-0.0903240894176207,3.71833045516016e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.0324575606609102,0.00232433524552232,0.0279018635796864,0.0370132577421339,3.78026990845752e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0318507808756072,0.00228333196722566,0.0273754502198449,0.0363261115313695,4.70861096566707e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0399682441339588,0.00286652838553409,-0.0455866397696057,-0.034349848498312,4.78052261327035e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,24381,0.0509152391153187,0.003655901992653,0.0437496712097189,0.0580808070209186,6.41217662401479e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0547306175416187,0.00393213824889358,-0.0624376085094501,-0.0470236265737873,6.71293272757291e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,24938,-0.0731931844114933,0.00527001202456241,-0.0835224079796356,-0.062863960843351,1.08054757315891e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0258275257099995,0.00186230211534126,0.0221774135639306,0.0294776378560684,1.42555073255528e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.0445805946382208,0.00321843211231123,0.0382724676980908,0.0508887215783508,1.69839870991053e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0562878717896108,0.00406696299787121,-0.0642591192654384,-0.0483166243137833,1.98967162030616e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.0844689527495966,0.00610399378560289,-0.0964327805693782,-0.0725051249298149,2.04708939108185e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.0867487831425665,0.00627393496244967,-0.0990456956689678,-0.0744518706161651,2.40597747718219e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0724629838142927,0.00523974524321329,-0.0827328844909908,-0.0621930831375947,2.47811392144901e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0563000403896688,0.00407793975231878,-0.0642928023042136,-0.048307278475124,3.38603437960557e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,29694,-0.0420776965493029,0.00305041740035708,-0.0480565146540028,-0.036098878444603,3.76028374538692e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0674420723000704,0.00488847270411186,-0.0770234788001296,-0.0578606658000111,3.91493833289351e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0577324068473825,0.00419142133840106,-0.0659475926706486,-0.0495172210241164,5.2683627721109e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0481500438137618,0.00350647067225583,-0.0550227263313832,-0.0412773612961404,8.87758216651301e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0358008086544709,0.002621897624545,-0.0409397279985791,-0.0306618893103627,2.69350234632871e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,29478,-0.0338848458633364,0.0024876255016327,-0.0387605918465365,-0.0290090998801363,4.01120300416824e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0683341446087034,0.0050188024333678,-0.0781709973781043,-0.0584972918393026,4.36674402736635e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,24922,-0.0655455424127354,0.00481999688222878,-0.0749927363019038,-0.056098348523567,5.75923628577383e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,24919,-0.0537287447368653,0.00395153973922818,-0.0614737626257526,-0.0459837268479781,5.89831231825132e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,29349,-0.0499056318735206,0.0036740638091221,-0.0571067969393999,-0.0427044668076413,6.74390235314488e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,28797,-0.0598439872332432,0.00442633625407938,-0.0685196062912388,-0.0511683681752476,1.59649940091459e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0272163509786163,0.00201359871711582,0.0232696974930693,0.0311630044641633,1.76919706832905e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0380218163823821,0.00281830482615576,-0.0435456938416474,-0.0324979389231168,2.47054698935141e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0262121358071101,0.00194544737687896,-0.0300252126657929,-0.0223990589484274,2.96616288869257e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0769883605708706,0.00572511102547619,-0.0882095781808039,-0.0657671429609372,4.43835944414399e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,29372,0.0596708807771102,0.00444047614813189,0.0509675475267717,0.0683742140274488,4.79250853470576e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0413482112793042,0.00308092052396559,0.0353096070523316,0.0473868155062768,6.03394991816573e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.0999377316289232,0.00744954976465328,-0.114538849167644,-0.0853366140902028,6.49298925755539e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.0916216377474813,0.00684238566488581,-0.105032713650657,-0.0782105618443051,9.07142360796145e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.0900968571250147,0.00673183012093294,-0.103291244162043,-0.0769024700879861,9.8847555727133e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0343255143937481,0.00256816327004721,-0.0393591144030406,-0.0292919143844555,1.25902996502193e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,-0.0209382782602205,0.00156715155387296,-0.0240098953058115,-0.0178666612146295,1.41453937451369e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0858108136605981,0.00643260033741035,-0.0984187103219224,-0.0732029169992738,1.77657812495189e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,24793,-0.0931160881598509,0.0069873147120931,-0.106811224995553,-0.0794209513241485,2.23771439420005e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,24381,-0.0490908312168068,0.00368558889727773,-0.0563145854554711,-0.0418670769781424,2.46202872079087e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.0709148124734818,0.00532994112791255,-0.0813614970841904,-0.0604681278627732,2.99246283231047e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,29639,-0.0540028170024467,0.00406108616068699,-0.0619625458773932,-0.0460430881275002,3.11667329081411e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,29786,-0.0385857368004223,0.00290241000684688,-0.0442744604138422,-0.0328970131870024,3.25003047431021e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,28424,-0.0856748128718141,0.00644851398748351,-0.0983139002872817,-0.0730357254563464,3.67979601773172e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0393307559116453,0.00296148625394189,-0.0451352689693714,-0.0335262428539192,3.90167551277267e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0470013965400055,0.00353992759531887,-0.0539396546268305,-0.0400631384531806,4.07935895557414e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0461042288501485,0.00347537468640051,-0.0529159632354935,-0.0392924944648035,4.78139103097365e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,24229,-0.0869352238463977,0.00655626396796326,-0.0997855012236057,-0.0740849464691897,5.45420523122754e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0363683264189393,0.00274424012688739,-0.0417470370676385,-0.03098961577024,6.00490115706387e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0565973292432819,0.00427382713319804,-0.0649740304243501,-0.0482206280622137,6.50177478981117e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0227885496461457,0.00172092369585033,-0.0261615600900124,-0.019415539202279,6.84162085835442e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0367432697115254,0.0027765539320936,0.031301224004622,0.0421853154184289,7.35061090897167e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.0697555688326564,0.005287148431776,-0.0801183797589373,-0.0593927579063754,1.30037710179854e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.0788249166777033,0.00597983275510945,-0.0905453888777178,-0.0671044444776887,1.45303950063008e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,29434,-0.0559064226337971,0.00424973901938443,-0.0642359111117905,-0.0475769341558036,2.0513700905288e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,29163,-0.0572997470127758,0.00436351604282904,-0.0658522384567208,-0.0487472555688309,2.80779276816861e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,28931,-0.0437409027579764,0.00333313807107551,-0.0502738533772844,-0.0372079521386685,3.14621606586779e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0198037546439683,0.00150928448938362,0.0168455570447764,0.0227619522431602,3.21983172885859e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,24528,-0.0258998874932205,0.00197859383427203,-0.0297779314083936,-0.0220218435780473,5.07466461360432e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.0483709579950531,0.00369908356976345,0.0411207541983167,0.0556211617917894,5.76495439469649e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,28765,-0.0363243136244835,0.00277920092557909,-0.0417715474386185,-0.0308770798103485,6.3056100351741e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,29566,-0.0522407256531088,0.00400167931966304,-0.0600840171196484,-0.0443974341865693,7.65321428513106e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,28795,-0.0456450555315186,0.00349769222677786,-0.0525005322960032,-0.038789578767034,8.18611548778959e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.063607874688055,0.00487691877206145,-0.0731666354812955,-0.0540491138948146,9.38639802005276e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.0664948302266198,0.00510029892687886,-0.0764914161233023,-0.0564982443299372,9.58118901520768e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0469623913638465,0.00360120218614696,-0.0540207476486946,-0.0399040350789985,9.62389443500356e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0639073760791577,0.00491008038669251,-0.073531133637075,-0.0542836185212404,1.34533957495827e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0472699780498898,0.00363289963077411,-0.0543904613262071,-0.0401494947735726,1.35055611962335e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0520076617117645,0.003998192460065,-0.0598441189334919,-0.0441712044900371,1.41983687837897e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0444013325630759,0.00342414475348492,-0.0511126562799063,-0.0376900088462455,2.40471862827714e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.055801831498354,0.00430496066324594,-0.0642395543983161,-0.047364108598392,2.55205288807881e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0423951325045627,0.00327405075224347,-0.0488122719789599,-0.0359779930301655,3.03366534318003e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0773980618413615,0.005977061817902,-0.0891131030044494,-0.0656830206782735,3.03811503695476e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,29065,0.0250373028602668,0.00193660882351143,0.0212415495661844,0.0288330561543492,3.96450973372752e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0457022709279355,0.00353938673463685,-0.0526394689278238,-0.0387650729280473,5.11631069300223e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0723681242959098,0.00560960675568061,-0.0833629535370438,-0.0613732950547758,5.90350803165196e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0510529237862615,0.00395904011887337,-0.0588126424192533,-0.0432932051532697,6.06453360852484e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0359222477346098,0.00278642825449816,0.0304608483557934,0.0413836471134263,6.33671942878862e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,28774,-0.0556000006767402,0.00432001166800451,-0.064067223546029,-0.0471327778074513,8.40864896534778e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0462755349552311,0.00360842818104707,-0.0533480541900833,-0.0392030157203788,1.51017128824497e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.0294944595952305,0.00230405382110666,-0.0340104050845995,-0.0249785141058614,2.03219795105394e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.0329583234175472,0.0025745939294381,-0.0380045275192458,-0.0279121193158485,2.13298501540566e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0401215217312091,0.00313464083108677,-0.0462654177601391,-0.033977625702279,2.17059627373752e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0302564828356018,0.00236971464965069,0.0256118421222864,0.0349011235489171,3.11307172468894e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0342328699054585,0.00268519978637952,-0.0394958614867624,-0.0289698783241547,3.98068081800569e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.0691119050391799,0.00542116889944079,-0.0797373960820838,-0.0584864139962759,3.98280466227653e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0746284223629911,0.00585312399302023,-0.0861005453893108,-0.0631562993366715,4.08730447825106e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0649216015499128,0.00509826636015334,-0.0749142036158134,-0.0549289994840123,4.79438677597413e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,29786,-0.0336301968009001,0.00264627546001754,-0.0388168967025345,-0.0284434968992657,6.61551441774612e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0730267467512945,0.00574680193359954,-0.0842904785411496,-0.0617630149614394,6.71538748501963e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.0711431765427153,0.00560359930923667,-0.0821262311888192,-0.0601601218966114,8.10725577388788e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0763788993697703,0.00602965082441417,-0.0881970149856221,-0.0645607837539185,1.12032834075858e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0511904586864665,0.00404430206738756,-0.0591172907385461,-0.0432636266343869,1.27036191663992e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0501570123208902,0.00396504451097804,-0.0579284995624071,-0.0423855250793732,1.39299057907833e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.020766136744213,0.00164131604260925,-0.0239831161877271,-0.0175491573006989,1.41096644354944e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,29478,-0.0962527047758972,0.00761124710538508,-0.111170749102452,-0.0813346604493424,1.46313124987521e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0603388528646164,0.00477546138051809,-0.0696987571704319,-0.0509789485588009,1.67821677310405e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,29434,-0.0843059731771186,0.00667935257315956,-0.0973975042205113,-0.0712144421337259,1.98843018853331e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,29443,-0.0331608355016299,0.00263047490596094,-0.0383165663173134,-0.0280051046859465,2.41716717942916e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,29169,-0.0454262325282148,0.00360478292154202,-0.0524916070544372,-0.0383608580019925,2.57165242641823e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.0967496000244694,0.00768522572655442,-0.111812642448516,-0.0816865576004227,3.13412809326666e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,24938,-0.0223888881768301,0.00178299785823938,-0.0258835639789792,-0.0188942123746809,4.68621213580841e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0254676904924162,0.00203306578919397,-0.0294524994392364,-0.021482881545596,6.87749073217907e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,28797,-0.0653268730205911,0.00522335846332184,-0.0755646556087019,-0.0550890904324803,8.50482359837848e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,24867,-0.0466466242792514,0.00373119282642174,-0.053959762219038,-0.0393334863394648,9.35051991017803e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,28797,-0.0413697987084502,0.00331039629898098,-0.047858175454453,-0.0348814219624475,9.60808018811844e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,24229,-0.040415380853108,0.00323751297331616,-0.0467609062808076,-0.0340698554254083,1.18336623096095e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0346091593160819,0.00277495975177987,-0.0400480804295705,-0.0291702382025934,1.30335499459151e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,29030,-0.0372623167370011,0.00299072612377667,-0.0431241399396033,-0.0314004935343988,1.53495528262718e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0676145901346227,0.00542587503790213,-0.0782493052089109,-0.0569798750603346,1.54532746782734e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0178976334336069,0.0014401394484563,-0.0207203067525812,-0.0150749601146325,2.26358460867345e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,23389,-0.0214197340338103,0.00172365219704848,-0.0247980923400253,-0.0180413757275953,2.41372194891003e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0720353627506559,0.00581595322402072,-0.0834346310697365,-0.0606360944315753,3.81297054606391e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0285895191687439,0.00230799149827156,0.0240658558321316,0.0331131825053561,3.8916623209549e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0129297060094426,0.0010447785589016,0.0108819400339955,0.0149774719848897,4.49673900795794e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0590509242885509,0.00477141369322182,-0.0684028951272657,-0.0496989534498362,4.50672600037418e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,29434,-0.0252061322384052,0.00203993485202002,-0.0292044045483645,-0.021207859928446,5.49844573904301e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0556179694442116,0.0045012202043965,-0.0644403610448288,-0.0467955778435945,5.53256039715437e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0704543038925825,0.0057035903891329,-0.081633341055283,-0.0592752667298821,5.75726804955303e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.050188347975754,0.0040739598878601,-0.0581733093559598,-0.0422033865955482,8.71951655604913e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.053016653446139,0.00430629731287147,-0.061456996179367,-0.0445763107129109,9.61867693717722e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0516764334597381,0.00419849591959108,-0.0599054854621366,-0.0434473814573395,9.98288021338759e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0441050874174424,0.00358448788134936,-0.0511306836648871,-0.0370794911699976,1.04842537881758e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,28774,-0.055719908293084,0.00453700536082848,-0.0646124388003078,-0.0468273777858602,1.39533721593452e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.0844793157954101,0.00687850038012311,-0.0979611765404514,-0.0709974550503688,1.43190469542624e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0352493610014276,0.00287087453760914,-0.0408762750951415,-0.0296224469077137,1.43668543050043e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,29319,-0.0681364179448808,0.00555013418146736,-0.0790146809405568,-0.0572581549492048,1.47240377313564e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.0186301087999635,0.00151802610468559,0.0156547776347798,0.0216054399651473,1.59940116592813e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0690530006077062,0.00563052785057064,-0.0800888351948247,-0.0580171660205877,1.7886529450736e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0498892460215298,0.00407018988780946,-0.0578668182016364,-0.0419116738414233,1.87337619175496e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,29725,-0.0344973741835767,0.00281885676617654,-0.0400223334452828,-0.0289724149218707,2.35463960096502e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,29218,-0.0573936615152658,0.00469555745108165,-0.0665969541193858,-0.0481903689111457,2.84243756640189e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,29335,-0.0394903646451737,0.00323130402524262,-0.0458237205346492,-0.0331570087556982,2.90302116229834e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.0520101375004079,0.00426005590958959,-0.0603598470832035,-0.0436604279176123,3.37795228253514e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,23693,-0.0201707960466075,0.00165257321432514,-0.0234098395466848,-0.0169317525465303,3.67164957784221e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0783192391341184,0.00643239334117307,-0.0909267300828177,-0.0657117481854192,5.05392745363381e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0196968209165828,0.00161884864532907,-0.0228697642614278,-0.0165238775717378,5.61696128911414e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,24966,-0.0185295656222487,0.00152361872522254,-0.0215158583236849,-0.0155432729208125,6.21383421013146e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,29343,-0.0263623925217308,0.0021685813535538,-0.0306128119746962,-0.0221119730687654,6.39289167386646e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0505822662834772,0.00416582707635835,-0.0587472873531396,-0.0424172452138148,7.59358267241226e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.047438744184833,0.00391076514077185,-0.0551038438607458,-0.0397736445089201,8.78862099587236e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.025655148621006,0.00211645340298612,0.0215068999511532,0.0298033972908588,9.72572886533452e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.049251985032149,0.00406467135586487,-0.0572187408896442,-0.0412852291746539,1.03016636416133e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0619787795700498,0.00511667123189471,-0.0720074551845634,-0.0519501039555362,1.12653263269065e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.103207324696555,0.00852422334885839,-0.119914802460317,-0.0864998469327924,1.20572250594075e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0653055345349135,0.0053954646560016,-0.0758806452606766,-0.0547304238091503,1.21323208710643e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0234722336485353,0.00194015990814565,-0.0272749470685008,-0.0196695202285698,1.29800764513704e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.053923787042489,0.00445818496287801,-0.0626618295697299,-0.0451857445152481,1.34097407344513e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,29349,-0.0870434091481347,0.00720056401880353,-0.10115651462499,-0.0729303036712797,1.46155809123257e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.0812509046908271,0.00673872320758054,-0.094458802177685,-0.0680430072039693,2.13479613070718e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.0878548205830697,0.00728640408094163,-0.102136172581715,-0.0735734685844241,2.19963812531256e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,29218,-0.0448025622278015,0.00371981423403978,-0.0520933981265195,-0.0375117263290835,2.49321830040969e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,0.0254423696938651,0.00211195654532957,0.0213029348650191,0.029581804522711,2.49783728444668e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0876495881158335,0.00729009556895326,-0.101938175430982,-0.0733610008006851,3.21485541128657e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,28705,-0.0588323538524904,0.0048960186728152,-0.0684285504512082,-0.0492361572537726,3.50248952509627e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,29694,-0.0202574880254041,0.00168777561906488,-0.0235655282387712,-0.0169494478120369,4.11446364906344e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0165237051447081,0.00137890010846617,-0.0192263493573018,-0.0138210609321144,5.21886875758021e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.022753192060807,0.00190026349238574,-0.0264777085058831,-0.019028675615731,5.8171220162768e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,24445,-0.10862886453998,0.00907234675158712,-0.126410664173091,-0.0908470649068691,6.04087858224824e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,29478,-0.0572500401550735,0.00478329320928269,-0.0666252948452676,-0.0478747854648794,6.17704604274622e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,29786,-0.0792288764885063,0.00662279215743785,-0.0922095491170845,-0.0662482038599281,6.60100140608861e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.0947729098581327,0.00794785597491118,-0.110350707568959,-0.0791951121473068,1.08927914693662e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0351208730389247,0.00295060784866507,-0.0409040644223082,-0.0293376816555412,1.35493168660242e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,29443,-0.0373966983737119,0.00314741323599115,-0.0435656283162545,-0.0312277684311692,1.74792492248286e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0719451112754089,0.0060615902644922,-0.0838258281938136,-0.0600643943570042,2.03226180834919e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0951320400385042,0.00802840863639808,-0.110867720965844,-0.079396359111164,2.56657013704399e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0241262810175905,0.00203737492265918,0.0201330261691786,0.0281195358660025,2.80613366364138e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.0950369113563342,0.0080355861401955,-0.110786660191117,-0.079287162521551,3.45552672424607e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.0490150930985652,0.00414498450239116,-0.0571392627232518,-0.0408909234738785,3.53163610115924e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,24610,0.0902060444564085,0.00762877333728118,0.0752536487153373,0.10515844019748,3.56693633246692e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.0297375702316202,0.0025184898424837,0.0248013301403521,0.0346738103228882,4.20216283004811e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.0820125039707701,0.00695056988842688,-0.0956356209520868,-0.0683893869894535,4.63473330782193e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,29362,-0.0349991184400846,0.00296750247071776,-0.0408154232826914,-0.0291828135974778,4.94384488887303e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0443169947130768,0.00375805540293782,-0.0516827833028349,-0.0369512061233186,5.04232185205569e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,29566,-0.0443585767009613,0.00376894850496538,-0.0517457157706935,-0.0369714376312292,6.60685553471926e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0430052353992435,0.00365605127105229,-0.0501710958905059,-0.035839374907981,7.15371887744554e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0248350656576813,0.00211370412452607,-0.0289779257417524,-0.0206922055736102,8.36515421099401e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,24951,-0.0228190876556817,0.00194343724003966,-0.0266282246461594,-0.019009950665204,9.45484041104179e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0255746341816298,0.00217832618961195,-0.0298441535132692,-0.0213051148499904,9.63369595312498e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0596748101315154,0.00508543963542528,-0.069642271816949,-0.0497073484460819,1.02987632474656e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0206395741572323,0.00175991873168325,0.0171901334431332,0.0240890148713315,1.0808554077085e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0651587835396629,0.0055567515053334,-0.0760500164901164,-0.0542675505892095,1.10670282251847e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.0197141880221451,0.00168248068430107,0.016416525880915,0.0230118501633752,1.2211881447266e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,29566,-0.0329966233145692,0.0028208905238338,-0.0385255687412835,-0.027467677887855,1.54547907613581e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0249978168753681,0.00214070869069967,-0.0291936059091394,-0.0208020278415967,2.00874972729635e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0368913110047809,0.00316250286321073,-0.043089816616674,-0.0306928053928879,2.31558180557404e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0311899540954422,0.00268308132501255,-0.0364487934924668,-0.0259311146984176,3.60687185976086e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0359461992443648,0.00309789778869087,-0.0420180789101989,-0.0298743195785307,4.63256397988974e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0682838622919501,0.0058884130615184,-0.0798251518925261,-0.056742572691374,5.02601238444948e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,29443,0.0196172276155256,0.00169317768668107,0.0162985993496307,0.0229358558814205,5.66283797159688e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,24381,-0.0571924643007784,0.00494101570250974,-0.0668768550776974,-0.0475080735238593,6.64324758202091e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0430119570223018,0.00371610491159675,-0.0502955226490314,-0.0357283913955721,6.66298634942658e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0244324321205029,0.00211292842990128,-0.0285737718431094,-0.0202910923978964,7.58748725710763e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.023465338495634,0.00203182161431693,0.0194829681315728,0.0274477088596952,8.69412035430892e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0363539515485468,0.00315052138827095,-0.0425289734695579,-0.0301789296275358,9.75047431624367e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0605000236612164,0.0052553826025626,-0.0708005735622391,-0.0501994737601937,1.37859395674836e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0669595615907234,0.00583722479005436,-0.0784005221792299,-0.0555186010022169,2.13866492444359e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0212182378043124,0.00185040468839359,0.017591444615061,0.0248450309935638,2.30922299276587e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,24229,0.0244264526448447,0.00213516556194706,0.0202415281434285,0.028611377146261,3.15306764477832e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0508596882566121,0.0044473737670518,-0.0595765408400337,-0.0421428356731906,3.29330787175126e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0670357222934941,0.0058673452736288,-0.0785357190298066,-0.0555357255571817,3.72258244797262e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,29434,-0.0653647623312118,0.00573334070237998,-0.0766021101078765,-0.054127414554547,4.79014286988446e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0585306484811965,0.00514078852720767,-0.0686065939945235,-0.0484547029678695,5.88883213408764e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,24867,-0.0840401490897014,0.00738338906872153,-0.0985115916643956,-0.0695687065150072,6.07565423600335e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0281025523239146,0.0024743523740766,-0.0329522829771047,-0.0232528216707245,7.85029317239983e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0419636615948286,0.00369623998345869,-0.0492082919624076,-0.0347190312272496,8.51770103159029e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.0530398625156343,0.00467648088244225,-0.0622057650452211,-0.0438739599860475,9.38138645861856e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,29218,-0.0333568322164661,0.0029420123395574,-0.0391231764019986,-0.0275904880309336,9.80544704332757e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0136636486654194,0.00120522833339658,-0.0160258961988767,-0.0113014011319621,1.01757793459975e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0456281614768381,0.00402847311572461,-0.0535239687836584,-0.0377323541700179,1.12152272353097e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0243579751867676,0.00215250113171345,-0.0285768774049259,-0.0201390729686092,1.25606131843046e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0406355918882748,0.00359543780909513,-0.0476826499941013,-0.0335885337824483,1.47613074679836e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,24381,0.0170729104809059,0.00151102814624673,0.0141112953142623,0.0200345256475494,1.57427518405734e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0330027158670298,0.00292154464777426,-0.0387289433766674,-0.0272764883573923,1.62032227156789e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.059056110638458,0.00524315167141624,-0.0693326879144338,-0.0487795333624821,2.28293691896929e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0323343735047983,0.00287549641433741,-0.0379703464768996,-0.0266984005326969,2.88964992072443e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.0209732895736189,0.00186700375899384,0.017313962205991,0.0246326169412468,3.1962492339062e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0666362201001376,0.00593439029532173,-0.0782676250789682,-0.055004815121307,3.37673953079324e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.0499264790760286,0.0044462959257119,-0.058641219090424,-0.0412117390616333,3.46324609996288e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.0212821482124108,0.00189685176619794,-0.0249999776741587,-0.0175643187506628,3.73755007848442e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,29434,-0.030990040085541,0.00276248455635602,-0.0364045098159988,-0.0255755703550832,3.80542354670771e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0746017723409659,0.00665444653480629,-0.0876444875491862,-0.0615590571327456,4.13825944353289e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.108075502872222,0.00966314683083372,-0.127015270660656,-0.0891357350837882,5.57151574041843e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.110291251023149,0.00986074937989063,-0.129618319807735,-0.0909641822385637,5.67380057660763e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.037993498438662,0.00339759606387385,-0.0446527867238547,-0.0313342101534693,5.82971914600412e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0299662345306623,0.00268185252979764,0.0247098035722589,0.0352226654890657,6.28222305032426e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,29694,0.0235944870261839,0.00211429377764891,0.019450471221992,0.0277385028303757,7.34492533243053e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0474495871151974,0.0042561988305238,-0.0557917368230241,-0.0391074374073708,8.33327694715056e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,29163,-0.0628168257948628,0.00563581532637006,-0.0738630238345482,-0.0517706277551775,8.56430230545251e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0218619711824866,0.00196639519705235,-0.0257161057687092,-0.018007836596264,1.17281432193573e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.0676024385465981,0.00608657626710483,-0.0795321280301236,-0.0556727490630726,1.33024167310028e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0358888403477607,0.00323645917750094,-0.0422323003356626,-0.0295453803598589,1.61729120977459e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0455202022592397,0.00410567234828205,-0.0535673200618726,-0.0374730844566069,1.65476133711941e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.0358062607907617,0.00323049909576526,-0.0421380390184617,-0.0294744825630618,1.71300491332565e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,24922,-0.0361438576792657,0.00326223539230596,-0.0425378390481854,-0.029749876310346,1.83917496152833e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,29594,-0.0781283742567781,0.00706182123523027,-0.0919695438778294,-0.0642872046357268,2.1444420392962e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0286188505303009,0.00258940444696513,-0.0336940832463526,-0.0235436178142493,2.42995857156577e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0607857844677146,0.00550000886591338,-0.0715658018449048,-0.0500057670905244,2.49744131933659e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0518266437235617,0.00469035731724796,-0.0610197440653677,-0.0426335433817557,2.51026489463661e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0163537234494996,0.00148367187636253,0.0134457265718291,0.0192617203271702,3.4747224920787e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0364587989179433,0.00331251463055773,-0.0429513275938365,-0.0299662702420502,4.05118150055706e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0177557063066265,0.00161291918942347,-0.0209170279178965,-0.0145943846953565,4.05412696467861e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.0136454091140761,0.00124195208186295,0.0112111830336248,0.0160796351945275,5.00073526702913e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.051581933187701,0.00469741104397457,-0.0607888588338911,-0.0423750075415108,5.34704684709586e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0683180240040676,0.00622987373102921,-0.0805285765168849,-0.0561074714912504,6.43932893522583e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0634930532111556,0.00579129534491959,-0.074843992087198,-0.0521421143351132,6.62790328064466e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,29594,-0.0437153746246471,0.00399574159626977,-0.0515470281533359,-0.0358837210959583,8.34392045311689e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,29434,-0.0252054424561385,0.00230816704861109,-0.0297294498714162,-0.0206814350408608,1.04423938111991e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0655951323731853,0.00600702748707102,-0.0773689062478445,-0.0538213584985261,1.0485945600741e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,24381,-0.0238330147047959,0.00218221857900134,-0.0281101631196385,-0.0195558662899533,1.05531020505884e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.032475728802682,0.00297473196105112,-0.0383062034463422,-0.0266452541590218,1.07813598118266e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,29478,-0.0326591607161704,0.00299686324334781,-0.0385330126731321,-0.0267853087592087,1.33340194221915e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.060024293502182,0.00550912440926951,-0.0708221773443503,-0.0492264096600138,1.40314857621526e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.050363076550516,0.00462857906434998,0.0412910615843901,0.059435091516642,1.60470839892628e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,29531,0.0214621489319522,0.00197731485785332,0.0175866118105597,0.0253376860533447,2.14612373577479e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0293525023375502,0.00270549169057992,-0.0346552660510868,-0.0240497386240136,2.27420867592013e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0652517373725505,0.00601518484518738,-0.0770414996691177,-0.0534619750759832,2.35256494798386e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0286557181473758,0.00264316644254557,-0.0338363243747651,-0.0234751119199864,2.46700211149383e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0209810345817818,0.00193616643835992,-0.0247759208009672,-0.0171861483625963,2.60823321112246e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.0724363515986357,0.00668564854726034,-0.085540222751266,-0.0593324804460055,2.65605207016125e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0585446355739323,0.00540245496359759,-0.0691334473025836,-0.047955823845281,2.65641409675681e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,24966,-0.0237771861770767,0.00219448009829415,-0.0280783671697333,-0.0194760051844202,2.70280060853792e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,24966,0.017741451400842,0.00163756861830735,0.0145318169089596,0.0209510858927244,2.73167610212597e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.082422703521606,0.00760908475961286,-0.0973365096504472,-0.0675088973927647,2.78985919158279e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,24805,-0.0795650302508063,0.00734659148351261,-0.093964349558491,-0.0651657109431216,2.8501985216188e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.049694823909928,0.00458927330142965,-0.0586897995807301,-0.0406998482391259,2.91091708043299e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0151459408698678,0.00140020558610875,-0.0178903438186409,-0.0124015379210946,3.22052159100861e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,0.0343695756261813,0.00317987374730838,0.0281370230814568,0.0406021281709057,3.52893203287319e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,24240,-0.0307319118796484,0.00284372698945627,-0.0363056167789827,-0.0251582069803141,3.68194984476819e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,29455,-0.0385792066702615,0.00357503654477746,-0.0455862782980253,-0.0315721350424977,4.25397644345039e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0554923590561704,0.00514166964795878,-0.0655700315661697,-0.0454146865461712,4.27984635862222e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,29349,0.0342327106009245,0.00318178485619797,0.0279964122827765,0.0404690089190726,6.03756715952123e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0321583733976155,0.00299100355617938,-0.0380207403677271,-0.026296006427504,6.52429375285707e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0384471140129035,0.00357777070670658,-0.0454595445980484,-0.0314346834277586,7.10142103719427e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.0408982488567404,0.00380766931790202,-0.0483612807198284,-0.0334352169936525,7.32866341112391e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,29581,-0.035772885408603,0.00333443777628901,-0.0423083834501295,-0.0292373873670766,8.39754772042946e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,23907,-0.0538071171620177,0.00501531884852963,-0.0636371421051358,-0.0439770922188996,8.6040354036534e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0570548527273148,0.00532322414168932,-0.0674883720450259,-0.0466213334096037,9.38407545523038e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,29349,-0.0230001109346122,0.00215016941640118,-0.0272144429907585,-0.0187857788784659,1.17878763295351e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0300563805311874,0.00281452984720139,-0.0355728590317021,-0.0245399020306727,1.43637044932797e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,29478,-0.0428490639563497,0.00401373980806662,-0.0507159939801603,-0.0349821339325391,1.48074556381929e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0418312753401242,0.00392180349594263,-0.0495180101921718,-0.0341445404880767,1.63960047648516e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0324185122935479,0.00303981467217462,-0.0383765490510102,-0.0264604755360857,1.70709552057852e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0285585753267755,0.00267965488106711,-0.033810698893667,-0.023306451759884,1.79466954510893e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,29694,-0.0453953170473649,0.00426166293350478,-0.0537481763970342,-0.0370424576976955,1.90475208784389e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,24966,0.022854132301083,0.00214568505902656,0.018648589585391,0.0270596750167751,1.9617817896729e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0457488753693435,0.00429644273431054,-0.0541699031285922,-0.0373278476100949,1.99027840113044e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0211641462447206,0.00198951295714461,-0.0250635916407241,-0.0172647008487172,2.21656424779224e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,24565,-0.0822401874301335,0.00773107385470329,-0.097393092185352,-0.0670872826749151,2.27329349300901e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0367395684157895,0.00345865172090635,-0.0435185257887659,-0.029960611042813,2.61019202697457e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,29536,-0.0431304165465673,0.0040610103009181,-0.0510899967363668,-0.0351708363567678,2.66608738558302e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0345689270436519,0.00325568838016589,0.0281877778185267,0.040950076268777,2.7493586563564e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0517872335730298,0.00488037310186758,-0.0613527648526902,-0.0422217022933693,2.95041212176911e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0174803707063877,0.00164853195714101,-0.0207114933423841,-0.0142492480703914,3.19757888139757e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,28750,0.0893814086364461,0.00843314905160454,0.0728524364953012,0.105910380777591,3.37346956520155e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0303909706513977,0.00286737799335409,-0.0360110315183717,-0.0247709097844236,3.43096783502371e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0320374701537509,0.00302487218223379,-0.0379662196309291,-0.0261087206765726,3.72603130438066e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0557911188269774,0.00526791778398443,-0.0661162376835869,-0.045465999970368,3.73974836406648e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,29454,-0.0196115168553872,0.00185588221928643,-0.0232490460051886,-0.0159739877055858,4.70831914950126e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0415373955303347,0.00393208918159494,-0.0492442903262607,-0.0338305007344086,4.89981993471325e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0294025281572441,0.00278877998017833,-0.0348685369183936,-0.0239365193960946,6.07835864706862e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0286625295297067,0.00272196797768299,-0.0339975867659654,-0.0233274722934481,6.99643148451097e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0431146442537688,0.00410102469872656,-0.0511526526632729,-0.0350766358442648,8.53438260609016e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0495549610889232,0.0047200038618827,-0.0588061686582133,-0.0403037535196331,9.7262063212415e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0246033126136416,0.00234335654455921,-0.0291962914409776,-0.0200103337863055,9.91703644155019e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0667821980071952,0.00636849126786253,-0.0792644408922057,-0.0542999551221846,1.12945169960947e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.0471014301515562,0.00449195454472543,-0.055905661059218,-0.0382971992438944,1.13634141229189e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,24793,-0.0157133684585386,0.00149987525876596,-0.0186531239657199,-0.0127736129513573,1.25378904918721e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0317026755527775,0.00303213620093597,-0.037645662506612,-0.0257596885989429,1.53245202097455e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,29594,0.0349416101849033,0.00336105909163469,0.0283539343652993,0.0415292860045073,2.85802636953007e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0337746498341037,0.00325016636995779,-0.0401449759192209,-0.0274043237489864,2.99263466747745e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0474429867205003,0.00456804539428071,-0.0563963556932905,-0.0384896177477101,3.17741641073912e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,29443,0.0333595209433262,0.00321428960360287,0.0270595133202646,0.0396595285663878,3.43314710017978e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0309365791270589,0.00298268139414037,-0.036782634659574,-0.0250905235945438,3.6687010021171e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,28931,-0.0322038801330095,0.00310580724577644,-0.0382912623347314,-0.0261164979312877,3.80064098039864e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,28797,-0.0295624365103347,0.00285578375762439,-0.0351597726752785,-0.0239651003453909,4.54602316546998e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.022501718037721,0.00217520080681298,-0.0267651116190744,-0.0182383244563675,4.88201906257914e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.0711634410473039,0.00689422110888007,-0.0846761144207089,-0.057650767673899,6.18292100157647e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0310564418998972,0.00300939549699083,0.0251580267257951,0.0369548570739992,6.45630616000469e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,24623,0.0304533098848073,0.00295191366644774,0.0246675590985697,0.0362390606710449,6.67313061625665e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0419408154806568,0.00406716996103573,-0.0499124686042869,-0.0339691623570268,6.85948113612027e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0318942322838416,0.00310161195331059,-0.0379733917123303,-0.0258150728553528,9.4326641907072e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,24888,-0.0321663481745525,0.00313449210163729,-0.0383099526937616,-0.0260227436553434,1.16979102308689e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.0804797169064484,0.00784667705396271,-0.0958592039322153,-0.0651002298806815,1.21807158998075e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,0.0225933080603845,0.00220339364649488,0.0182746565132546,0.0269119596075145,1.25041703182776e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.028103907091646,0.0027453375291502,-0.0334847686487804,-0.0227230455345116,1.51853608395888e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0229239453273087,0.00224129690121091,-0.027316887253682,-0.0185310034009353,1.63115833868032e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,0.0254033492498497,0.00248558558235721,0.0205316015084296,0.0302750969912698,1.8039916777342e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0536528913936068,0.00525283617869671,-0.0639484503038524,-0.0433573324833613,1.91727588458115e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0240529461198188,0.00235702520647935,-0.0286727155245183,-0.0194331767151193,2.07697233138627e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0384178093645938,0.00377281446393708,-0.0458125257139105,-0.0310230930152771,2.65320579430864e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.0134934858749503,0.00132596883490669,0.0108945869585332,0.0160923847913674,2.82195220535172e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0254868164306873,0.00250976325430057,0.0205676804522582,0.0304059524091164,3.44825374989773e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0584942171246319,0.00576630997043876,0.0471922495825719,0.0697961846666919,3.8548730181068e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,24688,-0.0670975976243008,0.00661609519270574,-0.080065144202004,-0.0541300510465975,4.02827207679679e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0445512157547872,0.00439483931563355,-0.0531651008134289,-0.0359373306961454,4.2242228135286e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0326703660520804,0.00322853229780326,-0.0389982893557748,-0.026342442748386,4.97279798736527e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,24845,-0.0440576953535713,0.00435382691869268,-0.0525911961142089,-0.0355241945929336,5.05030588195795e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0505556067264011,0.00500643618083459,-0.0603682216408369,-0.0407429918119653,6.16461751443344e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0584445818822922,0.00580103155696002,-0.0698146037339338,-0.0470745600306506,7.93006626930027e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0198930693115106,0.00197593630472805,-0.0237659044687776,-0.0160202341542437,8.38970083733415e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0544386296802982,0.00540862977143026,-0.0650395440323015,-0.0438377153282949,8.7730078240371e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,24240,0.0460015980737315,0.004572003806948,0.0370404706121134,0.0549627255353496,9.09470339415913e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0388152350153546,0.00386144140717246,-0.0463836601734126,-0.0312468098572965,1.00199919696823e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0348898849547051,0.00347774415834407,-0.0417062635050595,-0.0280735064043507,1.19856623240736e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0229150474713901,0.00228436062644981,0.0184377006435485,0.0273923942992318,1.23451684676332e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0266056218812898,0.00265276778192808,-0.0318050467338689,-0.0214061970287108,1.23767502205106e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,29227,-0.0510523627462273,0.00509653687458828,-0.0610415750204203,-0.0410631504720343,1.40001366166153e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0266638263801939,0.00266278511797655,-0.0318828852114279,-0.0214447675489598,1.45243966367708e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0415550530953485,0.00415112640896807,-0.0496912608569259,-0.0334188453337711,1.49513639644784e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0498450752726714,0.00498670333591423,-0.0596190138110632,-0.0400711367342795,1.76503826503596e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.044583216068014,0.00446259020145772,-0.0533298928628712,-0.0358365392731569,1.85791866022221e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.0877104403794703,0.00879952865070223,-0.104957516534847,-0.0704633642240939,2.29935549003533e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0590527557816971,0.00592594279698792,-0.0706676036637934,-0.0474379078996008,2.35963560823088e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0207617276241213,0.00208348132933528,-0.0248453510296185,-0.0166781042186241,2.40037087899915e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.0562207073670627,0.00564599199640324,-0.0672868516800131,-0.0451545630541124,2.58283768250507e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0367371453878717,0.003694532279831,-0.0439784286563405,-0.0294958621194029,2.9299411808586e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0510051517855534,0.00513217268558156,-0.0610642102492933,-0.0409460933218136,3.09015219175159e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.0331818257625608,0.00334173511253269,-0.0397316265831249,-0.0266320249419967,3.43026797914567e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.0400823976323954,0.00403869453759731,-0.0479982389260862,-0.0321665563387047,3.53678744071129e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.041667580027238,0.00419806098793527,-0.0498957795635911,-0.0334393804908849,3.56317025889285e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0305247306457187,0.00307955514425338,-0.0365606587284553,-0.0244888025629821,4.08341983071359e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0387291702074668,0.00390950574992838,-0.0463918014773264,-0.0310665389376071,4.23924606228459e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0298916401238564,0.00301824696391756,-0.0358074041731348,-0.023975876074578,4.36215835554568e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0288185959622187,0.00291007619787582,-0.0345223453100554,-0.0231148466143821,4.39506568217491e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0558358628628535,0.00564399434554454,0.0447736339455862,0.0668980917801208,4.85153548682553e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0481972431317998,0.00487166171333434,-0.0577457000899351,-0.0386487861736645,4.91874066973314e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0329742449307398,0.00333342560977626,-0.0395077591259013,-0.0264407307355783,4.9748935927766e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0179307960790644,0.00181304465842256,0.0143772285485561,0.0214843636095726,5.00255110500301e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,29218,0.0235109399278104,0.00237843464742349,0.0188492080188604,0.0281726718367604,5.25295294206042e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0224243414277848,0.00226905295512746,-0.0268716852198346,-0.0179769976357349,5.37015905520387e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0409440667693319,0.00414369812246316,-0.0490657150893597,-0.0328224184493041,5.47300388855524e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,29163,0.0337677320375768,0.00341783828431449,0.0270687690003204,0.0404666950748332,5.53254675779418e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,29820,0.021110203343509,0.00213859415645387,0.0169185587968594,0.0253018478901586,6.02646821511727e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0732170971201999,0.00742264638968266,-0.0877654840439779,-0.0586687101964219,6.4679245932336e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,24845,-0.0263202064099419,0.00267077448494212,-0.0315549244004285,-0.0210854884194554,7.19091295033321e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0384245362116986,0.00390031584628859,-0.0460691552704243,-0.030779917152973,7.42569434449147e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0460408934294663,0.00467882928290268,-0.0552113988239555,-0.036870388034977,8.19072279994524e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0575279419791033,0.00584694269335887,-0.0689879496580866,-0.0460679343001199,8.42105486862381e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0274227380752129,0.00278867006553727,-0.032888531403666,-0.0219569447467599,8.76160744576533e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0355678905704002,0.00361945506675946,-0.0426620225012487,-0.0284737586395517,9.51414668149558e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,24805,-0.0586575411159275,0.00596960266641135,-0.0703579623420938,-0.0469571198897613,9.5708024381487e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.054331440783105,0.00553974710514007,-0.0651893451091795,-0.0434735364570305,1.13085896336717e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,29820,-0.0384156232042824,0.0039195518509215,-0.0460979448320885,-0.0307333015764762,1.20590956986829e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,24938,-0.0194414168189918,0.00198533236459835,-0.0233326682536046,-0.0155501653843791,1.33166492704335e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,24793,-0.027258325143084,0.00279204926331298,-0.0327307416991774,-0.0217859085869906,1.78442263429213e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0518108259299239,0.00531405076169181,-0.0622263654228398,-0.0413952864370079,2.02814072643012e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.0587112956930294,0.00602275487616058,-0.0705158952503042,-0.0469066961357547,2.02865476798519e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0224080293485595,0.00230097752645062,-0.0269179453004027,-0.0178981133967163,2.23398594711241e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0705269905795888,0.00724388643599097,-0.0847250079941311,-0.0563289731650465,2.28589232911912e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,29478,-0.0833340059934206,0.00855932208112169,-0.100110277272419,-0.0665577347144221,2.28708743718032e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.0443174058805568,0.00455265647363214,-0.0532406125688758,-0.0353941991922378,2.32486580552233e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0491179155129329,0.00505076122215725,-0.0590174075083611,-0.0392184235175047,2.5500975836231e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.053078250826223,0.00546546994528942,-0.0637905719189902,-0.0423659297334557,2.94864548280702e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,29640,-0.0494816869991633,0.00509756965837477,-0.0594729235295779,-0.0394904504687488,3.04078530397073e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0285563281385562,0.0029420870960729,-0.0343228188468591,-0.0227898374302534,3.06716116605677e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0665111294970029,0.00685719008798561,-0.0799512220694547,-0.0530710369245511,3.27207067546936e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0709602765912337,0.00732633176039243,-0.0853198868416029,-0.0566006663408646,3.7433512632345e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0407584830202404,0.00420947917581314,-0.0490090622048342,-0.0325079038356467,3.86487414881008e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,29218,0.0287747103934931,0.00297191166174088,0.022949763536481,0.0345996572505053,3.87420318949132e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.0700170116627103,0.00723293253325545,-0.084193559427891,-0.0558404638975297,4.00128815885363e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,29443,0.0215035205637104,0.00222679181579844,0.0171390086047454,0.0258680325226753,4.96334044561827e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,24845,-0.037912416362783,0.00392777535364743,-0.045610856055932,-0.0302139766696341,5.24957573924149e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0225239430445421,0.00233788197103735,-0.0271061917077753,-0.0179416943813089,6.26920687932328e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0443013984479664,0.00460000307055127,-0.0533174044662469,-0.0352853924296859,6.38516535366373e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.0361451367030983,0.00376085723013371,-0.0435164168741603,-0.0287738565320362,7.86264736908738e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.022480299357857,0.00234337200260474,-0.0270733084829623,-0.0178872902327518,9.19673416726678e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.026124317371613,0.00272325968884408,-0.0314619063617474,-0.0207867283814786,9.20117388163565e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0317474493237005,0.00331216377246854,-0.0382392903177388,-0.0252556083296622,9.94557064116968e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,28774,-0.0482740064436042,0.00503690591817115,-0.0581463420432197,-0.0384016708439888,1.0054768983682e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,29694,-0.0243960216315905,0.00254861468880821,-0.0293913064216546,-0.0194007368415264,1.12406212836711e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0454824433098464,0.00475071672255182,-0.054793848086048,-0.0361710385336448,1.12501529266505e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0387508488644616,0.00405044034631575,-0.0466897119432405,-0.0308119857856827,1.18244604354785e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,24966,-0.0139654348038378,0.00146043748544548,-0.0168278922753109,-0.0111029773323646,1.251914836711e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.0608124717407085,0.00636177078256467,-0.0732815424745353,-0.0483434010068818,1.2975894861831e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0281185270105473,0.00294184319634788,-0.0338845396753891,-0.0223525143457054,1.30623067523287e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.0655785625255529,0.00686654069803843,-0.0790369822937082,-0.0521201427573976,1.40941722314307e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0433447753359731,0.00454421750214634,-0.0522514416401799,-0.0344381090317662,1.57802669665743e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,24240,-0.0496721308984805,0.00520935855550164,-0.0598824736672637,-0.0394617881296973,1.63231220078142e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0298436471563416,0.0031302523591972,-0.0359789417803681,-0.0237083525323151,1.65049158655733e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0323386707994123,0.00339321880740586,-0.0389893796619278,-0.0256879619368968,1.70539829730289e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.019395623766712,0.00203568801499966,-0.0233855722761114,-0.0154056752573127,1.72820341527944e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,24407,0.0208038839895156,0.00218422853806201,0.0165227960549141,0.0250849719241172,1.80569942399264e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,29434,-0.039297547926676,0.0041281561199996,-0.0473887339218752,-0.0312063619314768,1.8703900107631e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0436463712707502,0.00459067375856179,-0.0526440918375313,-0.0346486507039691,2.09362977023384e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,29433,-0.0248375825267524,0.00261936755748472,-0.0299715429394224,-0.0197036221140823,2.66841133887972e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0210675077192728,0.00222200482587037,-0.0254226371779787,-0.0167123782605669,2.70064746802899e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,0.0391256546118821,0.00412925994371561,0.0310323051221995,0.0472190041015647,2.85263642834906e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0176261820233132,0.00186262594729334,-0.0212769288800081,-0.0139754351666182,3.20412509488003e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,28931,-0.0349438598294225,0.00369294757453704,-0.0421820370755151,-0.0277056825833299,3.23243713960537e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,24793,-0.0417326265360102,0.00443272131966831,-0.0504207603225601,-0.0330444927494603,5.14514489178698e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,24966,-0.0237388278308466,0.00252443367397952,-0.0286867178318464,-0.0187909378298467,5.71008190790329e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,29786,-0.0310187001744278,0.00330267675914971,-0.0374919466223612,-0.0245454537264943,6.29382137160931e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,0.0172546346062047,0.00183821333878521,0.0136517364621857,0.0208575327502237,6.70647645341005e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,24867,-0.0363538162286475,0.00387525853931628,-0.0439493229657074,-0.0287583094915876,7.07530950259868e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0513720197304498,0.0054771998434826,-0.0621073314236757,-0.0406367080372239,7.11623672833589e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,-0.0251045617194056,0.00267780457980729,-0.0303530586958279,-0.0198560647429833,7.48628176753132e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,24816,-0.0559054806250221,0.0059681282528706,-0.0676030120006484,-0.0442079492493957,8.05136749364471e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.061555015221784,0.00657691887181119,-0.074445776210534,-0.0486642542330341,8.59347507923267e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0417297671875123,0.00446020504093203,-0.0504717690677391,-0.0329877653072855,8.95714879574435e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0372144596152281,0.00398446345709606,-0.0450240079911364,-0.0294049112393199,1.04480857684454e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.0503005197285534,0.0053898120294421,-0.0608645513062599,-0.0397364881508469,1.11778481256237e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,28774,-0.0229122773477072,0.00245558995495281,-0.0277252336594147,-0.0180993210359997,1.12532488935548e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0210351799242262,0.00225649319108781,-0.0254579065787583,-0.0166124532696941,1.2180904621361e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0443700504225179,0.00476731345494694,-0.0537139847942139,-0.0350261160508219,1.40075205624504e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0236558853953898,0.00254232983618255,-0.0286388518743076,-0.018672918916472,1.45009260712947e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,29478,-0.0353785787058206,0.00380698169712398,-0.0428402628321836,-0.0279168945794576,1.59894277241364e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0165903577732765,0.00178549450017951,-0.0200899269936284,-0.0130907885529247,1.63825223470462e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0374192441544812,0.00402816568550061,-0.0453144488980624,-0.0295240394109,1.65752114245757e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,29536,0.03302065254038,0.00355731098783299,0.0260483230042273,0.0399929820765326,1.76564627179633e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0244086917264108,0.00263085570914642,-0.0295651689163378,-0.0192522145364838,1.86965345453643e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.043938018828377,0.00473839308396966,-0.0532252692729575,-0.0346507683837964,1.93248153965822e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.0319011292953082,0.00344451511719299,-0.0386523789250064,-0.0251498796656099,2.18002207025813e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0472699490430112,0.00510666158599029,-0.0572790057515521,-0.0372608923344702,2.2820484471081e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0224273819734633,0.00242390637225273,-0.0271782384630787,-0.017676525483848,2.3357710885655e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0535827979400792,0.00580526326896125,-0.0649611139472433,-0.0422044819329152,2.91528932572545e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0546675059810283,0.00594148313357443,-0.0663128129228342,-0.0430221990392224,3.7747276297522e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.0318742906665031,0.00346907926354015,-0.0386736860230418,-0.0250748953099644,4.25384240398894e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0520299720416306,0.00566445860248753,-0.0631323109025062,-0.040927633180755,4.42253106049654e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.041887496410606,0.00456187579139024,-0.0508287729617308,-0.0329462198594811,4.54971545764317e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0426533495004743,0.00464606652458304,-0.0517596398886571,-0.0335470591122916,4.61454182326485e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,24845,-0.0143476833405208,0.0015638206927147,-0.0174127718982416,-0.0112825947828,4.86776972543255e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,29163,-0.0411884953118112,0.00449289548045316,-0.0499945704534994,-0.032382420170123,5.15157927771922e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0246785421347194,0.00269234861145758,-0.0299555454131762,-0.0194015388562625,5.21062757663869e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,24805,-0.0646937139948722,0.00707205850835788,-0.0785549486712537,-0.0508324793184908,6.24561096565052e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,29694,-0.014534869086403,0.00158929158504362,-0.0176498805930885,-0.0114198575797175,6.3037412488318e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,24805,-0.043592247863736,0.00476663372010632,-0.0529348499551444,-0.0342496457723277,6.39134426409312e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0249716740696309,0.00273751976312351,-0.030337212805353,-0.0196061353339089,7.8309354854179e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0237778316917026,0.0026077932476812,-0.0288891064571577,-0.0186665569262474,8.12751704028142e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,29694,0.0148207879645401,0.00162970062618312,0.0116265747372212,0.018015001191859,1.01085576489693e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,28868,-0.0244726992520137,0.00269285562501258,-0.0297506962770384,-0.0191947022269891,1.07149563015449e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,24845,-0.0687529088321625,0.00757905450578292,-0.083607855663497,-0.0538979620008279,1.25934112640315e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,28774,-0.0431461720838299,0.00475813290229828,-0.0524721125723345,-0.0338202315953253,1.28871146740249e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0203372626772257,0.00224369099532494,-0.0247348970280626,-0.0159396283263888,1.34550589228572e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,24922,-0.0200062237503406,0.00220906073003982,-0.0243359827812186,-0.0156764647194625,1.44407791164425e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.0693137560054038,0.00765578975308228,-0.0843191039214451,-0.0543084080893625,1.48019766469358e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.0245660760180423,0.00271997489949297,-0.0298972268210485,-0.0192349252150361,1.80946333357462e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0460653980602664,0.00510628430407089,-0.0560737152962454,-0.0360570808242875,1.98943368665048e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0257460208806749,0.00285657157641209,-0.0313449011704426,-0.0201471405909072,2.15039766868614e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.0407519083215109,0.00452329396270325,-0.0496175644884093,-0.0318862521546126,2.22213185096595e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,29163,-0.0221466527643237,0.00246132180616363,-0.0269708435044045,-0.017322462024243,2.43759061426251e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0287674266833069,0.00319751524134002,-0.0350345565563333,-0.0225002968102805,2.49015585669967e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0389012056155701,0.00432893654027258,-0.0473859212345043,-0.0304164899966358,2.7385671901104e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0191578222774378,0.00213232170605048,-0.0233371728212967,-0.0149784717335788,2.78001004203103e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0596250839884014,0.00664441005572288,-0.0726481276976183,-0.0466020402791846,3.03332685053467e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,24867,0.0294551051536511,0.0032832777654046,0.0230198807334581,0.0358903295738441,3.13366617327671e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.0290036773867082,0.00324037273175265,-0.0353548079409434,-0.0226525468324731,3.73946089585761e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0205442581053151,0.00229625203884417,-0.0250449121014496,-0.0160436041091805,3.86449763256668e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,29478,-0.0227089794087152,0.00253998177961854,-0.0276873436967676,-0.0177306151206629,4.09110773726329e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.0312342875385261,0.00349442482106694,-0.0380833601878173,-0.0243852148892349,4.22677652524401e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0648277618631515,0.00725612911987185,-0.0790497749381004,-0.0506057487882027,4.38631275632433e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0373588145010819,0.00418299192772253,-0.045557478679418,-0.0291601503227457,4.4552584198085e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,24752,-0.0273496513655314,0.0030667540586836,-0.0333604893205513,-0.0213388134105116,5.06359754688607e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.0375158403563142,0.00420798507670294,-0.045763491106652,-0.0292681896059765,5.14161234097357e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,24845,-0.0240097771494759,0.00269358931361219,-0.0292892122041558,-0.018730342094796,5.26849732736685e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,29135,-0.0214919756900909,0.00241893060935895,-0.0262330796844344,-0.0167508716957474,6.75738442943863e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0151870719812736,0.00171012305067835,0.011835230801944,0.0185389131606032,7.01391758197565e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0371817882176294,0.00418984037937174,-0.045393875361198,-0.0289697010740608,7.51547962170177e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,24951,-0.0456074455747103,0.00514159771623509,-0.055684977098531,-0.0355299140508895,7.77409930070521e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.0485239814162565,0.00547247762450184,-0.0592500375602801,-0.0377979252722329,8.02757270194666e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.039287933668963,0.00443341690758233,0.0305984365301016,0.0479774308078244,8.4099244680007e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0607807799623629,0.00686793180313715,-0.0742419262965117,-0.0473196336282141,9.34290882118862e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.0291457932282428,0.00329760049752783,0.0226824962530883,0.0356090902033974,1.02314685919672e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,29757,0.0286992006410744,0.00324760695411234,0.0223338910110142,0.0350645102711346,1.03592360221847e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0177653216003412,0.00201080043073082,-0.0217064904445736,-0.0138241527561088,1.05544701273405e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.04125297756362,0.00467876774198191,-0.0504233623379046,-0.0320825927893355,1.25047165355123e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,29349,-0.0342344099679441,0.00388323807656947,-0.0418455565980203,-0.026623263337868,1.2510328069983e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,24822,-0.0604893217318519,0.00686109593690648,-0.0739370697681886,-0.0470415736955151,1.25936243896703e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.016314010086611,0.00185166012154685,0.0126847562483791,0.0199432639248428,1.32561499854596e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,24240,-0.0427110182803256,0.00484901594282754,-0.0522150895282676,-0.0332069470323836,1.35539505596849e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.021224388971492,0.00241076479415188,-0.0259494879680297,-0.0164992899749543,1.39154601103006e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,29786,-0.034883638472968,0.00396395375813838,-0.0426529878389192,-0.0271142891070168,1.43782821511903e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,29383,-0.0178980164651681,0.00203381037759389,-0.0218842848052521,-0.0139117481250841,1.43852112583031e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0207901086767978,0.00236338516255782,-0.0254223435954111,-0.0161578737581844,1.48333217787011e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0413855921604406,0.00470676915921915,-0.0506108597125101,-0.0321603246083711,1.55164012235313e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.0150377901230243,0.00171140516108564,0.0116834360072965,0.0183921442387522,1.62022341930958e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,29344,-0.0542464638019113,0.00617519307066136,-0.0663498422204075,-0.042143085383415,1.65326474023991e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.026134958547774,0.00298289095246167,-0.0319814248145988,-0.0202884922809491,2.02456938178028e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.041188062002154,0.00470476283098044,-0.0504093971508756,-0.0319667268534323,2.15701449079461e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0274325657890296,0.00313633715897036,-0.0335797866206115,-0.0212853449574477,2.31446321835475e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0411429059489677,0.00471116540291801,-0.050376790138687,-0.0319090217592484,2.63664583988167e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,29349,0.0173265778837326,0.0019848314088376,0.0134363083224109,0.0212168474450543,2.69112082804043e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.0328992461036064,0.00377232920784804,-0.0402930113509885,-0.0255054808562242,2.92615509772166e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0422691165454335,0.00485148500576372,-0.0517780271567304,-0.0327602059341366,3.15153814839342e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0274494225490195,0.00315138872542321,-0.033626144450849,-0.02127270064719,3.22195600581872e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.0613605719275637,0.00704940042323089,-0.0751773967570963,-0.0475437470980312,3.38762647336345e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0408865342324488,0.00469776349520597,-0.0500941506830525,-0.0316789177818451,3.42320662205174e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,29434,-0.0407805204783694,0.00468771933458445,-0.0499684503741549,-0.0315925905825838,3.50586682517392e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,24890,-0.0286705673996216,0.00329736169122998,-0.0351333963144324,-0.0222077384848109,3.67840474100092e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0479111535302526,0.00551359024032821,-0.0587177904012959,-0.0371045166592093,3.82210981859511e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,29786,0.0242264309828992,0.00278851772442898,0.0187609362430184,0.02969192572278,3.87666009859213e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0367647193544892,0.00423680781992376,0.0284605760274387,0.0450688626815398,4.28979138368076e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0571942346702227,0.00659691886970253,-0.0701241956548396,-0.0442642736856057,4.58667161951077e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0328382070785393,0.00379190691691576,-0.0402703446356942,-0.0254060695213844,4.94873245477137e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,29498,-0.0566193954440116,0.00654946968753368,-0.0694563560315776,-0.0437824348564456,5.6539381791057e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,24111,-0.0240322410717198,0.00278263250109237,-0.0294862007738609,-0.0185782813695788,6.14856252059496e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,29443,-0.0255963676865854,0.00296512463916853,-0.0314080119793557,-0.0197847233938151,6.3012131689682e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0680018655815497,0.00789623525507455,-0.0834784866814958,-0.0525252444816036,7.5363328942965e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0151301746700491,0.00175766230343574,-0.0185751927847831,-0.011685156555315,7.78563820703323e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,29820,0.0178453684249727,0.00207366477756123,0.0137809854609527,0.0219097513889927,7.95047908648058e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0274162407497964,0.00318801726853307,0.0211677269034716,0.0336647545961212,8.37504270500474e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0241559566463346,0.00281031814250691,-0.0296641802056481,-0.018647733087021,8.78951045658022e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0205663843991712,0.00239304430766214,-0.025256751242189,-0.0158760175561534,8.79015085739178e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0580645615203658,0.006759595449538,-0.0713133686014603,-0.0448157544392713,9.12768228849253e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,29566,-0.0424841906329348,0.00494833536680584,-0.0521829279518743,-0.0327854533139954,9.4763580927141e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0240464049295465,0.00280082014357062,-0.0295360124109449,-0.018556797448148,9.48284015507047e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0419841597350259,0.00489006087132219,-0.0515686790428174,-0.0323996404272344,9.56678811319948e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,24951,-0.0140136088780748,0.00163360160382356,-0.017215468021569,-0.0108117497345806,1.01749783737811e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0208666194280304,0.00243450870174123,-0.0256382564834432,-0.0160949823726176,1.07315038673335e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0427324329310292,0.00498801469446737,-0.0525089417321853,-0.0329559241298732,1.11280554598599e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.058144190628923,0.00679265910443446,-0.0714578024736145,-0.0448305787842314,1.1846076100521e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,29443,-0.0456571194216118,0.00533685986376512,-0.0561173647545914,-0.0351968740886321,1.23442442655303e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0279239419888922,0.00326554326976852,-0.0343244067976385,-0.0215234771801459,1.27680989161965e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0700584785820674,0.00821234863256863,-0.0861546819019019,-0.0539622752622329,1.52196277341622e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.021141962700914,0.00248285718700962,-0.0260083627874528,-0.0162755626143751,1.75859650718126e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0373646413446007,0.0043902739730561,-0.0459695783317906,-0.0287597043574108,1.82380175802135e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0456707897273974,0.00537304289330845,-0.056201953798282,-0.0351396256565129,1.98409815278472e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.0784031664249679,0.0092381933876499,-0.0965100254647617,-0.0602963073851741,2.24318417331142e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0271705354062792,0.00320382785816806,-0.0334500380082886,-0.0208910328042698,2.36569828184933e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0575700759771859,0.00678930030254204,-0.0708771045701683,-0.0442630473842035,2.36765602291202e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,29566,0.0164176074607316,0.00193700180494122,0.0126210839230468,0.0202141309984164,2.44200632372299e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,24229,-0.0251455778098676,0.00297490348484762,-0.0309763886401689,-0.0193147669795662,3.00790476118971e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,29434,-0.020231262076813,0.00239394090936677,-0.0249233862591719,-0.0155391378944541,3.01881808358125e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.0241964829017575,0.00286327964059475,0.0185844548061918,0.0298085109973232,3.02937280185555e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0178894128325718,0.00211722214879731,-0.0220391682442145,-0.013739657420929,3.05914216552573e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.0238952562624559,0.00282782975262851,-0.0294378025776078,-0.0183527099473041,3.06991575960742e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0208774668548548,0.00247151826693461,-0.0257216426580466,-0.016033291051663,3.14841002269429e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.02599156986835,0.00307970513791572,-0.0320277919386648,-0.0199553477980352,3.3591153886681e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0130174920743853,0.0015449173311243,-0.0160455300433889,-0.00998945410538162,3.77134989218198e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0318999151503574,0.00378658057455869,-0.0393216130764925,-0.0244782172242224,3.82136857473644e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0457682495263217,0.0054330627174045,-0.0564170524524345,-0.0351194466002089,3.83693063808416e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.03750960488508,0.00445411115450549,-0.0462396627479107,-0.0287795470222492,3.89254856613028e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0568495327572177,0.00675651672797487,-0.0700923055440484,-0.0436067599703869,4.13863042729982e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,29349,-0.053203841624378,0.00632511458215656,-0.0656010662054049,-0.0408066170433511,4.22840846766722e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,24381,-0.0399366867707133,0.00474851955041022,-0.0492437850895173,-0.0306295884519092,4.30917661659241e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,28534,-0.0452655544696352,0.0053872559389703,-0.0558245761100169,-0.0347065328292534,4.57744646765404e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0359526184602263,0.00428501940199978,-0.0443512564881458,-0.0275539804323067,5.10337016332087e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.011971379360631,0.0014271579352992,0.0091741498074446,0.0147686089138175,5.14998405175717e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0328037988198845,0.00391420797159459,-0.0404756464442099,-0.0251319511955591,5.49175890472483e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.029375585983676,0.00350546137370188,-0.0362462902761317,-0.0225048816912203,5.58535983840947e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0392785994454863,0.00468954136718005,-0.0484701005251592,-0.0300870983658134,5.77181531115663e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,0.0166725954055408,0.0019929951362629,0.0127663249384656,0.0205788658726161,6.29768235261076e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,29368,-0.040387397758998,0.0048302570760507,-0.0498547016280574,-0.0309200938899386,6.47205088048519e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0168489110052597,0.00201593663870403,0.0128976751933998,0.0208001468171196,6.66121007374381e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0593652945531776,0.00710648903296064,-0.0732940130577805,-0.0454365760485748,6.90441158053093e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0448119756809066,0.0053671954205387,-0.0553316787051624,-0.0342922726566507,7.22423490473755e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0279647022500792,0.003357555644378,-0.03454551131306,-0.0213838931870983,8.57548202237299e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0396553146997354,0.0047709474509627,-0.0490063717036223,-0.0303042576958485,9.91510008545229e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.042299509355887,0.00509113289312078,-0.0522781298264038,-0.0323208888853703,1.01063804165494e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.0317408777801067,0.00383728488859287,-0.0392619561617487,-0.0242197993984646,1.38753677643165e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,29541,0.0159260059660892,0.00192619861491493,0.0121506566808559,0.0197013552513224,1.41756438892889e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.017377307147773,0.00210179087646205,-0.0214968172656387,-0.0132577970299074,1.43140718113876e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0281007089248943,0.00339966675594773,-0.0347640557665518,-0.0214373620832368,1.45710080760168e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0335133202934185,0.0040577781202708,0.0255600751776878,0.0414665654091493,1.52886820489941e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,29786,-0.0288379220008613,0.00349198172876647,-0.0356822061892436,-0.021993637812479,1.53779753727627e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,28797,-0.0356136344991945,0.00431551213408259,-0.0440720382819964,-0.0271552307163927,1.61711226822374e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,24111,-0.0278236295235585,0.00337474637352521,-0.0344381324156679,-0.0212091266314491,1.73994267524886e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.034500940599199,0.00418857812708258,0.0262913274701171,0.0427105537282808,1.84052337923463e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,24326,-0.0661553979568681,0.00803184106303755,-0.0818978064404217,-0.0504129894733145,1.8593648462177e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.0342047846749173,0.0041529850866972,-0.0423446354448438,-0.0260649339049908,1.86436754571256e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0407702252907707,0.00495067962833146,-0.0504735573623004,-0.031066893219241,1.86482797523608e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0331786123883991,0.00403169194147293,-0.0410807285936861,-0.0252764961831122,1.95757121833412e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0309557395497074,0.00376357335044434,-0.0383323433165783,-0.0235791357828365,2.02982237135545e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,24801,-0.0186621811112579,0.00227057149169409,-0.0231125012349784,-0.0142118609875375,2.14866341197351e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0405732840466808,0.00493705121694206,0.0308966636614744,0.0502499044318872,2.15105490744275e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.037742295435369,0.00460147366310322,-0.0467611838150513,-0.0287234070556867,2.45721407209034e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,29491,-0.0610677907671543,0.00746179431354172,-0.075692907621696,-0.0464426739126125,2.85379599829504e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,24381,-0.0669771315573745,0.00818518566335501,-0.0830200954575503,-0.0509341676571986,2.90927433204462e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,0.0117999271251222,0.00144225230942831,0.00897311259864267,0.0146267416516016,2.91232728150151e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0327235529696062,0.00400110936449451,-0.0405657273240154,-0.024881378615197,2.98767722878276e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0315598042199185,0.00386004881885261,-0.0391254999048696,-0.0239941085349673,3.07634363830199e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,29478,0.0196031876540027,0.00239999857634471,0.0148991904443671,0.0243071848636384,3.25960170483956e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0295472920411978,0.00361774438455464,-0.0366380710349249,-0.0224565130474707,3.28096323346236e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,29169,-0.0301549858407613,0.00369361170617943,-0.037394464784873,-0.0229155068966496,3.36799474472298e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0202794123933383,0.00248664178169982,-0.0251532302854699,-0.0154055945012066,3.64543027721969e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,29725,-0.0633487773532035,0.00777302836101022,-0.0785839129407836,-0.0481136417656235,3.78650472466886e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,24951,0.0278200621798967,0.00341912257729822,0.0211185819283922,0.0345215424314013,4.25291295062957e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,24111,-0.0382338275662048,0.00470230983816247,-0.0474503548490032,-0.0290173002834063,4.46595331618654e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0411487607881717,0.00506468568171685,-0.0510755447243368,-0.0312219768520067,4.69789083883862e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.044791727732707,0.00553139924041883,-0.0556332702439279,-0.0339501852214861,5.81924362150348e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.044566589974832,0.0055147258263577,-0.0553754525944931,-0.0337577273551709,6.64804653915943e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,29169,-0.029327804083816,0.00363597114857546,-0.0364543075350239,-0.0222013006326081,7.53928041955577e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0152758198758353,0.00189532095452809,-0.0189906489467104,-0.0115609908049602,7.93138373630157e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.0651132641544059,0.00808307276381945,0.0492704415373198,0.080956086771492,8.21400784800231e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,24793,-0.0273754587816509,0.00339863988777332,-0.0340367929616866,-0.0207141246016152,8.31456009596908e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0302563866586826,0.00375946758646985,-0.0376249431281635,-0.0228878301892017,8.7324029602501e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,29694,-0.0696174602652082,0.00865189718618796,-0.0865751787501366,-0.0526597417802798,8.83509788353766e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,28931,-0.0399280192903492,0.00496269938334096,-0.0496549100816975,-0.0302011284990009,8.90656992993644e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,29014,-0.0312191419787046,0.00388218052428089,-0.0388282158062951,-0.023610068151114,9.19863525137361e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0203584396934933,0.00253536129911239,-0.0253277478397536,-0.015389131547233,1.0204177632838e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,24761,-0.0160983476851835,0.00200583374840467,-0.0200297818320567,-0.0121669135383104,1.05343401840838e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.0171881171929899,0.00214529283859331,-0.0213928911566328,-0.012983343229347,1.17796445742262e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.0216797413720727,0.00270685546978819,-0.0269851780928576,-0.0163743046512879,1.19648699000736e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0587063475063047,0.00734284266280872,-0.0730983191254098,-0.0443143758871996,1.34242039420974e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,29291,-0.0315774726691633,0.00395255198833618,-0.0393244745663022,-0.0238304707720244,1.40843871481542e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,29434,-0.0271645944893328,0.00340212169760408,-0.0338327530166368,-0.0204964359620288,1.46077965855929e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0587772403983372,0.00736097100755517,-0.0732047435731453,-0.044349737223529,1.4670519693928e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0366762169652008,0.00459974633856366,-0.0456917197887856,-0.027660714141616,1.59767372003178e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.0176693455059877,0.00221718792974471,-0.0220150338482874,-0.0133236571636881,1.6644338559486e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0124912442467856,0.00156806623876189,-0.0155646540747589,-0.0094178344188123,1.69669004513968e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0254065565263638,0.00319025212786203,-0.0316594506969734,-0.0191536623557543,1.72934951336682e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0250639145737735,0.00315122337629913,-0.0312403123913198,-0.0188875167562272,1.8747985487362e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0577969450054955,0.0072706544800441,-0.0720474277863819,-0.0435464622246091,1.94180965450516e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.0352060893710034,0.0044321563207309,-0.043893115759636,-0.0265190629823708,2.0374090884942e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0284130270554527,0.00357864075458106,-0.0354271629344316,-0.0213988911764739,2.11314266168122e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00944802434320587,0.00119020369015,0.00711522511051187,0.0117808235758999,2.1378855515737e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,28353,0.0176308261146314,0.00222192816478685,0.0132758469116492,0.0219858053176136,2.18353764033567e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0293803638363147,0.00370451784155294,-0.0366412188057585,-0.0221195088668709,2.25045310847143e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,29349,0.0163763089404191,0.00206647939942324,0.0123260093175496,0.0204266085632887,2.36681900978286e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0296173302134147,0.00374031153343617,-0.0369483408189496,-0.0222863196078798,2.48976196585334e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.02361320260236,0.00298683025710579,-0.0294673899062873,-0.0177590152984327,2.77274536138621e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0259523897783968,0.00329104906623849,-0.0324028459482242,-0.0195019336085693,3.23324849610442e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0303632825236141,0.00385038495868945,-0.0379100370426455,-0.0228165280045828,3.23537187424674e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),24484,0.0995306405635461,0.0126248456588424,0.074785943072215,0.124275338054877,3.30985280946304e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0435792632035375,0.00552980901479208,0.0327408375345451,0.05441768887253,3.36477288182707e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0271865075665662,0.00345075759086859,0.0204230226884638,0.0339499924446686,3.45369022781784e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0191794067025095,0.00243787257770085,-0.0239576369548032,-0.0144011764502159,3.74861472914577e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0369128750162635,0.00470241195623856,-0.046129602450491,-0.0276961475820359,4.33810901568217e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,24229,-0.0275386937723548,0.00350848429066333,-0.0344153229820549,-0.0206620645626547,4.3605396010046e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,28654,-0.0389844099198547,0.00497173593100807,-0.0487290123446305,-0.0292398074950789,4.61676998940145e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.0811795348925467,0.0103544672560344,-0.101474290714374,-0.0608847790707194,4.68405183934598e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0287167997238357,0.00366486841347018,-0.0358999418142372,-0.0215336576334342,4.8201974547589e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,29456,0.0352704284137019,0.00450263816948902,0.0264452576015034,0.0440955992259004,4.9122846604909e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.04402898933479,0.00562253424140171,-0.0550491564479374,-0.0330088222216427,5.00952523193227e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0461059341951886,0.00589116071596052,-0.0576526091984712,-0.034559259191906,5.19266186145864e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0221546337875841,0.0028322507961563,-0.0277058453480505,-0.0166034222271178,5.39334900829128e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0175326711744226,0.00224522351505403,0.0131320330849167,0.0219333092639285,5.96084400434212e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0244462064118017,0.00313172853446418,-0.0305843943393515,-0.018308018484252,6.14212962946755e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0198993843990514,0.00255176921946961,0.014897916728891,0.0249008520692119,6.48446097301049e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0283371173080951,0.00363872462274412,-0.0354690175686735,-0.0212052170475166,7.05530851452367e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,24951,-0.0391589778500036,0.00503164759090551,-0.0490210071281784,-0.0292969485718288,7.38324922391096e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.0414707894008795,0.00533011542654728,-0.0519178156369122,-0.0310237631648468,7.46583828607863e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0183957623787681,0.00236912429438647,-0.0230392459957656,-0.0137522787617706,8.4399372592904e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0461350607237793,0.00594319240689791,-0.0577837178412992,-0.0344864036062594,8.63499045448052e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,29786,-0.0479217344216164,0.00617939911621936,-0.0600333566894063,-0.0358101121538264,9.10979298221443e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0500775800186812,0.00645787538844717,-0.0627350157800377,-0.0374201442573248,9.16144240589093e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,23498,-0.0675527987827769,0.00871776674620687,-0.0846396216053424,-0.0504659759602115,9.64611085941924e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0619782021713667,0.00800625516612552,-0.0776704622969727,-0.0462859420457606,1.01620410252095e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0202824773006835,0.00261988076365055,-0.0254174435974385,-0.0151475110039284,1.01780048195786e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.0267208569941311,0.00345220283460702,-0.0334871745499608,-0.0199545394383013,1.03100585305525e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0258577456082889,0.00334135689981979,-0.0324068051319357,-0.0193086860846421,1.04236727004732e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0261306061833906,0.00338407749519568,-0.0327633980739741,-0.0194978142928071,1.19175322455861e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0467886142977417,0.0060600248238443,-0.0586662629524765,-0.0349109656430069,1.19984068226251e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0290167162625503,0.00375843022928101,-0.0363832395119411,-0.0216501930131595,1.20291489529555e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0438438000449454,0.00568697784496137,-0.0549902766210697,-0.0326973234688211,1.30307960393851e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,29114,-0.0216353824858383,0.00280774495082515,-0.0271385625894556,-0.016132202382221,1.34356451952806e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.0364963543858374,0.00474020014284345,-0.0457871466658106,-0.0272055621058643,1.41164963468686e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,29349,-0.0321148961269249,0.00418043263067613,-0.0403085440830501,-0.0239212481707997,1.61252084171374e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,29390,-0.0152853115927353,0.00198985800653209,-0.0191854332855382,-0.0113851898999324,1.61982147044764e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0365700352742119,0.00476933197209601,-0.04591792593952,-0.0272221446089037,1.81438860792587e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0346433298837109,0.00451853098241401,-0.0434996506092423,-0.0257870091581794,1.81688237030272e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0156553668716134,0.00204257177805842,-0.0196588075566079,-0.0116519261866189,1.84955621469424e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.0116766808344019,0.00152435956396652,0.00868893608902757,0.0146644255797763,1.92752162972565e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,24966,-0.0224170690114814,0.00293463879054181,-0.0281689610409433,-0.0166651769820194,2.27145253517131e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0276222556598355,0.00361649007801486,-0.0347105762127447,-0.0205339351069264,2.27477478168825e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,24793,-0.0174991938057215,0.00229212177503449,-0.0219917524847891,-0.0130066351266539,2.34872213214781e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0368666019601921,0.00483362129126881,-0.0463404996910789,-0.0273927042293052,2.47262771477972e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,29434,0.0229576742839852,0.0030111162296422,0.0170558864738865,0.0288594620940839,2.52734055651583e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0294288208299996,0.00386061400527234,-0.0369956242803334,-0.0218620173796658,2.55651364876399e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,24195,-0.0224265073731843,0.00296548192464397,-0.0282388519454865,-0.0166141628008821,4.0939917543324e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,29218,-0.0701243723841984,0.00928186337313307,-0.0883168245955392,-0.0519319201728576,4.31145281985648e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0460174380178745,0.00609956640808932,-0.0579725881777295,-0.0340622878580194,4.70059760228295e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,29349,0.00805518112655544,0.00106898843244193,0.00595996379896926,0.0101503984541416,5.01131818702755e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0305085438246444,0.00405074179408191,-0.0384479977410449,-0.0225690899082438,5.15609494399083e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,24381,-0.0287621240801425,0.0038226474282442,-0.0362545130395011,-0.0212697351207838,5.49040123838788e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0327662326286502,0.00436301024825203,-0.0413177327152242,-0.0242147325420763,6.08392922643269e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0340560573832378,0.00453475675679578,-0.0429441806265575,-0.0251679341399181,6.11171884477237e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0187162728418606,0.00249506653990559,-0.0236066032600756,-0.0138259424236457,6.49661210222451e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.0182058970456878,0.00242699239442942,0.0134489919526061,0.0229628021387695,6.52943220603159e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0306033213820752,0.00408359507666168,-0.0386071677323321,-0.0225994750318183,6.89821791034608e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0358466934373316,0.00478574242133925,-0.0452267485831565,-0.0264666382915067,7.06382721845257e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0354567152004054,0.00473980703453898,-0.0447467369881018,-0.026166693412709,7.64192035444342e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.0141697185405411,0.00189780521819203,-0.0178894167681974,-0.0104500203128847,8.47076789471045e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,28774,-0.0160822174539279,0.00215427407813167,-0.020304594647066,-0.0118598402607899,8.54890257455471e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,24445,-0.0286435833766881,0.00383699694868413,-0.036164097396109,-0.0211230693572672,8.6014085925689e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0267192820331756,0.00358090507652898,-0.0337378559831724,-0.0197007080831787,8.82861395515317e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0318537357551056,0.00427220972479585,-0.0402272668157054,-0.0234802046945057,9.2102154076282e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0270081594612058,0.00362292253408737,-0.034109087628017,-0.0199072312943945,9.30208484880338e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0474970390959649,0.00637751181447166,-0.0599969622523294,-0.0349971159396005,9.82400743819563e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,24177,-0.0229745272838129,0.00308499970147061,-0.0290211266986953,-0.0169279278689305,9.85521682525696e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0226723800321431,0.00304649194760422,-0.0286435042494473,-0.0167012558148388,1.02300338306438e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0356075195825407,0.00478533191557048,-0.0449867701370588,-0.0262282690280225,1.02682100772551e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,24845,-0.0372065750621081,0.00500357717408565,-0.047013586323316,-0.0273995638009003,1.07141388314394e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,24845,-0.0371844756643156,0.00500638394176664,-0.0469969881901782,-0.027371963138453,1.14309429070593e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,29443,-0.0139951981320256,0.00188490069654569,-0.0176896034972551,-0.010300792766796,1.15921402235844e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0161524294558776,0.0021757721739575,0.0118879159949209,0.0204169429168343,1.17492544942117e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,29443,-0.0382978702056688,0.00515983966014961,-0.048411155939562,-0.0281845844717755,1.18217083341208e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0541550924830055,0.0072996134439943,-0.0684623348332343,-0.0398478501327766,1.21295722069834e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.0143575238792319,0.00193587631395642,0.0105632063038773,0.0181518414545865,1.23408933115479e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,29443,-0.0339628002505254,0.00458399149115897,-0.0429474235731969,-0.0249781769278538,1.30669831088974e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0330471807932956,0.00446480382253672,-0.0417981962854676,-0.0242961653011236,1.38006522903533e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,28797,-0.022757487512516,0.00307569421475295,-0.0287858481734318,-0.0167291268516003,1.40814100485159e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0251202842711047,0.00340214271855915,-0.0317884839994806,-0.0184520845427287,1.58156062293941e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0294747356111517,0.00399489541666094,-0.0373047306278071,-0.0216447405944962,1.64804060342747e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0270767181382358,0.00367315043625944,-0.0342760929933043,-0.0198773432831673,1.73125708279352e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0357798502703472,0.00485696417215932,-0.0452995000477795,-0.0262602004929149,1.79433260175956e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0265425999264622,0.00360288810111638,-0.0336042606046503,-0.019480939248274,1.80094711718443e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,24329,0.0159501022085009,0.0021652142750117,0.011706282229478,0.0201939221875239,1.80710128047735e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.036640795175902,0.00498100371417596,0.0268780278961171,0.0464035624556869,1.95228805542191e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0555502925311576,0.00756241928228043,-0.0703726343244273,-0.040727950737888,2.11188610537767e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.026760597309096,0.00364524410983475,-0.0339052757643721,-0.0196159188538199,2.17231770564031e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,29786,-0.0179786307660465,0.00245113599360899,-0.0227828573135201,-0.0131744042185729,2.27686324495475e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,29169,0.0166134959796212,0.00226548481511689,0.0121731457419921,0.0210538462172503,2.30382897834849e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0418685500151679,0.00571367406920138,-0.0530673511908026,-0.0306697488395332,2.41330392708499e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.01770368360693,0.00241605248611135,-0.0224391464797082,-0.0129682207341517,2.41573588018315e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0468365490907245,0.0063941836693984,-0.0593691490827454,-0.0343039490987037,2.46397437012078e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,29331,-0.0147630284102447,0.00201884632071045,-0.0187199671988372,-0.0108060896216523,2.68712000112823e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0389893706488476,0.00534038763527337,-0.0494565304139834,-0.0285222108837118,2.94545902017831e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0435419686040562,0.00597804741457967,-0.0552589415366324,-0.03182499567148,3.33256936981744e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.0395006912013279,0.00542519348693891,-0.0501340704357282,-0.0288673119669277,3.3971719896385e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.022119618056967,0.00305351505099046,-0.0281045075569084,-0.0161347285570257,4.46385779190641e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0305294310555806,0.00421512066817773,-0.038791067565209,-0.0222677945459523,4.5020838456559e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0548662390146759,0.00757473017340023,-0.0697127101545404,-0.0400197678748115,4.50530306343984e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,29581,-0.0470618142770594,0.00650757675741048,-0.0598166647215839,-0.0343069638325349,4.88022829202579e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0429596891030102,0.00594256543711646,-0.0546071173597585,-0.031312260846262,4.98220395375861e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,28870,-0.0254348899635626,0.00352044567842285,-0.0323349634932714,-0.0185348164338538,5.13871657031333e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,24240,-0.0265410929632464,0.00368229147376499,-0.0337583842518258,-0.019323801674667,5.85437839346963e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0452859421908339,0.00628321935667231,-0.0576010521299116,-0.0329708322517561,5.86438769900681e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0376483595349167,0.00522524975723497,-0.0478898490590972,-0.0274068700107361,5.96953231798929e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.0410954181050317,0.00570662546853007,-0.0522804040233506,-0.0299104321867128,6.13867944397252e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,24381,-0.0283773682791003,0.00394737163805006,-0.0361142166896784,-0.0206405198685221,6.71844124366323e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.022003026361089,0.00306153270799025,-0.0280036304687499,-0.0160024222534281,6.81861624187684e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0172041516037891,0.0023948600723223,-0.0218980773455408,-0.0125102258620374,6.9416272960921e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.0656486730608354,0.00914428946040358,-0.0835714804032265,-0.0477258657184444,7.17739786824881e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,29218,-0.0342950258743455,0.00477768834186284,-0.0436592950243967,-0.0249307567242944,7.23397207150016e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0430181465570129,0.00599560410667484,-0.0547695306060956,-0.0312667625079302,7.4421829560769e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.0445626702591133,0.00622149237634469,-0.0567567953167488,-0.0323685452014777,8.09670545814943e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0400746797995877,0.00559998358561776,-0.0510506476273985,-0.0290987119717769,8.49098804609664e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,29581,0.0324867965847206,0.00454526771732223,0.023578071858769,0.0413955213106722,9.04923788881026e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,29443,-0.0230648821788243,0.00323268733353506,-0.029400949352553,-0.0167288150050956,9.91000170986088e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0297544403328253,0.00417754226579665,-0.0379424231737867,-0.0215664574918638,1.08899514962376e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,28774,-0.0412191395391666,0.0057945202818278,-0.0525763992915491,-0.0298618797867841,1.158068380512e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0200656227759534,0.00282928980684147,-0.0256110307973627,-0.0145202147545441,1.35614268603683e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0168841630465703,0.0023839914204158,-0.0215567862305852,-0.0122115398625553,1.45647341117183e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0328305586320529,0.00464238723327463,-0.0419296376092712,-0.0237314796548346,1.56952760268202e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0132581208423742,0.0018813490861078,-0.0169455650511455,-0.00957067663360286,1.86623371194858e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,29349,-0.0271003795443779,0.00385150905815927,-0.0346493372983701,-0.0195514217903858,2.01740336785961e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0588359549900348,0.0083631721696349,-0.0752277724425192,-0.0424441375375504,2.04244653126966e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,24229,-0.0285400833598796,0.00405844028928765,-0.0364946263268834,-0.0205855403928758,2.08586571304325e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,24240,-0.0449468732923837,0.00639694320607947,-0.0574848819762995,-0.0324088646084679,2.17688585992844e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.037950968411011,0.0054086647799895,-0.0485519513797904,-0.0273499854422316,2.3318582332682e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.014369072631749,0.00204884331450255,-0.018384805528174,-0.010353339735324,2.38806465694813e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.038052369367151,0.00542715293347745,-0.0486895891167668,-0.0274151496175352,2.40896836667886e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.0138700812243662,0.0019809964928005,-0.0177528343502552,-0.00998732809847722,2.59756636998346e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0212533572123497,0.00303582864169041,-0.0272035813500629,-0.0153031330746365,2.59829825985947e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0113432059760761,0.00162099241099578,-0.0145203511016278,-0.00816606085052433,2.6579079404398e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0378388623962469,0.00540791631819443,-0.048438378379908,-0.0272393464125858,2.67211544029754e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,24793,-0.0195053642783307,0.00278880961685601,-0.0249714311273685,-0.014039297429293,2.73644131416949e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0390155112969481,0.00558342814170662,-0.0499590304546931,-0.0280719921392031,2.85351194235155e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.0463007390780781,0.006629403127723,-0.0592943692084152,-0.033307108947741,2.92720325852343e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0446158553974058,0.00639244587974802,-0.0571450493217119,-0.0320866614730997,3.03946578473932e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,24845,-0.0671763797110135,0.00963946057018305,-0.0860697224285722,-0.0482830369934547,3.27425310309175e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0452877464893089,0.00650311964246944,-0.058033860988549,-0.0325416319900688,3.37803701739909e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0187520402309069,0.00270154874603354,-0.0240470757731326,-0.0134570046886812,3.96976131238913e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,29594,0.014751494464949,0.00212966440250952,0.0105773522360303,0.0189256366938676,4.39653054733747e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0269663012674614,0.00389277235870531,-0.0345961350905238,-0.0193364674443989,4.39852924307091e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0198807549055615,0.00287053457717156,-0.0255070026768178,-0.0142545071343053,4.4235528695248e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0205481164028575,0.00296736929806975,0.0147320725786408,0.0263641602270742,4.47574338113922e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.0247898519913639,0.00359496391276032,-0.0318359812603742,-0.0177437227223537,5.46725178080664e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0282166010416439,0.00409171550220439,-0.0362363634259645,-0.0201968386573233,5.4755847327544e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0224789942002486,0.00326269145144419,-0.0288738694450792,-0.016084118955418,5.72419473594079e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0345719392668475,0.00502561469951101,-0.0444221440778891,-0.024721734455806,6.14112712861814e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0271989232224703,0.00395677051305427,-0.0349541934280567,-0.019443653016884,6.39323828415447e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.0429615314176622,0.0062513439627627,-0.055214165584677,-0.0307088972506473,6.46369563997012e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,24732,-0.022587813364717,0.00328881424249394,-0.0290338892800051,-0.0161417374494289,6.6617403659869e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0436940457722188,0.00637328809259054,-0.0561856904336963,-0.0312024011107414,7.23445847848107e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.02768088887763,0.00403817016428135,-0.0355957023996214,-0.0197660753556386,7.28109887666602e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0171735412930625,0.00250700009031517,-0.0220872614700803,-0.0122598211160448,7.51897175293799e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,24938,-0.0404854429079301,0.00591320658740214,-0.0520753278192383,-0.0288955579966219,7.7373449019717e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.0127839729282969,0.00186746951918395,0.00912373267069633,0.0164442131858974,7.79678892708438e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0325825544149247,0.00476032573674771,-0.0419127928589502,-0.0232523159708992,7.81880724440401e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,24195,-0.0237255706747804,0.00347117447011389,-0.0305290726362036,-0.0169220687133571,8.3938560537269e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0301401322391054,0.0044184945249058,-0.0388003815079207,-0.02147988297029,9.23107155178336e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0172888735454674,0.00253612742244684,-0.0222596832934632,-0.0123180637974716,9.51314374061237e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0130128646908545,0.0019146368802585,-0.0167655529761611,-0.00926017640554781,1.09204553036536e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0180576508290709,0.00266215430440417,0.0128398283924387,0.0232754732657031,1.19901936723529e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,29443,-0.0429544523678945,0.00633270733477189,-0.0553665587440474,-0.0305423459917416,1.19971445293014e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0545686554882212,0.00805594927150506,-0.0703583160603711,-0.0387789949160713,1.28322489579114e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0108680377186235,0.00160614258993443,0.00771999824235198,0.0140160771948949,1.34358299953838e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0468083483193217,0.00691880179101086,-0.060369199829703,-0.0332474968089404,1.35501839063007e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.0609119362361236,0.00900395760123804,-0.0785596931345501,-0.043264179337697,1.35784366200701e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.0300712582606679,0.00444599719225263,-0.038785412757483,-0.0213571037638527,1.37525921214307e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,28797,-0.0181898464147833,0.00269567601236913,-0.0234733713990268,-0.0129063214305398,1.52962054621732e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0415317739524696,0.00615642395018849,-0.0535983648948391,-0.0294651830101002,1.55306512539576e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.0142936029926844,0.00212143403732187,-0.0184516137058353,-0.0101355922795336,1.64490214925308e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,24922,-0.0262308947060087,0.00389369546594329,-0.0338625378192575,-0.0185992515927598,1.65484540559133e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0132069479991513,0.00196057165874967,-0.0170496684503007,-0.00936422754800196,1.66148510859005e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0226371750026141,0.00336394398432205,-0.0292305052118853,-0.0160438447933428,1.73540922887587e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,0.0193947631858421,0.00288220493746821,0.0137456415084044,0.0250438848632798,1.73805773710024e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,24922,-0.0141379530123546,0.00210410730558751,-0.0182620033313061,-0.0100139026934031,1.86643084549733e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.0289274703138891,0.00430710612612179,-0.0373693983210878,-0.0204855423066904,1.89877791413603e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0436176588219695,0.00650872338401189,-0.0563747566546328,-0.0308605609893062,2.109393309813e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0323336367102182,0.00483085164422744,-0.041802105932904,-0.0228651674875325,2.23071693152203e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,24938,0.0235430285951381,0.00352382292559948,0.0166363356609631,0.0304497215293131,2.42144247556326e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.0226537619190123,0.00339518137858741,-0.0293083174210437,-0.015999206416981,2.57208098921999e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0264119157655681,0.00396037047159849,-0.0341742418899011,-0.018649589641235,2.62927909125576e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.017225076227639,0.00258323080204408,-0.0222882085996454,-0.0121619438556326,2.64856195612543e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.0232742081925035,0.00350050602251309,-0.0301351999966291,-0.0164132163883778,3.01697887255202e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.0413705655167858,0.00622460091255566,-0.0535707833053949,-0.0291703477281768,3.06800745316555e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0251242814796839,0.00378046717754209,-0.0325339971476664,-0.0177145658117014,3.07770960683709e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0116731531464515,0.00175686756401484,-0.0151166135719205,-0.00822969272098236,3.10949308371776e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,24951,0.0115380504918339,0.00173703696059645,0.00813345804906491,0.014942642934603,3.15020419480834e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,24805,-0.0363636377001649,0.00547814011199222,-0.0471007923196697,-0.0256264830806602,3.24635355303776e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0121417774767655,0.00182918850779556,0.00855656800148622,0.0157269869520448,3.24941486040827e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,24845,-0.0131137196958075,0.00197718411604675,-0.0169890005632591,-0.00923843882835583,3.36776010302261e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,29536,-0.0404788409259701,0.0061074938284543,-0.0524495288297405,-0.0285081530221997,3.46745723875532e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0279762623257017,0.00422300448921984,-0.0362533511245726,-0.0196991735268308,3.54014470546866e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0284774808816335,0.00430297706723454,-0.0369113159334132,-0.0200436458298538,3.70121292418597e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0120270776000492,0.00181857016100238,-0.0155914751156138,-0.00846268008448452,3.81783112615951e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0172063769181598,0.00260882988820968,-0.0223196834990508,-0.0120930703372689,4.31182283801173e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0127709988238708,0.00193978184321279,-0.0165729712365679,-0.00896902641117375,4.66416110532486e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,24101,-0.0254293280322003,0.00386443560263446,-0.0330036218133639,-0.0178550342510368,4.78988777208957e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,0.0258160210095036,0.0039252498474929,0.0181225313084175,0.0335095107105897,4.88374614953673e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,24966,0.0147529120567159,0.00224338599984606,0.0103558754970176,0.0191499486164142,4.92226590456873e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,24951,-0.0320276343925546,0.00487183484754384,-0.0415764306937405,-0.0224788380913686,4.99355457985859e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.0482633253353109,0.00737025881866358,-0.0627090326198915,-0.0338176180507303,5.91256596886294e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0413898413991689,0.00632465439448416,-0.0537861640123579,-0.02899351878598,6.07975261681454e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0407938372711064,0.00623310526000437,-0.053010723580715,-0.0285769509614979,6.08045503552123e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.0462434185161564,0.00707630221317703,-0.0601129708539834,-0.0323738661783294,6.46694271054117e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,24381,-0.0357593724407238,0.00547246025211837,-0.0464853945348758,-0.0250333503465718,6.51157276547168e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0313208419756369,0.00479769798555808,-0.0407243300273307,-0.021917353923943,6.78012964534747e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0124094262384574,0.00190194676293615,-0.0161372418938122,-0.00868161058310251,6.94943527144885e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0224733502094282,0.00344890650846222,-0.0292332069660142,-0.0157134934528423,7.33549562485907e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0317810347390109,0.00488941632477892,-0.0413642907355776,-0.0221977787424443,8.162715997659e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,24101,-0.0293830727241702,0.00452646905669984,-0.0382549520753018,-0.0205111933730385,8.67034398184818e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,0.0311864540034625,0.00480870769158654,0.0217613869279529,0.0406115210789721,9.01531345276636e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0135986847882387,0.00209712145129641,-0.0177090428327797,-0.00948832674369778,9.04756955925305e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.0260039711505591,0.00401039150884313,-0.0338643385078916,-0.0181436037932266,9.06795385625286e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0471472811704027,0.0072803471077195,-0.0614167615015329,-0.0328778008392725,9.60061567021024e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0406393355836681,0.00627607645614913,-0.0529404454377204,-0.0283382257296158,9.61328715734485e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,29443,-0.0177097108238637,0.00274029335826999,-0.0230806858060729,-0.0123387358416545,1.04454156511744e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,29725,0.0203292349519582,0.00314582605130842,0.0141634158913937,0.0264950540125227,1.04727281097415e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0270818141134642,0.00419581619804697,-0.0353056138616363,-0.0188580143652921,1.10309373913021e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,29787,0.0195932350766586,0.00303817019833793,0.0136384214879162,0.0255480486654009,1.14296470276436e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,23779,-0.0212710424960617,0.00329828475488067,-0.0277356806156278,-0.0148064043764956,1.14662272864467e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,24845,0.0170007571157673,0.00263876890869519,0.0118287700547247,0.0221727441768098,1.19528412613795e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.0129615592472797,0.00201283816921244,-0.0169067220589361,-0.00901639643562336,1.22097285174187e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.0106612935621228,0.00166189387580761,-0.0139186055587057,-0.00740398156553986,1.42843290507555e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0235494722024781,0.00367240011233498,-0.0307473764226546,-0.0163515679823015,1.453192087275e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,28931,-0.0513922658393762,0.00801705548420119,-0.0671056945884106,-0.0356788370903419,1.47406379552096e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,29694,0.0131604820346099,0.00205494788390199,0.00913278418216204,0.0171881798870578,1.53329418135117e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0163090306805262,0.00254836074000456,-0.0213038177309352,-0.0113142436301173,1.58440544731357e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0409868981363399,0.00640646027652266,-0.0535435602783243,-0.0284302359943555,1.60570756040322e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0227760267114494,0.00356053747003838,0.0157973732701742,0.0297546801527246,1.61503248228272e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,29349,-0.0331776337304672,0.00520204605165244,-0.043373643991706,-0.0229816234692284,1.8231804606507e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,29383,-0.0212527332135121,0.00333530840011605,-0.0277899376777395,-0.0147155287492846,1.89287838380868e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,29618,0.0186033165894934,0.0029195710756888,0.0128809572811434,0.0243256758978435,1.8940089579323e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0373571000300867,0.00586445199179791,-0.0488514259340107,-0.0258627741261628,1.92211824004987e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0269407511541045,0.00423755002096096,0.018635153113021,0.035246349195188,2.08459921600243e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0152212922942088,0.00239966347662166,-0.0199246327083872,-0.0105179518800303,2.2913900843209e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,24805,-0.0460665043313655,0.00726473531214231,-0.0603053855431645,-0.0318276231195666,2.32043456047309e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,24966,0.0101417584589121,0.00159942247963884,0.00700689039881999,0.0132766265190042,2.32356157780223e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.030110389931246,0.00475111874318844,-0.0394225826678953,-0.0207981971945967,2.36846769685503e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0171589462711147,0.00271173304840013,-0.022473943045979,-0.0118439494962504,2.52557328500527e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0297971976818468,0.0047147705712491,-0.0390381480014951,-0.0205562473621986,2.65358041774496e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0189649679147228,0.00300209009173848,-0.0248490644945303,-0.0130808713349154,2.70122662628684e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0488605167970666,0.00774177657574888,-0.0640343988855344,-0.0336866347085988,2.80658710713153e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0189177512335899,0.00300229028051232,0.0130332622837858,0.0248022401833941,2.99688786586121e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0379503792666687,0.00603322462578485,-0.049775499533207,-0.0261252590001303,3.22378783526636e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0358582400522789,0.00571071701962585,-0.0470512454107456,-0.0246652346938122,3.46287934005271e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,29725,0.020271029818885,0.00323130699654513,0.0139376681056565,0.0266043915321134,3.58290975036556e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,29443,-0.0110415549335441,0.00176149309321114,-0.014494081396238,-0.00758902847085031,3.70085987634993e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,29760,-0.00907072694471965,0.00144711850613292,-0.0119070792167402,-0.00623437467269912,3.70418809461344e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,29795,-0.0149352403259123,0.0023857424825379,-0.0196112955916866,-0.010259185060138,3.89706412982539e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0366975886698705,0.00586587519544499,-0.0481947040529427,-0.0252004732867984,4.01140147861989e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.0119862813979792,0.00191985198927982,0.0082233714989908,0.0157491912969677,4.34104223475236e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.032178954237276,0.00515969955195333,-0.0422919653591046,-0.0220659431154475,4.53266939153174e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0303986079050383,0.00487781509267804,-0.0399591254866872,-0.0208380903233893,4.68021309839396e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0247455150070919,0.00397270675600678,-0.0325320202488652,-0.0169590097653186,4.77439874765043e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0190305969445309,0.00305585174432005,-0.0250200663633982,-0.0130411275256636,4.80057131371779e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,29433,-0.0169621181681643,0.0027254239552165,-0.0223039491203886,-0.0116202872159399,4.92228718599135e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.0254651468233656,0.0041029909913668,-0.0335070091664445,-0.0174232844802867,5.49110436239319e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,29566,-0.027338040486176,0.00441132044249474,-0.0359842285534657,-0.0186918524188863,5.82176848460333e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0276276041189639,0.00445893711450295,-0.0363671208633897,-0.0188880873745381,5.86716252429599e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0224493707226514,0.00362391278421326,-0.0295522397797094,-0.0153465016655934,5.92816981415225e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0114063365973106,0.0018441802344384,-0.0150209298568099,-0.00779174333781134,6.29061168890898e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,28774,-0.031724107577393,0.00513414968058793,-0.0417870409513453,-0.0216611742034407,6.53578230870477e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0268733509497089,0.00435686952275189,-0.0354128152143025,-0.0183338866851152,7.02048226699136e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0194170540497003,0.00314921320683488,-0.0255895119350966,-0.0132445961643039,7.1111872121754e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0425214865665229,0.00692531205466679,-0.0560950981936698,-0.028947874939376,8.3763156564244e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0584406553615539,0.00952251232614438,-0.0771047795207969,-0.0397765312023109,8.51142570902736e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,24845,-0.0363600806681198,0.00593033894905648,-0.0479835450082705,-0.0247366163279691,8.85346490526469e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.0288554379974449,0.00471060885037227,-0.0380882313441746,-0.0196226446507153,9.17248600642783e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0400710119866616,0.00654475922945311,-0.0528987400763897,-0.0272432838969335,9.32390228091146e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.0205573917309416,0.00335790428042405,-0.0271388841205727,-0.0139758993413105,9.37387173465564e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,29478,-0.0104907749210792,0.00171579937331796,-0.0138537416927824,-0.00712780814937597,9.82483815121878e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,28774,-0.0452549122909358,0.0074164252412393,-0.0597911057637648,-0.0307187188181068,1.06096382989431e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0121217939565918,0.00198815103826982,0.00822501792158299,0.0160185699916007,1.09666593462247e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.0499573557395687,0.00819552548160321,-0.066020585683511,-0.0338941257956264,1.10326327597746e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0390283326869745,0.00640388935677716,-0.0515799558262578,-0.0264767095476913,1.11417454083295e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0508893769774513,0.00837616582027572,-0.0673066619851917,-0.0344720919697109,1.2545635944926e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,29079,-0.0162762468258484,0.00267922333635421,-0.0215275245651026,-0.0110249690865941,1.25536500723208e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0224519378692871,0.0036976594651428,-0.0296993504209669,-0.0152045253176072,1.27960822758081e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0181747013602589,0.00299330711716829,-0.0240415833099088,-0.0123078194106091,1.2804017609512e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0397562408070944,0.00655031723257177,-0.0525948625829351,-0.0269176190312537,1.30280305956026e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,24111,-0.0340258184033946,0.00561038650885102,-0.0450221759607426,-0.0230294608460466,1.3409257220412e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0148175861754937,0.00244514858252257,-0.0196100773972379,-0.0100250949537495,1.37808880060626e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,29443,0.0209316073329704,0.00345476169172201,0.0141602744171952,0.0277029402487455,1.38829569329506e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0204951198636303,0.00338605543511391,-0.0271317885164535,-0.013858451210807,1.44383767812395e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,24587,-0.0229237676114941,0.00378783957184856,-0.0303479331723173,-0.0154996020506709,1.45185643398542e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0342168147163574,0.00565694315042065,-0.0453044232911819,-0.0231292061415329,1.48214492992132e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,24111,-0.0169539942817667,0.00280468370671177,-0.0224511743469218,-0.0114568142166116,1.51712417851579e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,29333,-0.0145721759050552,0.00241250671547656,-0.0193006890673893,-0.00984366274272116,1.55713502590557e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0242919336704835,0.00402239832629045,-0.0321758343900128,-0.0164080329509542,1.57170915032614e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,29725,-0.012065347845923,0.00199903203039909,-0.0159834506255052,-0.00814724506634082,1.60251930852179e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0365596957737586,0.00606018843726582,-0.0484376651107996,-0.0246817264367176,1.63500871720556e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0271800654817461,0.00450600183909908,-0.0360118290863803,-0.0183483018771119,1.63948951482933e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0518767163574521,0.00860104888349556,-0.0687347721691033,-0.0350186605458008,1.64502182163508e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,24240,-0.0220367880777088,0.00365559785047868,-0.029201759864647,-0.0148718162907706,1.68160766563011e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,29434,-0.0287789183177135,0.00477866974834781,-0.0381451110244752,-0.0194127256109518,1.73917573621089e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,24951,-0.0388820605292028,0.00645793632953868,-0.0515396157350986,-0.026224505323307,1.75962980919581e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,29478,0.0158213875864471,0.0026293327744346,0.0106678953485553,0.0209748798243389,1.79481962710642e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.0143138637341642,0.00238879475695228,-0.0189959014577906,-0.00963182601053768,2.09571930895406e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.00702345981675924,0.001173995191633,-0.00932449039235992,-0.00472242924115856,2.22692782046233e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,29274,0.0120751013970627,0.00202540754013324,0.00810530261840153,0.0160449001757238,2.52310555545167e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,29311,-0.0146519137999134,0.00245772104036987,-0.0194690470390384,-0.00983478056078845,2.52658598816319e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.0245909193358718,0.00412624267393946,-0.0326783549767931,-0.0165034836949505,2.56209295219418e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,29639,0.0106801020923055,0.00179376426484857,0.00716432413320229,0.0141958800514087,2.64583995407368e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0287560115302104,0.00482961557190381,-0.0382220580511419,-0.0192899650092789,2.65116358816081e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,29165,0.0201566950069773,0.00338649331679493,0.0135191681060592,0.0267942219078953,2.67771748320736e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0291315431872468,0.00489715818898356,-0.0387299732376545,-0.019533113136839,2.74072010935507e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0287278009497752,0.00483473202180527,-0.0382038757125136,-0.0192517261870369,2.85483559058479e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0494816865872855,0.00832875850165475,-0.0658060532505288,-0.0331573199240422,2.86956548044777e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0176767441134464,0.00297719605592667,-0.0235120483830627,-0.0118414398438301,2.93469728693109e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.027596028369729,0.00465288170425243,-0.0367156765100638,-0.0184763802293943,3.04598687083551e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0285331427803758,0.00481096219711359,-0.0379626286867184,-0.0191036568740331,3.05336120175763e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0347634095949148,0.00586455059324533,-0.0462579287576757,-0.023268890432154,3.10586198974317e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,0.0148166798083764,0.0025066559909056,0.00990363406620142,0.0197297255505514,3.44600226465463e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.0170160024370616,0.00287920389290609,-0.0226592420671575,-0.0113727628069657,3.46649322434306e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,29174,-0.024284422405266,0.0041149170116962,-0.0323496597481905,-0.0162191850623414,3.64060234414504e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.0365316228437649,0.00619298547786628,-0.0486698743803828,-0.024393371307147,3.70746024027359e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0126875615495741,0.00215200976332624,-0.0169055006856935,-0.00846962241345467,3.78085524158169e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.0131573970540199,0.0022324052109601,0.00878188284053806,0.0175329112675017,3.81420796595443e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.0294293431980065,0.00499533427755714,-0.0392201983820185,-0.0196384880139945,3.87963311879018e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0160497683029367,0.0027265478869061,-0.0213938021612726,-0.0107057344446007,3.98800745054249e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,24111,-0.0245404858224088,0.00417513173433145,-0.0327237440216984,-0.0163572276231191,4.21291309481493e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0200962309120545,0.00341981819555414,-0.0267990745753406,-0.0133933872487684,4.24771658303458e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0447400161294398,0.00761426284323972,-0.0596639713021897,-0.02981606095669,4.26141656045176e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0232728209711166,0.00396777889702807,-0.0310496676092916,-0.0154959743329416,4.53779673938564e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0280116117812985,0.00478610113204625,-0.0373923700001091,-0.0186308535624878,4.89833116728534e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0203503794645571,0.00348175441075038,-0.0271746181096278,-0.0135261408194863,5.12449505805096e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0314562934569936,0.00539111149603674,-0.0420228719892256,-0.0208897149247616,5.45103670291559e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0113516531911951,0.00194863121843586,-0.0151709703793293,-0.00753233600306077,5.7545445914302e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,28277,-0.00946795219921927,0.00162616946597619,-0.0126552443525326,-0.00628066004590595,5.86908442187756e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0160531725991764,0.00275778946467729,-0.0214584399499439,-0.0106479052484089,5.90870053643934e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.0113057061092182,0.00194502606199762,0.00749345502770284,0.0151179571907335,6.21295810889964e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,28931,0.016401372431465,0.00282349009311579,0.0108673318489581,0.021935413013972,6.35427152732054e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,29381,-0.016786307865756,0.00289168777591828,-0.0224540159065558,-0.0111185998249562,6.50195074070847e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.0128351844826113,0.00221149083495367,0.00850066244610212,0.0171697065191205,6.56142652860496e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.00795563975736839,0.00137259578357029,-0.0106459274931662,-0.00526535202157062,6.85872069395258e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00645571629728202,0.00111739306733666,0.00426562588530216,0.00864580670926187,7.65813952490381e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0198965079884299,0.00344529682013358,-0.0266492897558917,-0.013143726220968,7.78805691938985e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0365524032433077,0.00632951952658603,-0.0489582615154163,-0.0241465449711991,7.79094054300273e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.00755485794282277,0.00130892998926278,-0.0101203607217778,-0.00498935516386772,7.93663073777058e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,29434,-0.0382212472348485,0.00662255030784618,-0.051201445838227,-0.02524104863147,7.94140358431712e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0299253979699993,0.00519316552307101,-0.0401040023952185,-0.0197467935447801,8.39022223814416e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,29443,0.00798476114828032,0.00138605815976503,0.00526808715514086,0.0107014351414198,8.45650028838876e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,29443,0.0097516920197879,0.00169619679371556,0.00642714630410541,0.0130762377354704,9.05783815298987e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0115033845631815,0.00200325696034319,-0.0154297682054541,-0.00757700092090881,9.4467119656786e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0367614708523615,0.00640281254590445,-0.0493109834423342,-0.0242119582623887,9.47887240470266e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,29478,-0.0276341215525542,0.00481309904080601,-0.0370677956725339,-0.0182004474325744,9.47957827219491e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0287260193369142,0.00501569430103199,-0.0385567801669369,-0.0188952585068915,1.03103967511172e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.0130794859525577,0.00228407886475,-0.0175562805274677,-0.00860269137764773,1.03780665377904e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0337055037818062,0.00588782690060333,-0.0452456445069887,-0.0221653630566236,1.04675308654244e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,29544,-0.0120089469678391,0.00209856454533954,-0.0161221334767046,-0.00789576045897361,1.0600876438568e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.021192707614825,0.003707383316123,-0.0284591789144261,-0.013926236315224,1.10113298241101e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,-0.0390029937749439,0.00683312085625184,-0.0523959106531975,-0.0256100768966903,1.15454275885317e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,24195,-0.0181485634626917,0.00317969519594952,-0.0243807660467528,-0.0119163608786307,1.15891390348975e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0239129699648282,0.00419271381512249,-0.0321306890424683,-0.0156952508871881,1.18736392349199e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0136446042420128,0.00239287328357227,-0.0183346358778144,-0.00895457260621115,1.19400217049612e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,24867,-0.0308205411274401,0.00540534712749364,-0.0414150214973276,-0.0202260607575525,1.19848996209367e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,29623,-0.0237114042131929,0.00416563719063311,-0.0318760531068338,-0.015546755319552,1.26638927461578e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.0266156982221663,0.00468302311575769,-0.0357944235290514,-0.0174369729152812,1.33487699084542e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,28867,-0.023940519713637,0.004215793351127,-0.032203474681846,-0.0156775647454281,1.36969573698983e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.0133684554969426,0.00235467055609781,0.00875330120699088,0.0179836097868943,1.38260287117248e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.0444769454680147,0.00783448219222354,0.0291213603712566,0.0598325305647729,1.3863957305459e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0233605596134925,0.00411521552310023,-0.031426382038769,-0.015294737188216,1.38674695829306e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0398938320947642,0.00703436101194332,-0.0536811796781731,-0.0261064845113553,1.4330858872785e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,24805,-0.0178477083480862,0.00315458177043728,-0.0240306886181432,-0.0116647280780291,1.55096898687621e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00701302314650913,0.00124304674010479,0.00457665153590375,0.00944939475711452,1.69822203266696e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0326883702127348,0.00579747696286154,-0.0440514250599434,-0.0213253153655262,1.73258101018789e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,28580,0.0265878313340972,0.0047156242153448,0.0173452078720214,0.035830454796173,1.73415010904682e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,28797,-0.023056570998717,0.00409365556798023,-0.0310801359119582,-0.0150330060854757,1.79511362070471e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0160243382519195,0.00285061003376935,-0.0216115339181074,-0.0104371425857316,1.91174204263029e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,24240,-0.011856268387837,0.00211207198643364,-0.0159959294812469,-0.00771660729442703,2.00360122084938e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0439105320830505,0.0078256037818945,-0.0592487154955637,-0.0285723486705372,2.02840640289183e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0143282120149717,0.00255435721779377,-0.0193347521618475,-0.00932167186809594,2.05337383677452e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0284559077523704,0.00507477956310986,-0.0384024756960657,-0.0185093398086751,2.07358461432038e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0245009172781514,0.00436994534065935,-0.0330660101458437,-0.0159358244104591,2.08493167730407e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0386230666514147,0.00689087199916,-0.0521291757697683,-0.0251169575330611,2.1051195925267e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0128462538780246,0.00229702240214817,-0.017348417786235,-0.00834408996981414,2.25725948885584e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0160490502861574,0.00287631922072621,-0.0216866359587808,-0.010411464613534,2.43483937654352e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0312092830972878,0.00559575453852769,-0.0421769619928021,-0.0202416042017735,2.46799393503667e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0244195747859853,0.0043816471115136,-0.033007603124552,-0.0158315464474187,2.52840301138868e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0462199642340819,0.00830574186308856,-0.0624992182857355,-0.0299407101824283,2.65196870538094e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,24903,0.0141487337107022,0.00254325168589215,0.00916396040635358,0.0191335070150508,2.67524849577106e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,29786,-0.0304489852824726,0.00547362178677377,-0.0411772839845492,-0.019720686580396,2.67668987097693e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0162225972681772,0.00291834459195752,-0.0219425526684139,-0.0105026418679404,2.74455842966781e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0415011532717704,0.00747976147389612,-0.0561614857606068,-0.026840820782934,2.9118483733685e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,29640,-0.0271995944997921,0.00490660575166195,-0.0368165417730495,-0.0175826472265347,2.99068808154414e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.014464834093788,0.00261343427900048,-0.019587165280629,-0.00934250290694706,3.14731932399759e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0465162306689905,0.00841061583962139,-0.0630010377146484,-0.0300314236233326,3.22307955054067e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,29820,0.00926152472132199,0.00167615844733354,0.00597625416454826,0.0125467952780957,3.3139284759492e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0164547851077806,0.0029810493828938,-0.0222976418982525,-0.0106119283173088,3.42849573224724e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,29349,0.0299031843137628,0.00542090917736048,0.0192782023261362,0.0405281663013893,3.49195364726761e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,29581,-0.0139110726808649,0.00252539770995738,-0.0188608521923814,-0.00896129316934843,3.64981531235397e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.0332018161575203,0.00602749853163614,-0.0450157132795271,-0.0213879190355135,3.65715874120917e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,29536,-0.0116257145003969,0.00211278039773835,-0.0157667640799641,-0.00748466492082972,3.77408167209926e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0276909955234232,0.00503288655578246,-0.0375554531727568,-0.0178265378740896,3.78681685053207e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00871972627449994,0.00158639294959304,0.00561039609329758,0.0118290564557023,3.90467614068689e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.0164094039625889,0.00298712032392905,-0.0222641597974899,-0.010554648127688,3.98264856947715e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0140337378192422,0.00255612984867659,-0.0190437523226483,-0.00902372331583606,4.04736483010381e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,24793,-0.0262566837085066,0.00478248574673879,-0.0356303557721146,-0.0168830116448985,4.0547342317059e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,24805,-0.0219441351910051,0.00401290554197963,-0.0298094300532851,-0.014078840328725,4.58523111743523e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,24938,0.0121013139430328,0.00221766738215957,0.00775468587400002,0.0164479420120655,4.89473686383799e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.013833104884071,0.00253620878399961,-0.0188040741007103,-0.0088621356674318,4.9663168887136e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0124643830809435,0.00228682964321021,-0.0169465691816356,-0.00798219698025152,5.07159772100561e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,28916,-0.0324170564777757,0.00595201461649551,-0.0440830051261069,-0.0207511078294445,5.18179307012534e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0136329925752434,0.00250619462113598,-0.0185451340326699,-0.00872085111781686,5.37930041165813e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,24776,-0.0362567252471595,0.00667260923698095,-0.0493350393516422,-0.0231784111426769,5.57284807533865e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,24381,-0.0416213939225003,0.00766004498002839,-0.056635082083356,-0.0266077057616447,5.57665676583925e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.01307848659114,0.00240755101256785,-0.017797286575773,-0.00835968660650705,5.61626951503769e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,29497,0.0127366346878075,0.00234605523121642,0.00813836643462326,0.0173349029409916,5.71310594428975e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0252242932524894,0.00464725072645889,-0.0343329046763488,-0.01611568182863,5.75064542452003e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.0293084851724107,0.00540028617776415,-0.0398930460808285,-0.018723924263993,5.77940601576612e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,29023,-0.0286743475349892,0.00529447791405086,-0.0390515242465289,-0.0182971708234495,6.14663396209755e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.0163312623449298,0.00302117947201659,-0.0222527741100823,-0.0104097505797773,6.52048002708417e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,28774,0.0282455542246891,0.0052283089881521,0.017998068607911,0.0384930398414672,6.62669040781381e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.0454295570018904,0.008411167478965,-0.0619154452606618,-0.0289436687431191,6.67448929538171e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0176944940038068,0.00328332112262765,-0.024129803404157,-0.0112591846034566,7.14139136699724e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,29396,-0.0098104575862992,0.00182871977457427,-0.0133947483444648,-0.00622616682813363,8.17150414348735e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,29820,-0.03312656646032,0.00619611712592966,-0.0452709560271421,-0.0209821768934979,9.04086071193652e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.023569875854924,0.00441255114756587,-0.0322184761041531,-0.0149212756056949,9.283061015065e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0145234080810315,0.00271880555083924,-0.0198522669606764,-0.00919454920138662,9.28449955852828e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0356095600503827,0.00666805776333572,-0.0486789532665207,-0.0225401668342447,9.35998190625837e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.0199556348001978,0.00374004989538441,-0.0272861325951513,-0.0126251370052444,9.60449736133419e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0179491446969609,0.0033652536507081,-0.0245450418523488,-0.011353247541573,9.69644560162034e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0144238080918238,0.00270651461516987,-0.0197285767375567,-0.0091190394460908,9.93139236644299e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.0311124925821431,0.00584188555714489,-0.0425625882741471,-0.0196623968901392,1.01421383051939e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0132312007360609,0.00248594443350019,0.00835874964640049,0.0181036518257212,1.03153989961027e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,29434,-0.0116774556914012,0.00220158469192551,-0.0159925616875752,-0.0073623496952272,1.14039011996966e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0112845074887126,0.00212814830184825,-0.0154556781603351,-0.00711333681708999,1.15200468774705e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,28774,-0.0253621677681784,0.0047947848946944,-0.0347599461617794,-0.0159643893745773,1.23525769751076e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.00868541809164874,0.00164285702881382,-0.0119054178681238,-0.00546541831517366,1.25384429010281e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0282140239288316,0.00533915976471841,-0.0386787770676796,-0.0177492707899835,1.27228811205914e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0120336667682731,0.00227963033623921,-0.0165017422273019,-0.00756559130924423,1.31160170808045e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.041403552884533,0.00787037569428583,-0.0568294892453332,-0.0259776165237327,1.44519935586972e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0142246210342872,0.00271135182354178,-0.0195388706084291,-0.0089103714601453,1.56439308474067e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0193906439144984,0.00369746004375225,-0.0266376656002528,-0.012143622228744,1.57938402061665e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,28916,-0.0184144240146083,0.00352780139359761,-0.0253289147460596,-0.011499933283157,1.80351611271377e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.0103750760606063,0.00199026592550548,-0.0142759972745971,-0.00647415484661557,1.87425173343546e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.0265229458855232,0.00509424675216118,-0.0365076695197591,-0.0165382222512873,1.93773596654129e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0165350409727426,0.00317736361711412,-0.0227626736622863,-0.010307408283199,1.96627919337028e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0183079072028192,0.00351883710738933,-0.0252048279333023,-0.0114109864723361,1.97843301898089e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,28797,-0.0196547969070523,0.00377949557544171,-0.0270626082349181,-0.0122469855791866,2.00245417220147e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.0179628668719742,0.00346418012141322,-0.0247526599099441,-0.0111730738340043,2.17342321489195e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0529744587988493,0.0102167438287523,0.0329496408944947,0.0729992767032039,2.17626898512053e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.0166722372087944,0.00321770376834013,-0.022978936594741,-0.0103655378228477,2.21937632925659e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.0144285489479108,0.00278553399682118,-0.0198881955816803,-0.00896890231414131,2.23838862207486e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0547016557815379,0.0105726263337891,-0.0754240033957645,-0.0339793081673113,2.30766890520872e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.018305873747867,0.00354104516960397,-0.0252463222802908,-0.0113654252154432,2.3638467443335e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.0103399348446289,0.00200038790411653,0.00641917455256049,0.0142606951366973,2.3692917934643e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.0150256949852301,0.00290823466424579,-0.0207258349271519,-0.00932555504330835,2.39970248587882e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0235627985306584,0.00456137223946341,-0.0325030881200066,-0.0146225089413101,2.41359518821221e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.0176889612866558,0.00342535841885903,-0.0244026637876195,-0.0109752587856921,2.4317234930061e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0205154973349585,0.00397702221603234,-0.0283104608783818,-0.0127205337915351,2.505444019191e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,24966,-0.0194070201509718,0.00377078400995152,-0.0267977568104768,-0.0120162834914668,2.67145216928439e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,28931,0.0110243124366023,0.00214312623600109,0.00682378501404013,0.0152248398591644,2.70655708976198e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0211466577548061,0.00411768187240025,-0.0292173142247106,-0.0130760012849016,2.83408611277293e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00759456646987944,0.00147980988735076,-0.0104949938490869,-0.00469413909067194,2.88317292678283e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,0.012134953877932,0.00236619211555208,0.00749721733144994,0.0167726904244141,2.93956648866339e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.0183245740739393,0.00357384717431794,-0.0253293145356025,-0.0113198336122762,2.95616708657849e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,24922,-0.025968387752087,0.00507025738488275,-0.0359060922264571,-0.0160306832777168,3.05032422573283e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,28628,-0.0404123087842715,0.00789604194954255,-0.0558885510053749,-0.0249360665631681,3.10711907249113e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0185600928378291,0.00362894110961281,-0.0256728174126702,-0.0114473682629879,3.16648750557943e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0174179469083757,0.00340948405695401,-0.0241005356600056,-0.0107353581567459,3.26494985273077e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0168272331827034,0.0032981766547431,0.0103628069394069,0.0232916594259999,3.38588981617516e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.0254859814436779,0.0049957299668152,-0.0352776121786357,-0.0156943507087201,3.39396958953049e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0186980499762545,0.00367027314452925,-0.0258917853395318,-0.0115043146129771,3.52306456466791e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.030993862183373,0.00610511409093029,-0.0429598858015964,-0.0190278385651496,3.86880260277068e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,29566,-0.010694113223671,0.00210788978148377,-0.0148255771953792,-0.00656264925196286,3.93187129601577e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0355714903540846,0.00702215485847283,-0.0493349138766913,-0.0218080668314779,4.10101642447485e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0262809301327042,0.00519843801501694,-0.0364698686421374,-0.016091991623271,4.32205951770618e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.00696379550922429,0.0013782311933517,-0.00966512864819362,-0.00426246237025496,4.38674537034027e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0122217261638758,0.00242320929999349,0.00747223593588853,0.016971216391863,4.59548228451373e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0262384047918192,0.00520597559264373,-0.0364421169534009,-0.0160346926302375,4.6871827627227e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0188759915500061,0.00374567449554146,-0.0262175135612674,-0.0115344695387448,4.70326536723393e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.0156438638869999,0.00311374705385485,-0.0217468081125554,-0.00954091966144437,5.08694526832998e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,28452,-0.0213418405960365,0.00425186673515176,-0.029675499396934,-0.0130081817951391,5.21444108752915e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0162492732477294,0.00324345169681598,-0.0226064385734887,-0.00989210792197008,5.478274572527e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0107054349493366,0.00214562560874689,-0.0149108611424805,-0.00650000875619271,6.09018906684389e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0186622534900351,0.00374359782233977,-0.025999705221821,-0.0113248017582491,6.23433783986635e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0250102244038017,0.00501764618753108,-0.0348448109313626,-0.0151756378762408,6.24873720457632e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,24636,-0.0349423534072664,0.00701816950476125,-0.0486979656365985,-0.0211867411779344,6.4397983482489e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.0190225103432232,0.00382111015662853,-0.0265118862502151,-0.0115331344362313,6.45191198175862e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,28890,-0.01945272892076,0.00391579601078306,-0.0271276891018948,-0.0117777687396252,6.81177591254988e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0226647527721529,0.00456291623085927,0.0137214369596687,0.0316080685846371,6.83181957833486e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.0152691563025086,0.00308223566322893,-0.0213103382024373,-0.00922797440257987,7.32109026750417e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0114544391073562,0.00231863840838297,0.00690990782692562,0.0159989703877869,7.84831581953705e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0210824506377602,0.00427161442893099,-0.029454814918465,-0.0127100863570555,8.04829831916451e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,0.00989329166993082,0.00200929233245389,0.0059550786983212,0.0138315046415404,8.53516981771077e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,28797,-0.0233219246436905,0.00474280390626087,-0.0326178202999618,-0.0140260289874192,8.82161550063119e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,28669,0.0312240859261251,0.00635275474104515,0.0187726866336766,0.0436754852185736,8.92511661509264e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,29296,-0.0106786978377979,0.00217421094661952,-0.0149401512931722,-0.00641724438242367,9.08560730077721e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,29218,-0.0114808443839854,0.00233804756407149,-0.0160634176095655,-0.00689827115840527,9.13621096255564e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,29518,-0.013133632838919,0.00267516503271731,-0.0183769563030449,-0.00789030937479302,9.18118618231925e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00709644725083258,0.00144729891856296,0.00425974137044917,0.00993315313121599,9.4884105086328e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0125738756707476,0.00256566422974894,-0.0176025775610555,-0.00754517378043972,9.59505840019789e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,24805,-0.0120464013816136,0.00246138841127752,-0.0168707226677176,-0.00722208009550968,9.93518007571627e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0131867109260499,0.00269559954091754,-0.0184700860262483,-0.00790333582585152,1.00481822195608e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.0252921684330305,0.0051709748889032,-0.0354272792152807,-0.0151570576507802,1.0077417337811e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,28751,-0.0299230410920435,0.00612479661310599,-0.0419276424537312,-0.0179184397303558,1.03691544822047e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0424728348482443,0.00869730871675338,-0.0595195599330809,-0.0254261097634077,1.0491544990778e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.0253688945774272,0.00521154199046833,-0.0355835168787451,-0.0151542722761093,1.13428680625402e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,28916,-0.0262453094346223,0.00539236486997915,-0.0368143445797814,-0.0156762742894632,1.13830448035426e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.0105050048545042,0.00215840299590091,0.00627453498253841,0.01473547472647,1.1388905354449e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,29478,-0.0117358716500904,0.00241484375141333,-0.0164689654028605,-0.00700277789732031,1.18055300948393e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0257820233200001,0.00530717618773151,-0.0361840886479539,-0.0153799579920463,1.19338460472896e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.012680156406439,0.00261041631410005,0.00756374043080287,0.0177965723820751,1.19599018153563e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0254655587632776,0.00524388410580148,-0.0357435716106485,-0.0151875459159067,1.20375308251039e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.0161663939678935,0.00333108573338276,-0.0226953220053238,-0.00963746593046332,1.22229073520997e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.014341600935767,0.00295777846809453,-0.0201388467332322,-0.00854435513830168,1.24862615025841e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.00942345678067792,0.00194382790830139,-0.0132333594809486,-0.0056135540804072,1.25535364109281e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.00884597053121412,0.00182522107569291,0.00526853722285602,0.0124234038395722,1.26279342713742e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,29820,0.005873748086461,0.00121385397956274,0.00349459428651803,0.00825290188640396,1.31195524602998e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,24920,-0.0125895263014653,0.00260331056276966,-0.0176920150044938,-0.00748703759843676,1.33289811103519e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,0.0097734776788734,0.00202195194493756,0.00581045186679578,0.013736503490951,1.34720961271626e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,28774,-0.0154592311325409,0.00320074713348268,-0.021732695514167,-0.00918576675091489,1.37316139987183e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,24240,-0.00997720614429519,0.00206614430981423,-0.0140268489915311,-0.0059275632970593,1.38126084604796e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.0192826367939908,0.0039963151108754,-0.0271154144113066,-0.011449859176675,1.4078100920698e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.020531667310046,0.0042591119465523,-0.0288795267252885,-0.0121838078948035,1.4396641494794e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,24421,-0.00752941677732982,0.00156719436215825,-0.01060111772716,-0.00445771582749966,1.5614357699546e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.0131791335078528,0.00274451020585847,-0.0185583735113354,-0.00779989350437023,1.57864089617596e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0145915851316682,0.00304238378086089,-0.0205546573421556,-0.00862851292118091,1.62587301080669e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,24111,0.0121470512993961,0.00253849362331782,0.00717160379769317,0.017122498801099,1.71878529086271e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0235421917714221,0.00492398487574033,0.0138911814149711,0.0331932021278732,1.75164616992756e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,28931,-0.0275922984957082,0.00577155334800973,-0.0389045430578073,-0.0162800539336092,1.75509050648932e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.0231499273105021,0.00484440310967074,-0.0326449574054568,-0.0136548972155475,1.77298597351173e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,24867,0.0119973384431468,0.00251082232542025,0.00707612668532307,0.0169185502009704,1.77836259740456e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.0145119253903707,0.00303742070846522,0.00855858080177889,0.0204652699789626,1.78338291254283e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,24606,0.0104742271082645,0.00219331802763175,0.00617532377410628,0.0147731304424227,1.80278137718961e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0314407146241638,0.00658791255051952,-0.0443530232231821,-0.0185284060251456,1.82832186258077e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0163092509670975,0.00341814094046067,-0.0230088072104004,-0.00960969472379455,1.84012796581095e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,24240,-0.0206200427614501,0.00432170798197417,-0.0290905904061195,-0.0121494951167808,1.84132555040786e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0229709207296909,0.00481670889767293,-0.0324116701691299,-0.013530171290252,1.86213990405357e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.0164923376163369,0.00346757602436831,-0.0232887866240988,-0.00969588860857502,1.9826840224924e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.0165212186374859,0.00347553063092578,0.00970917860087133,0.0233332586741004,2.00786325406397e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,28879,-0.0143153905516547,0.00301361896390921,-0.0202220837209168,-0.00840869738239267,2.04158948638859e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,24101,-0.0147222936067716,0.00310029601111201,-0.0207988737885512,-0.0086457134249921,2.05932736757417e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.00848432431455898,0.00178704158008591,-0.0119869258115274,-0.00498172281759059,2.06713606956295e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,24867,-0.023117993960435,0.00487411625931515,-0.0326712618286927,-0.0135647260921773,2.11731552872568e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.00903765057053301,0.00190622687736617,-0.0127738552501707,-0.00530144589089531,2.13522361412267e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.00875234179264376,0.00184630246835192,0.00513358895467399,0.0123710946306135,2.14433970550831e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.0228955123107045,0.00483561682065051,-0.0323733212791795,-0.0134177033422295,2.20554970174036e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,24938,0.008057687397421,0.00170507557086882,0.00471573927851812,0.0113996355163239,2.30567087604025e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0129915968043606,0.0027509554254038,0.00759972417056917,0.0183834694381521,2.33947370152033e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,29434,-0.0133195296542856,0.00282541137403196,-0.0188573359473882,-0.00778172336118294,2.43783226159337e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.0116643660716475,0.00247493018091818,-0.0165152292262472,-0.00681350291704791,2.454308301354e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,29566,0.00926863868711274,0.00196750125347158,0.00541233623030845,0.013124941143917,2.47784743588623e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,24951,0.019994717221457,0.00424967969587925,0.0116653450175337,0.0283240894253803,2.55234403419306e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,29117,0.0222515651249836,0.00474211354385303,0.0129570225790316,0.0315461076709355,2.71337509744371e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.0293361413418772,0.00625451614440878,-0.0415949929849184,-0.017077289698836,2.74126278453553e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.0208313892829447,0.00444722681530918,-0.0295479538409507,-0.0121148247249387,2.8268464738798e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.0095224017536804,0.0020332141397011,-0.0135075014674945,-0.00553730203986626,2.8338442585631e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0157924378816462,0.00337274770625831,-0.0224030233859124,-0.00918185237737986,2.8508171827199e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,29132,0.0223597290251972,0.00479321660173178,0.0129650244858029,0.0317544335645914,3.10184620848167e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.0107873243404098,0.00231458688876177,-0.0153239146423828,-0.00625073403843672,3.16943695379526e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.024998215946396,0.00537596695872921,-0.0355351111855053,-0.0144613207072868,3.33417225828816e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0170403435630733,0.00366596803680792,-0.0242256409152168,-0.00985504621092972,3.36209940309569e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.011981860367707,0.00258268545296904,-0.0170439238555263,-0.0069197968798877,3.51430845937337e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0192288072497175,0.00415330227434949,-0.0273692797074425,-0.0110883347919925,3.67628065651506e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0215941351499003,0.00468309710689254,-0.0307730054794097,-0.012415264820391,4.02576354754529e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.0229143583231731,0.0049716438819434,-0.0326587803317821,-0.013169936314564,4.06663707239118e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0197590306749405,0.00428823400461475,-0.0281639693239854,-0.0113540920258956,4.09100842606376e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.0127625284685737,0.00277013063012408,-0.0181919845036168,-0.00733307243353046,4.09879625579131e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0251259182240314,0.00545838461417113,-0.0358243520678068,-0.014427484380256,4.18202360141099e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,24229,-0.0141779099985933,0.00308257491931438,-0.0202197568404495,-0.0081360631567371,4.25909626991683e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,0.0111495215783718,0.00242897868700262,0.0063887233518467,0.015910319804897,4.44620191230651e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.00970580013539905,0.0021162856381979,-0.0138537199862669,-0.00555788028453116,4.53192696035145e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0283680124117769,0.00619207839092215,-0.0405044860579843,-0.0162315387655695,4.63904081754391e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,28916,-0.0144247806704435,0.00315029965516739,-0.0205993679945716,-0.00825019334631544,4.6946466935286e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.00936975962717424,0.0020467112015917,0.00535820567205452,0.013381313582294,4.71880823369497e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.0132270740789709,0.00289781587701376,-0.0189067931979179,-0.00754735496002397,5.03098471740084e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,24381,-0.0106637886036318,0.00233932605141375,-0.0152488676644028,-0.00607870954286088,5.17736407748892e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0212692442811269,0.00467663660938192,-0.0304354520355155,-0.0121030365267383,5.43849265254784e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0189016244425403,0.00415698381286411,-0.0270493127157539,-0.0107539361693266,5.46488756737494e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,28916,0.00733422956867633,0.00161511749290183,0.00416859928258875,0.0104998598547639,5.62170637269116e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,29349,-0.0263671553653659,0.00580813015354659,-0.0377510904663172,-0.0149832202644145,5.65586214066804e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0181004045857723,0.00399532846546872,-0.025931248378091,-0.0102695607934537,5.91035597491898e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.0120821939138023,0.0026673814516156,0.00685412626863576,0.0173102615589689,5.93343471534174e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.00925612538201123,0.00204574870062936,-0.0132657928352448,-0.00524645792877768,6.08070261152327e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.0146002487026191,0.00323595279130153,-0.0209427161735701,-0.0082577812316681,6.4557319123416e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.0233189464041329,0.00516957109981917,-0.0334513057597785,-0.0131865870484873,6.48274973583626e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0158004522354964,0.00350725657072083,-0.0226746751141093,-0.0089262293568836,6.66595460029077e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,29349,-0.0138771937917528,0.00308180043676284,-0.0199175226478079,-0.00783686493569759,6.7274550131269e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0223259748144147,0.00495885750557103,-0.0320453355253339,-0.0126066141034955,6.75461163354667e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0246952281639848,0.00550054380393972,-0.0354762940197066,-0.013914162308263,7.1628616751627e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0194058595319083,0.00432392657592884,-0.0278807556207288,-0.0109309634430878,7.22204521912127e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0224227912625771,0.00500833575222284,-0.0322391293369339,-0.0126064531882204,7.60014495292718e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0267344939894061,0.00597624882874543,-0.0384479416937472,-0.0150210462850651,7.72593537765381e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0170837713252676,0.00382393588692205,-0.0245786856636348,-0.0095888569869004,7.94076914249362e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.0189978034963645,0.0042568384906255,-0.0273412069379904,-0.0106544000547385,8.12174142653881e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0114267464195213,0.00257091629545583,-0.0164657423586147,-0.00638775048042787,8.84398688423827e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.0099063866066137,0.00223045840535216,-0.0142780850811039,-0.00553468813212346,8.97011979662456e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0211163901292988,0.00475691782982533,-0.0304399490757564,-0.0117928311828411,9.06752368488026e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.0255226450079577,0.00575752592446631,-0.0368073958199116,-0.0142378941960037,9.33018845905396e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0108505374758667,0.00245166668461323,0.00604527077402477,0.0156558041777086,9.64351063538497e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,29313,-0.00769053238253783,0.00173767504510913,-0.0110963754709517,-0.00428468929412393,9.64500418060978e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0239759037386624,0.00542407917120839,-0.0346070989142308,-0.013344708563094,9.90089690940698e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0115140858633128,0.00261423395536145,-0.0166379844158212,-0.00639018731080434,1.06468364320848e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,24538,-0.0102174327753182,0.00232246766677665,-0.0147694694022004,-0.00566539614843598,1.09014698094003e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.019172700879048,0.00435969576908623,-0.027717704586457,-0.010627697171639,1.09856198380282e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.0198516964144096,0.00451676222573967,-0.0287045503768594,-0.0109988424519599,1.11183963589782e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0187059923174604,0.00426181015123977,-0.0270591402138904,-0.0103528444210305,1.14154179725633e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,29443,-0.0374727880134304,0.00854077173601079,-0.0542127006160116,-0.0207328754108493,1.1504987741662e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0100774977717387,0.00230871605185878,-0.014602581233382,-0.00555241431009553,1.27565457514303e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.0201059156631587,0.00461596259824702,-0.0291532023557228,-0.0110586289705945,1.33149889953735e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.00695992840043709,0.00159965836310331,-0.0100952587921196,-0.0038245980087546,1.360426251826e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,29786,-0.0187341050688926,0.00430601375936044,-0.0271738920372391,-0.0102943181005462,1.36164745418698e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.014613430381711,0.00335938938202575,-0.0211978335704815,-0.00802902719294058,1.3658978040653e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0305366945316062,0.0070280489679793,-0.0443116705088456,-0.0167617185543667,1.39843886284108e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.029134804496483,0.00670883131780608,-0.0422841138793829,-0.0159854951135831,1.41177976273881e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,28774,-0.0187880462955516,0.00433231250858002,-0.0272793788123685,-0.0102967137787348,1.45113331334613e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.029121453221947,0.00671845501338294,-0.0422896250481776,-0.0159532813957165,1.46646287682664e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.0267060113457495,0.00617506937618525,-0.0388091473230726,-0.0146028753684264,1.53268660898819e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.0125684205922835,0.002907097976028,-0.0182663326252984,-0.00687050855926861,1.54189540771034e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0323028851890047,0.00749308046985953,-0.0469893229099294,-0.01761644746808,1.63122447474959e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0170955250949624,0.00396989265768698,-0.0248765147040289,-0.00931453548589593,1.66665088436024e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0196027737663464,0.00455235072461164,-0.0285253811865852,-0.0106801663461076,1.6671156281801e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.00701759676986095,0.00163222565315976,-0.0102167590500541,-0.00381843448966781,1.71801955633848e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0248436187390475,0.00579903195073095,-0.0362097213624801,-0.0134775161156148,1.84060704750653e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0121012257386482,0.00282664118273384,-0.0176414424568065,-0.00656100902048987,1.8664314816271e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,0.00786807744521257,0.00183961754551008,0.00426242705601281,0.0114737278344123,1.90002791937509e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0201549833242505,0.00472308365251829,-0.0294122272831863,-0.0108977393653146,1.98579363846837e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.0336673132107431,0.00789284486587682,-0.0491372891478617,-0.0181973372736245,2.00048106508181e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0129159647942436,0.0030284300619548,-0.018851687715675,-0.00698024187281217,2.00728022504893e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.0189285211253477,0.00444248713320316,-0.0276357959064259,-0.0102212463442695,2.04470976096294e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,29242,0.0149013593407482,0.00350045986250523,0.00804045801023792,0.0217622606712584,2.07860188266911e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,24111,-0.0188116149007207,0.00442962291637475,-0.0274936758168152,-0.0101295539846262,2.17681455063741e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,29725,-0.00633605605329231,0.00149345818833038,-0.00926323410241986,-0.00340887800416476,2.21673039009029e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,24111,0.00948096022818316,0.00223660390231586,0.00509721657964408,0.0138647038767222,2.2535469316355e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0207355483677787,0.00492905579717847,0.0110745990053089,0.0303964977302485,2.59801841880876e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,29137,0.0185522618921797,0.00441580045351448,0.00989729300329131,0.0272072307810681,2.66133706815935e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.0260568773831129,0.0062114226118285,-0.0382312657022967,-0.013882489063929,2.73860918405235e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,29478,0.0113227849742527,0.00270667918820048,0.00601769376537972,0.0166278761831256,2.88169905691597e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.0223072633718433,0.00533254767510933,-0.0327590568150575,-0.011855469928629,2.88239068643311e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0170180955605073,0.00406817416069597,-0.0249917169154714,-0.00904447420554317,2.8840574229942e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.0870632942488286,0.0208232317969274,-0.127876828570806,-0.0462497599268509,2.90984679047119e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0143685777259665,0.00344221231481389,-0.0211153138630017,-0.00762184158893129,3.00018911451348e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,24805,-0.0099412234243686,0.00239316076354556,-0.0146318185209179,-0.00525062832781931,3.27786885257544e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0154613674712655,0.00372757240089942,-0.0227674093770283,-0.0081553255655026,3.36591570004354e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.0182727762661912,0.00443339041907333,-0.0269622214875749,-0.00958333104480744,3.77236480571884e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,24647,-0.0127697095988053,0.00310186373314047,-0.0188493625157606,-0.00669005668184998,3.85443260431381e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.00720424896347982,0.00175471923199564,-0.0106434986581913,-0.00376499926876836,4.04291184506559e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0213046625469367,0.00519670641073788,-0.0314902071119829,-0.0111191179818904,4.14890953693692e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,29199,0.036823578327011,0.00898821738883393,0.0192066722448965,0.0544404844091255,4.19899543276171e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,0.00924568779896263,0.00225678323755248,0.00482239265335976,0.0136689829445655,4.2018565357912e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,29820,-0.0151550444155576,0.00370048885821187,-0.0224080025776529,-0.00790208625346237,4.22521054775442e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0147588125558467,0.00360452035829106,-0.0218236724580972,-0.00769395265359622,4.24407163741658e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.0156947936467698,0.00383554941704307,-0.0232124705041742,-0.00817711678936537,4.29153983658538e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0249388908327105,0.00610067389935879,-0.0368962116754537,-0.0129815699899672,4.36465831777573e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0178144612322871,0.00436036217602928,-0.0263607710973045,-0.0092681513672697,4.40917773821358e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0145495476103369,0.00356403328071751,0.00756404238013062,0.0215350528405432,4.47260662163007e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0132009825731623,0.00323455564538443,-0.0195407116381158,-0.00686125350820883,4.49140965093346e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,24281,-0.0123493512171829,0.00302824269231746,-0.0182847068941251,-0.00641399554024071,4.55581285061325e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0172695793853976,0.00424723123616299,-0.025594152608277,-0.00894500616251812,4.79356450653933e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,29545,-0.00668653331386506,0.00164691198974967,-0.00991448081377441,-0.0034585858139557,4.91900974326611e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.0208856553152045,0.00515384756746992,-0.0309871965474456,-0.0107841140829635,5.08176900509617e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0242391826489894,0.00599272835918194,-0.035984930232986,-0.0124934350649928,5.25089709368236e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0146982635865324,0.00363683925218484,-0.0218264685208147,-0.00757005865225015,5.32720492628476e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0198997542975865,0.00492722755577251,-0.0295571203069006,-0.0102423882882724,5.39048654110239e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0120702185565214,0.00299123503059124,-0.0179330392164803,-0.00620739789656263,5.46980849368464e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00739605419827619,0.00183387736484351,0.0038016545631829,0.0109904538333695,5.52353873714866e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.028378616545243,0.00704046949932334,-0.0421779367639167,-0.0145792963265693,5.57617443766521e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0158367178025122,0.00394401608181949,-0.0235669893228784,-0.00810644628214602,5.9530152604182e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0120852122049676,0.00302062466130943,-0.0180056365411341,-0.00616478786880113,6.32603525043496e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,29349,-0.00834039265035344,0.00209045230358704,-0.012437679165384,-0.00424310613532284,6.63021029505876e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,24845,0.0212849215945644,0.00533495110120666,0.0108284174361994,0.0317414257529295,6.63431203998515e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0187116885656186,0.00469110364179898,-0.0279062517035447,-0.00951712542769264,6.65807855022349e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0158444846533207,0.00397996054138844,-0.023645207314442,-0.00804376199219931,6.87745076451835e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.0150807202542445,0.00379370180848226,-0.0225163757988697,-0.00764506470961928,7.05243503113962e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.00955080522872352,0.00240338433944193,-0.0142614385340297,-0.00484017192341733,7.08769095465957e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,24229,-0.0112033648736323,0.00281981444336553,-0.0167302011826287,-0.00567652856463585,7.11528345000027e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0145653870868637,0.00366825654119388,-0.0217551699076038,-0.00737560426612374,7.18482228860434e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.00845102200455736,0.00213004975000587,-0.0126259195145689,-0.00427612449454585,7.28271527701166e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,29328,-0.0119334183713164,0.00302042455375331,-0.0178534504966729,-0.00601338624595991,7.80376072737876e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0130917318762514,0.00331391346373705,-0.019587002265176,-0.00659646148732679,7.8162943798215e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.00679822742600804,0.00172143886103195,-0.0101722475936307,-0.00342420725838541,7.86106616048815e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0104031717356624,0.00263649595708342,-0.0155707038115459,-0.00523563965977886,7.9742250104963e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.0137042464608398,0.00347594723882508,-0.020517103048937,-0.00689138987274264,8.07904275248629e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,0.00794081842619394,0.00201474592444006,0.00399191641429142,0.0118897204380965,8.12106781992115e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0228541017079396,0.00581023682254039,-0.0342421658801188,-0.0114660375357605,8.39377822836135e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0148946565161702,0.00379570086850375,-0.0223342302184375,-0.00745508281390282,8.72945036825327e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,-0.00685146793284744,0.00174649759308495,-0.0102746032152939,-0.00342833265040094,8.76596003326448e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,24229,-0.0142025639527347,0.00362835450437189,-0.0213141387813036,-0.00709098912416579,9.09049600550901e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.0124263502792327,0.00317611156966498,0.0062011716026893,0.018651528955776,9.16108451307912e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,24793,-0.0224945459560594,0.00574966568921091,-0.0337638907069128,-0.011225201205206,9.16566919535875e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.0165951869632402,0.00424204583026113,0.00828077713592837,0.024909596790552,9.17113495817608e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0100709774188654,0.0025746017853366,-0.0151171969181252,-0.00502475791960568,9.18727495084838e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.00648156927479711,0.00165990867865716,-0.00973499028496514,-0.00322814826462908,9.45211531394611e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.0145417799621233,0.00372639592011766,-0.0218455159655539,-0.00723804395869269,9.55053934616033e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.0126328203771588,0.003242471946276,-0.0189880653918597,-0.00627757536245782,9.80362606660783e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.00817902736287596,0.00210106861526081,-0.0122971218487872,-0.00406093287696476,9.93549953221563e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0132622977787921,0.0034077189170294,-0.0199414268561697,-0.00658316870141444,9.97059147342595e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.0128466230177541,0.00330412434920567,-0.0193227067421972,-0.00637053929331095,0.000101311851847317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,24805,-0.00982608711405444,0.00253262339218419,-0.0147900289627354,-0.00486214526537343,0.000104810039333765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.0111703907955768,0.00287924190409111,-0.0168137049275954,-0.00552707666355825,0.000104892481771503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.0158423132928923,0.00408419462456686,-0.0238473347570434,-0.00783729182874129,0.000105149381093112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,29373,-0.0182346102489551,0.00470235163495428,-0.0274512194534655,-0.00901800104444469,0.000105650443147545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0257126321369979,0.00663808805004792,-0.0387232847150918,-0.012701979558904,0.000107516384061572
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0101037404310068,0.00261234707946662,0.00498354015525219,0.0152239407067613,0.000110159808927424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0279351855324623,0.00723279692455898,-0.0421114675045979,-0.0137589035603267,0.000112619485048855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0131415173866656,0.0034049481642459,-0.0198152157885876,-0.00646781898474365,0.000113897446854887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,24938,-0.0239235260260276,0.00620152927906556,-0.0360785234129961,-0.0117685286390591,0.000114755545307651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.00862984962310289,0.00223933833894991,-0.0130189527674447,-0.00424074647876106,0.000116622392946371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.0162425029088226,0.00421765280664411,-0.024509102409845,-0.0079759034078001,0.000117902811875969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0236453176789112,0.00616619308894992,-0.035731056133253,-0.0115595792245694,0.000125993467599486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,24793,-0.0104852874070508,0.00273993157167201,-0.0158555532875279,-0.00511502152657364,0.000130115993862297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.0109558279327372,0.00286408207655532,-0.0165694288027856,-0.00534222706268874,0.000130967499065818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.0119216325612402,0.00312082492807634,-0.0180384494202699,-0.0058048157022106,0.000133772178881367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,0.0106485111031898,0.0027937319445498,0.00517279649187218,0.0161242257145074,0.000138366480229884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00741553276266687,0.0019487730764125,0.00359593753289836,0.0112351279924354,0.000141956759045751
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.00776017710018226,0.00204613556140336,-0.0117706028005328,-0.00374975139983168,0.000149380321742147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0252839902649147,0.00668013772145445,-0.0383770601989654,-0.0121909203308639,0.000154043793491465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.0134952639781873,0.0035671918247403,-0.0204869599546782,-0.00650356800169628,0.000155162029572251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.0199687787068024,0.00528270938363941,-0.0303228890987357,-0.00961466831486918,0.000157122394842926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.0265827234641034,0.00703975136872415,-0.0403806361468027,-0.0127848107814041,0.000159623673397917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,24951,0.00601555870306644,0.0015938337208872,0.00289164461012754,0.00913947279600535,0.000160848504214034
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.0193607447460414,0.00513247012907947,-0.0294203861990372,-0.00930110329304565,0.000162133196502341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,29566,-0.00849927996447344,0.0022541170184905,-0.0129173493207148,-0.00408121060823207,0.000163199686464207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,28916,-0.0125134727574119,0.00331888846031558,-0.0190184941396304,-0.00600845137519335,0.000163323101559617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,24726,-0.00924417743662313,0.00245245125647017,-0.0140509818993047,-0.0044373729739416,0.000164045686231291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.00892251213039311,0.00236766936166822,-0.0135631440792628,-0.0042818801815234,0.000164573157064712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0336728072844612,0.00894323994804814,-0.0512015575826355,-0.0161440569862868,0.000166819846007215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.023392273253851,0.0062211953319265,-0.0355858161044269,-0.011198730403275,0.000170184698694289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.00721582127191531,0.00192065109740164,0.00345134512100809,0.0109802974228225,0.000172380484198147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0200032366934521,0.00533970814394336,-0.0304690646555811,-0.00953740873132316,0.000179935443509121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.00878789039567981,0.00235150538915794,0.00417893983293024,0.0133968409584294,0.000186559751173389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0172854308291139,0.00462561990267607,-0.026351645838359,-0.00821921581986881,0.000186668997592631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.0105604720207448,0.00283094231183665,-0.0161091189519446,-0.00501182508954496,0.000191622513471988
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.00975955172129606,0.00262215701222658,-0.0148989794652601,-0.00462012397733197,0.000198122956623024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,28722,-0.0161469262437468,0.00434644650658872,-0.0246659613966607,-0.00762789109083293,0.000203611426671349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00725537539047309,0.00195337535866421,0.00342675968749123,0.0110839910934549,0.00020424597216031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00832290096648428,0.00224402468236082,0.00392461258905708,0.0127211893439115,0.000208537118581056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00775671461431657,0.00209149133214305,0.00365739160331619,0.011856037625317,0.000208790870995119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,24381,0.0245142098247233,0.0066116639179938,0.0115553485454554,0.0374730711039911,0.000209595799570156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,29536,0.00823132805589361,0.0022221391405202,0.00387593534047402,0.0125867207713132,0.000212415144828346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,24867,-0.0162801486603968,0.0044087437111544,-0.0249212863342594,-0.00763901098653415,0.000222364377293002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,24111,0.0145065394125947,0.00392867046129441,0.00680634530845763,0.0222067335167317,0.000222567363957949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,29157,0.00733025969750461,0.00198698346673824,0.00343577210269766,0.0112247472923116,0.000225422723030976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0326510223518691,0.00888546925503759,-0.0500665420917428,-0.0152355026119955,0.000238682643072582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.00712930221368446,0.00194198070864663,-0.0109355844026319,-0.00332302002473707,0.000241967205710024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0147980893999332,0.00403235595487553,-0.0227015070714893,-0.00689467172837719,0.000243214131370773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,24845,0.0102506112097859,0.00279378055240191,0.00477480132707812,0.0157264210924936,0.000243931549912301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,28916,-0.0346538682021439,0.00945062784380263,-0.0531770987759971,-0.0161306376282907,0.000246013751906031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0158725546356319,0.00434337493074673,-0.0243855694998954,-0.00735953977136828,0.000258304404483771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,24111,-0.00994502672155516,0.00272302676833631,-0.0152821591874943,-0.004607894255616,0.000260558211052218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.00922309052170614,0.00252783253960522,-0.0141776422993324,-0.00426853874407991,0.000264196106814423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,28797,0.0142225928703399,0.00390448053333044,0.0065698110250122,0.0218753747156675,0.000270336312098678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0121456353256016,0.00334337304337393,-0.0186986464906145,-0.00559262416058868,0.000280982037607494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,29820,0.0104787458371418,0.00288797185350881,0.00481832100426452,0.0161391706700191,0.000285648534779841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.005126577038972,0.00141408454299384,-0.00789818274323993,-0.00235497133470407,0.000289126909836879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00732995376597501,0.00202400118002736,-0.0112969960788286,-0.00336291145312139,0.00029346544665358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,29518,0.0115495215415296,0.00319151471155703,0.00529415270687779,0.0178048903761813,0.000296442356351037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0178695466898341,0.00493968836404905,-0.0275513358833702,-0.00818775749629793,0.000297998146482616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0216747626573634,0.00600009406630188,-0.0334349470273151,-0.00991457828741173,0.000303988518618955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.00898099530684769,0.00249135208456663,0.0040979452210971,0.0138640453925983,0.000312839328989749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,24793,0.0284603502037233,0.00789885844377041,0.0129785876539333,0.0439421127535133,0.000315064109941592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0244002263570919,0.00677261506842315,-0.0376745518912013,-0.0111259008229825,0.000315464962176403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0101019690108381,0.00280682800673741,-0.0156033519040434,-0.00460058611763279,0.000319980102079884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0148737098979574,0.00413455282517161,-0.0229774334352938,-0.00676998636062105,0.000322034605044677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0121765326513157,0.00338850573929781,0.00553506140229199,0.0188180039003394,0.000326939107071497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0249631737865485,0.00695276494704968,-0.0385905930827658,-0.0113357544903311,0.00033083403540062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0101281496477128,0.00282139924631493,-0.0156580921704901,-0.00459820712493557,0.000331638052984379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.0288556080768753,0.00803943647991466,-0.044612903577508,-0.0130983125762425,0.000332260650996748
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.0141454535923289,0.00394507507931808,-0.0218778007477924,-0.00641310643686551,0.00033696015220288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0190128412179424,0.00532512131461831,-0.0294500789945943,-0.00857560344129052,0.000357009801227538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,29395,-0.0101336214640516,0.00283932185174364,-0.0156986922934691,-0.00456855063463402,0.00035887785385551
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0302706672557168,0.00848579920163492,-0.0469028336909212,-0.0136385008205124,0.000361492078926479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0105240241574457,0.00295365833590866,-0.0163131944958267,-0.00473485381906474,0.000367258866934181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0193414316207996,0.00542871903932352,-0.0299817209378737,-0.00870114230372551,0.000367499507885734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,24922,0.00872872184884922,0.00245097973531623,0.0039248015676294,0.013532642130069,0.000369683669346156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,0.01206715776647,0.00339215630618023,0.00541853140635673,0.0187157841265833,0.000375174876342797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0274766111913093,0.00774193378925618,-0.0426508014182515,-0.0123024209643672,0.000387220997487812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.0226728443830022,0.00640122540634122,0.0101264425865735,0.035219246179431,0.000397925316911633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.0181155138032616,0.00512347426656331,-0.0281575233657257,-0.00807350424079755,0.000407314547391018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,29218,0.00303236657354215,0.000857908055576438,0.00135086678461233,0.00471386636247197,0.000409015546185004
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,29443,0.00839343595358373,0.00237867880167256,0.00373122550230551,0.013055646404862,0.00041838093878617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.00792380354767088,0.00224569226182142,-0.0123253603808409,-0.0035222467145009,0.000418636412686019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.0105458865658656,0.00299007192028734,0.00468534560210239,0.0164064275296287,0.000421105728308295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0156876200595337,0.00446440145130842,0.00693739321496918,0.0244378469040982,0.000442325976663952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.00775706629288162,0.00220837272155827,-0.0120854768271358,-0.0034286557586274,0.000444460329655369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,24845,-0.00950383768467248,0.00271240724287541,-0.0148201558807083,-0.00418751948863666,0.000459409917228076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,29434,-0.0128436975035152,0.00367130871566684,-0.0200394625862222,-0.00564793242080821,0.000468753932325356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,24229,0.00842763962554554,0.00241029685939145,0.00370345778113829,0.0131518214699528,0.000472221608237264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0148782980156983,0.00425580980939282,-0.0232196852421083,-0.00653691078928842,0.000473143438169265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0152118698340347,0.00436736978373079,-0.023771914610147,-0.0066518250579223,0.000496402984192913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.012720636816726,0.00365522842008813,-0.0198848845200987,-0.00555638911335326,0.000501907377853624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.00588954585292926,0.0017003506651136,-0.00922223315655191,-0.0025568585493066,0.000533672828991769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.00777976154718454,0.0022483646160349,-0.0121865561946129,-0.00337296689975614,0.000540572957400626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.00903771271112583,0.00262280439079169,-0.0141784093170775,-0.00389701610517411,0.000570288063569402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0131418466195174,0.00381570173402106,-0.0206206220181986,-0.00566307122083611,0.000573671461147979
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0186859823928824,0.0054347263440318,-0.0293380460271847,-0.00803391875858009,0.000586457778108234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,24938,0.0124946241901,0.00365999623112797,0.00532103157708923,0.0196682168031109,0.000641572154347821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,24966,0.0035676813590379,0.00104686543210852,0.00151582511210521,0.0056195376059706,0.000655525082578853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,24016,0.00845842529483806,0.00248366066808923,0.00359045038538317,0.013326400204293,0.000661200639701558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,29434,-0.0147193189628689,0.00432863434300529,-0.0232034422751593,-0.00623519565057857,0.000673635875609077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.014248936267873,0.00419918971803786,-0.0224793481152272,-0.00601852442051878,0.000691590325924179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.0168310066221095,0.00496401977579261,-0.026560485382663,-0.00710152786155596,0.000698486912271889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00675903406949853,0.00199371283058959,0.00285135692154293,0.0106667112174541,0.00069960255932462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.00879410780897561,0.00259449023631746,0.00370890694579339,0.0138793086721578,0.000701209096728396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.0209753627551459,0.00619746195590349,-0.0331223881887167,-0.00882833732157503,0.000714162736232327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.0109959112414894,0.00325008378985429,-0.0173660754696038,-0.00462574701337496,0.000717415552442217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.0105081450720458,0.00310913797791315,-0.0166020555087555,-0.00441423463533602,0.00072662190740017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0125305547504734,0.00370958153784412,-0.0198013345646479,-0.00525977493629896,0.000731409075000791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,24445,0.00812049710850266,0.00240533986855438,0.00340603096613608,0.0128349632508692,0.000736547069688327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.00610249868688731,0.00180802325543723,0.00255877310623034,0.00964622426754428,0.000738684457353835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,24111,0.00963245871757237,0.00285541217329102,0.00403585085792197,0.0152290665772228,0.000743618409129198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,29566,0.00894461387967804,0.00265767704822178,0.00373556686516336,0.0141536608941927,0.000764812585824172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0166788481858334,0.00495609717772302,-0.0263927986541705,-0.00696489771749626,0.000765538134120351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,29400,0.0167903637037978,0.00499731188856583,0.00699563240220883,0.0265850950053869,0.000780757687663118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,29349,0.00498965760223985,0.00148560797280591,0.00207786597554027,0.00790144922893943,0.000784199652808768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.00528977706666107,0.0015762536977555,-0.00837923431426186,-0.00220031981906029,0.000792207692811583
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.0138260822340896,0.00412405556886261,-0.0219092311490603,-0.00574293331911885,0.000801937163642781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.0281962136789977,0.00841388312127953,-0.0446874245967055,-0.0117050027612898,0.000805764392746239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0189743120631726,0.00567361078168297,-0.0300945891952712,-0.00785403493107397,0.000826098171789308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,21656,-0.0249037029587783,0.00745129676851463,-0.039508244625067,-0.0102991612924897,0.000832587771142461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.00864668589126432,0.00258976063529378,0.00357075504608852,0.0137226167364401,0.000842451222362375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.00706215782547401,0.00211956517331998,-0.0112165055651812,-0.00290781008576684,0.000863636747715103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0107349070152895,0.00322507311396443,-0.0170560503186598,-0.00441376371191923,0.000873966589876845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0122673055753021,0.00369128495736666,-0.0195022240917407,-0.00503238705886344,0.000890615027634576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.0215122059405843,0.00647671049856857,-0.0342065585177788,-0.00881785336338995,0.000896766868339516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.0105658073460468,0.00318171564862795,-0.0168019700173576,-0.00432964467473602,0.000898929223479686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00884957240682482,0.00266772242143747,0.00362083646080738,0.0140783083528423,0.000910341536878746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.0129000439667936,0.0038955463271092,-0.0205353147679276,-0.00526477316565959,0.000929348091278845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0118727450381922,0.00359471679434555,-0.0189183899551095,-0.00482710012127497,0.000958526224338559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00518367256959126,0.00157170334720249,0.00210313400907438,0.00826421113010815,0.000974486036290513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.0142202460694739,0.00434864823044999,-0.0227435966011559,-0.0056968955377919,0.00107683004262886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.00818001885089759,0.00250680881289766,-0.013093364124177,-0.00326667357761818,0.00110321125367349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.0158212002100537,0.00485131538027813,-0.0253297783553988,-0.00631262206470853,0.00111086845236678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0099151274086793,0.00305624339601254,0.00392489035249472,0.0159053644648639,0.00117927602118573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,28671,-0.0108519351768461,0.00334667331244107,-0.0174114148692306,-0.00429245548446158,0.00118578285772261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.0060038846087248,0.0018550634115242,-0.00963980889531223,-0.00236796032213737,0.00121169575208627
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.00805755526624245,0.00249146342761316,-0.0129408235843642,-0.00317428694812066,0.00122178604199788
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00966901141779345,0.00298999820646142,0.00380861493312907,0.0155294079024578,0.00122325043873784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,29761,-0.0136409739905054,0.00423231605011286,-0.0219363134487266,-0.00534563453228419,0.00126969233425916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00838112334268789,0.00260231091259928,0.0032805939539933,0.0134816527313825,0.00128069810204123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.00939629850919529,0.00292573590256898,0.00366185614016009,0.0151307408782305,0.00132170482216271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,24229,-0.0142894329889715,0.00445342986864826,-0.023018155531522,-0.00556071044642086,0.00133540079009935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,28650,-0.00689490982969634,0.00215214222590325,-0.0111131085924667,-0.00267671106692597,0.00135802153849877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.00748525464455979,0.00233697656808196,0.00290478057111916,0.0120657287180004,0.00136196245344799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.00956900581185056,0.00299294592638508,-0.0154351798275653,-0.0037028317961358,0.0013895511776225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.00748586474655912,0.00234611030334368,-0.0120842409411127,-0.00288748855200551,0.00142051796038596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,28443,-0.00808243037292507,0.00253404716425753,-0.0130491628148698,-0.00311569793098032,0.0014265677964633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.00790041279210981,0.00248123435746046,-0.0127636321327323,-0.00303719345148731,0.0014537600459951
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.00790687516500195,0.00248372800459411,-0.0127749820540064,-0.0030387682759975,0.00145672094972183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00638737242343348,0.00200838236178382,-0.0103238018525298,-0.00245094299433719,0.00147246934477896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0136607618729678,0.00430203157157455,0.00522877999268168,0.0220927437532539,0.0014977346569869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.012524006751474,0.00395847073985764,-0.0202826094015949,-0.004765404101353,0.0015588481339129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.00479855732898245,0.00151695109889984,-0.00777178148282613,-0.00182533317513877,0.00156184683400569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0100020524608086,0.00317069364718778,-0.0162166120092967,-0.00378749291232056,0.00160918356571026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.00510049044942631,0.0016174989400518,-0.00827078837192784,-0.00193019252692477,0.00161622201460845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,24922,0.00592452090364623,0.00187901641512525,0.00224164873000074,0.00960739307729173,0.00161798820837106
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,28774,-0.00798933241437682,0.00253516916161441,-0.0129582639711411,-0.00302040085761259,0.00162656384401609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.0170937303282651,0.00542675449462116,-0.0277301691377226,-0.0064572915188076,0.00163524118154133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00765519206554978,0.00243162603557,0.00288920503583258,0.012421179095267,0.00164491963891023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.00629195921473589,0.0019989525896142,-0.0102099062903797,-0.00237401213909205,0.00164765068991952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.0136107947916968,0.0043326572599164,-0.0221028030211329,-0.00511878656226063,0.00168314344911465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,24229,0.00886800630432769,0.00282654753252905,0.00332797314057076,0.0144080394680846,0.00170658499058845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,29566,0.00609625898940286,0.0019440437868884,0.0022859331671016,0.00990658481170411,0.00171515979223392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.00850464608148002,0.00271300444793258,-0.0138221347994279,-0.00318715736353216,0.00172188867935645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,0.00744685140453096,0.00239012050414418,0.00276221521640837,0.0121314875926536,0.00183697514951635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.0216111756740577,0.00694217206485,-0.0352178329211637,-0.00800451842695171,0.00185389129584559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,29536,0.0181719734968885,0.005838290737048,0.00672892365227442,0.0296150233415026,0.0018565548362807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.0089454648105336,0.00288434233694288,-0.0145987757909416,-0.00329215383012556,0.00192799151839356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,28797,0.0178387272617322,0.00576045248269659,0.00654824039564684,0.0291292141278175,0.00195837563991486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.00784725223925631,0.00253429532904785,0.00288003339432253,0.0128144710841901,0.00196054272105113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,29694,0.00686127174349477,0.00221851863936621,0.002512975210337,0.0112095682766525,0.00198510679599137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.011015817315841,0.00358047971248909,0.00399807707936238,0.0180335575523196,0.00209547429027269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.00791250944078318,0.00258187846520335,-0.0129729912325817,-0.00285202764898462,0.00218174913325458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00888142948203756,0.00290069703013514,0.0031960633029727,0.0145667956611024,0.00220187173345739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0133203094203479,0.00435076731494825,0.00479280548304932,0.0218478133576465,0.00220399892003346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,0.00939838621833052,0.00307343717423808,0.00337444935682389,0.0154223230798371,0.00223107359850129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,28916,-0.0250842139400799,0.00822920666697748,-0.0412134590073558,-0.00895496887280405,0.00230429612648353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,0.00854412417738739,0.00280480776307799,0.00304670096175454,0.0140415473930202,0.00231963135672862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0173108143009656,0.0056842964208339,-0.0284520352858001,-0.00616959331613119,0.00232600408983802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.00692884029844811,0.00227635331772884,-0.0113904928011966,-0.00246718779569959,0.00233828532280671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,0.00756480149923992,0.00249535759328673,0.00267390061639794,0.0124557023820819,0.00243552071382914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.0134746054679868,0.00445229571897036,0.00474810585880485,0.0222011050771687,0.00247713269579137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,24111,0.00989647981315143,0.0032708327556608,0.00348564761205628,0.0163073120142466,0.00248339650187118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.00872307645370768,0.0028840150120848,0.00307040703002148,0.0143757458773939,0.00249154938392148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,24111,0.00772474856790544,0.00255447388969432,0.00271797974410458,0.0127315173917063,0.00249712636000791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.0137214105640971,0.00454160393366138,-0.0226229542740734,-0.00481986685412081,0.00251975604038313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00646762641331689,0.00214245882359166,0.00226840711907724,0.0106668457075565,0.00254055496851297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,29208,-0.00967984268140447,0.0032105408629367,-0.0159725027727604,-0.00338718259004854,0.00257183669389389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,24111,0.00892087819512016,0.00297166189633482,0.00309642087830391,0.0147453355119364,0.00268502064563207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.00908235552500605,0.00302706715930629,-0.0150154071572464,-0.00314930389276571,0.00269865981364339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,-0.0110912533636643,0.00370696063654637,-0.0183568962112952,-0.00382561051603345,0.00277384468244116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,24966,-0.00539037883456107,0.00180329465819566,-0.00892483636462457,-0.00185592130449757,0.00279996477364914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,24229,0.00599691602983702,0.00200693517211548,0.00206332309249068,0.00993050896718337,0.00281002290979817
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,29725,0.00524334157794234,0.00175756761015363,0.00179850906204122,0.00868817409384346,0.00285395186416562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.00649128158327351,0.00217967970014676,-0.0107634537955612,-0.00221910937098586,0.00290338355093849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.00545219071901262,0.00183733020442447,-0.00905335791968457,-0.00185102351834066,0.00300563360743811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.00801402292390569,0.00270956057370168,-0.013324761648361,-0.0027032841994504,0.00310207732933014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,24195,-0.00979801594152989,0.00332082775896186,-0.0163068383490951,-0.00328919353396465,0.00317590900800154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.0120730372089509,0.00409876811016367,-0.0201066227048717,-0.0040394517130301,0.00322655937037087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.00974475801814584,0.0033105671511053,-0.0162334696343122,-0.00325604640197946,0.00324750091092652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,24111,0.00835447832031265,0.00284203350411783,0.0027840926522417,0.0139248639883836,0.00328934431257119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',24111,-0.00894179182073173,0.00304656368484742,-0.0149130566430327,-0.0029705269984308,0.00333817478618199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,29434,0.0102176813714105,0.00348439881438854,0.00338825969520894,0.017047103047612,0.00336602940684073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00824089295298196,0.00281252659373958,0.00272834082925239,0.0137534450767115,0.00339204471969281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.00941162275207881,0.00321403347598381,0.00311211713915054,0.0157111283650071,0.00341149033652279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.0129040037307119,0.00440759650316903,-0.0215428928769232,-0.00426511458450057,0.00341817163592733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.0201840163979774,0.00691206388704945,-0.0337316616165944,-0.00663637117936053,0.00350170734591252
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,29327,-0.0121957467604274,0.00417880977937506,-0.0203862139280026,-0.00400527959285233,0.00352016780163372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.0147069593081766,0.00504674442654834,-0.0245985783842113,-0.00481534023214181,0.00356978959659904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,29434,-0.0131842240133627,0.0045384932634007,-0.0220796708096281,-0.00428877721709734,0.00367552138356186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,24111,0.00960735361802726,0.00330891189025045,0.00312188631313637,0.0160928209229181,0.00369377495052185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.00418479036063742,0.00144296527096444,-0.00701300229172773,-0.00135657842954711,0.0037334044500735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.00587373084896853,0.00202716054115045,-0.00984696550962341,-0.00190049618831365,0.00376465110384005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0100241249353136,0.00346526208414607,-0.0168160386202399,-0.00323221125038725,0.00382168557930343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00641531959764793,0.00221947500297097,-0.010765490603471,-0.00206514859182482,0.0038500313002713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,28774,0.00665606537205151,0.00231335321526079,0.00212189307014035,0.0111902376739627,0.00401469319795867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.00650820078790636,0.00226265828199362,-0.0109430110206138,-0.00207339055519886,0.00402590282749142
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,24111,0.0147082314949384,0.00511356239466505,0.00468564920139493,0.0247308137884819,0.00402696999489017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,0.00947118685321997,0.00329503256797297,0.00301292301999295,0.015929450686447,0.00405161464191799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,24101,0.0100221453953438,0.0034913607915262,0.00317907824395241,0.0168652125467351,0.00410107962911512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00633810023069141,0.00221064363257135,0.00200523871085157,0.0106709617505313,0.0041457286865717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00598770148545756,0.00209935330831544,-0.0101024339697558,-0.0018729690011593,0.00434584002686332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00802571724199023,0.00281966300018292,-0.0135522567223488,-0.00249917776163171,0.00442624019258125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00633085269107546,0.00223353462372971,0.00195312482856524,0.0107085805535857,0.00459421411955253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,29478,0.0153796080917722,0.00542661399626755,0.00474344465908777,0.0260157715244566,0.0045985092484078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.00957629925218998,0.00338345829601268,-0.0162078775123748,-0.00294472099200513,0.00465324894146746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,0.0118098519874645,0.00418429013258263,0.00360864332760253,0.0200110606473264,0.00477007707633511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00519714212539812,0.0018434248984248,0.00158402932448552,0.00881025492631072,0.00481700155528068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,29478,0.00523148715118434,0.00185630819622323,0.0015931230865868,0.00886985121578187,0.00483226935301916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0115770920933382,0.00410857298970706,-0.0196298951531641,-0.00352428903351239,0.00483883663356609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0186659612324697,0.00662845239074788,-0.0316577279183356,-0.00567419454660387,0.00486525270590215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00668520958521023,0.00237528721055642,-0.0113407725179008,-0.00202964665251965,0.00488949647200929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.00972273188988895,0.00345644432169963,-0.0164973627604202,-0.00294810101935768,0.00491249958954428
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.0055805232159641,0.00199043245812682,-0.00948177083389266,-0.00167927559803553,0.00505569199733266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.00910012934340005,0.00324594534739339,-0.0154621822242911,-0.00273807646250901,0.0050585762776281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0125692750749828,0.00449313532043719,-0.0213758203030397,-0.00376272984692588,0.0051542582741459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.0189396445636246,0.00677162887256732,-0.0322120371538565,-0.00566725197339263,0.00516334566237682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00553200367739173,0.00199115696970002,-0.00943467133800378,-0.00162933601677969,0.00546885352805942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00842400103547798,0.00303617256343569,0.00247310281114404,0.0143748992598119,0.00553213591905319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,24845,-0.0189745626481215,0.00683893279841758,-0.03237887093302,-0.00557025436322309,0.0055329340430861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,29694,-0.00585296907521538,0.00210990155457842,-0.00998837612218908,-0.00171756202824169,0.00553980198887286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,29581,0.00410810196827766,0.00148374558206246,0.00119996062743524,0.00701624330912008,0.00563090048987922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,24016,0.00609185610835241,0.0022036763141566,0.00177265053260546,0.0104110616840993,0.00570700293382286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,24793,0.0112988418005084,0.00409422304173857,0.00327416463870077,0.019323518962316,0.00578963228633648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.00718235712274441,0.00260296622029705,-0.0122841709145266,-0.00208054333096218,0.00579614959861592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,24445,0.00813246008160697,0.002948110070548,0.0023541643433329,0.013910755819881,0.00581045528729543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,24101,0.01866727275683,0.00677214401046731,0.00539387049631408,0.0319406750173459,0.0058471319494418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00839627072680944,0.00305377592079951,0.0024108699220424,0.0143816715315765,0.00597357258198455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.00987847917688336,0.00359993935291126,0.00282259804517729,0.0169343603085894,0.0060727823871775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,24111,0.00662395438100978,0.00241778838969598,0.00188508913720566,0.0113628196248139,0.0061545208157048
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00528936868772214,0.00193535451712207,0.00149607383416289,0.00908266354128139,0.00627929195540009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.00561934696614598,0.00207034496088082,-0.00967722308947239,-0.00156147084281957,0.00664810416138458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00606311774183921,0.0022378198526179,-0.0104492446529703,-0.00167699083070812,0.00674468821725099
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0145460198771071,0.00537543483997277,-0.0250818721634537,-0.00401016759076041,0.00681356068460163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,29594,-0.0088843900027559,0.00328713837596678,-0.0153271812196508,-0.00244159878586102,0.00688028664063013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,28797,-0.0141740849788914,0.00524499719203773,-0.0244542794752853,-0.0038938904824974,0.00688810697760011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.0100511953262749,0.00372068287883147,0.00275865688376519,0.0173437337687845,0.00690885728891528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0112115994718888,0.00415497362708408,0.00306785116280403,0.0193553477809736,0.00697313441832687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00539275501748392,0.00200085224593882,0.00147108461544383,0.00931442541952401,0.00703883951842334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0096210488653818,0.00357225371345563,0.00261943158700877,0.0166226661437548,0.00707956243857101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,29434,-0.0123341918665016,0.004597866489724,-0.0213460101863607,-0.0033223735466426,0.0073095248845762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,28490,0.00498165006123663,0.00185724951492303,0.00134144101198748,0.00862185911048578,0.00731659683444633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.00753499968210149,0.00281087861609873,-0.013044321769655,-0.00202567759454798,0.00735197756785228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,24845,0.00577686608375293,0.00215714368969576,0.00154886445194923,0.0100048677155566,0.00741083262859079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,0.00153924532113523,0.000574819767036191,0.000412598577744296,0.00266589206452616,0.0074159501207217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00729481017830579,0.00272432238132512,0.00195513831090857,0.012634482045703,0.00741885816711424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,29434,-0.011032930682987,0.00413120401520271,-0.0191300905527843,-0.00293577081318973,0.00757499480688934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0101468855122694,0.00380701337257669,-0.0176086317225198,-0.00268513930201912,0.00769675871466575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00696996247430588,0.00261565462470451,0.00184327940988503,0.0120966455387267,0.00771057517830768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00893596317046694,0.00335517342525845,-0.0155121030839735,-0.00235982325696039,0.00774195146709376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0272330447694591,0.0102476323344414,-0.0473184041449641,-0.00714768539395402,0.00787669630364492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0144838204276514,0.00545850565343021,-0.0251824915083746,-0.00378514934692815,0.00797195510208383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00517960561086097,0.00195206973085798,-0.0090056622833426,-0.00135354893837934,0.00797311320743511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.0162917026514843,0.00616121831849278,-0.0283676905557302,-0.00421571474723846,0.0081928363631087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.00626054468768152,0.00237139142103457,0.00161261750245377,0.0109084718729093,0.00829428059522918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00524545372976942,0.00198814421283915,-0.00914221638693414,-0.00134869107260469,0.00833583768905019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.00480739710370936,0.00182302221953205,-0.00838052065399218,-0.00123427355342654,0.0083674779311714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0124315320934419,0.00471979233094717,-0.0216823250620984,-0.0031807391247855,0.00844515376917645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,29594,0.0108361276062054,0.00411835057226282,0.00276416048457024,0.0189080947278405,0.00851327152320894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00593515602662526,0.00226469603707819,0.001496351793952,0.0103739602592985,0.00877969004537187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0221775757959909,0.00847475791839907,-0.0387881013160531,-0.00556705027592871,0.00887782618196181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,28847,-0.0164259185807147,0.00629157632678296,-0.0287574081812093,-0.00409442898022005,0.009038285551767
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,29349,-0.00599269090254786,0.0023014087301307,-0.010503452013604,-0.00148192979149168,0.00922099185379975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00563578577276176,0.00216538523515058,0.00139163071186663,0.00987994083365689,0.00925574816463464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,29566,-0.0102842471061864,0.00395439340332939,-0.018034858176712,-0.00253363603566077,0.00930762404064764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,24966,-0.00491769163690144,0.00189153952332834,-0.00862510910262499,-0.00121027417117789,0.00933233891731245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0439730238951936,0.0169230070391604,-0.077142117691948,-0.0108039300984391,0.00937100934169181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.0163542907090145,0.00629657151497997,-0.0286955708783752,-0.00401301053965374,0.00940073646380919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.00707707614199072,0.00272879345922326,-0.0124255113220683,-0.00172864096191313,0.0095066735918331
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,28931,0.00605243678025214,0.00233552634273815,0.00147480514848536,0.0106300684120189,0.00956160409209543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.00425809335915527,0.00164330991212112,-0.00747898078691266,-0.00103720593139788,0.00956973683262235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,29169,0.00845009729016401,0.00326120725613731,0.00205813106813488,0.0148420635121931,0.00957187743365987
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.0100402103088225,0.00388102901236991,-0.0176470271730676,-0.00243339344457749,0.00968727459898246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.00604082369947093,0.00234984369386616,-0.0106465173394486,-0.00143513005949326,0.0101540873409598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,24805,-0.0205475130148247,0.00801385970409539,-0.0362546780348517,-0.00484034799479775,0.0103532800235824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.00967367927220049,0.00377389053347654,-0.0170705047178145,-0.00227685382658646,0.0103735395249793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,24546,0.00620598336027312,0.00242211502010133,0.00145863792087451,0.0109533287996717,0.0104065589510937
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.00848860280755257,0.00331661084279876,0.001988045555667,0.0149891600594381,0.010490746384519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.00732758100758378,0.00287297564297822,-0.0129586132678211,-0.00169654874734647,0.0107612735643738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,24195,-0.00720834813336808,0.00282806534546335,-0.0127513562104763,-0.0016653400562599,0.0108136299630517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.0164804066337462,0.00647373136350536,-0.0291689201062167,-0.00379189316127568,0.0109107679162003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0078610689657881,0.00308898635475443,-0.0139154822211068,-0.00180665571046942,0.0109370140532802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,24195,-0.0117444859948789,0.00462313167232647,-0.0208058240726387,-0.00268314791711897,0.0110795808611821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0217124752900682,0.00854721995397313,-0.0384650263998555,-0.00495992418028087,0.011080940018479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,0.00511953852335047,0.00201536552543649,0.00116942209349494,0.00906965495320599,0.0110823613864853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,24343,-0.0103645531231814,0.00408404599667512,-0.0183692832766646,-0.00235982296969815,0.0111608786445358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.011652255539785,0.00459499300949867,-0.0206584418384024,-0.00264606924116758,0.0112233573560019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00932441293557593,0.00368380937064168,0.00210414656911823,0.0165446793020336,0.0113738315068714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,24381,-0.00646226235759053,0.00256067534046443,-0.0114811860249008,-0.00144333869028025,0.0116204722946116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,24914,0.00402339050645994,0.00159741975981347,0.000892447777225545,0.00715433323569434,0.011785751224244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,29694,-0.0116157757927842,0.00461350373033652,-0.0206582431042438,-0.00257330848132466,0.0118150094544684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.0102207714573342,0.00406205704516485,-0.0181824032658573,-0.0022591396488111,0.0118696664344245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,23603,0.0124701739471549,0.00495675343149058,0.00275493722143334,0.0221854106728764,0.0118830198631779
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.0104972128257598,0.00417825253462751,0.00230783785788986,0.0186865877936297,0.0119996509231727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.00699758700439468,0.00279130409994238,-0.0124685430402817,-0.00152663096850762,0.0121852208532332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,24101,0.00623714877434901,0.00249012862726611,0.00135649666490744,0.0111178008837906,0.0122603612035307
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.00677537026559859,0.00271574666310319,-0.0120982337252808,-0.00145250680591634,0.0126076290933485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.00800264354556891,0.0032092362214618,-0.014292746539634,-0.00171254055150378,0.0126498742715306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.015089280195599,0.00606124228459455,-0.0269693150734043,-0.00320924531779366,0.0128000661764989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.0190124700651502,0.00766297344368379,-0.0340318980147705,-0.00399304211553,0.0131039633619218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,24381,-0.00678480897484859,0.00274453025165923,-0.0121640882681007,-0.0014055296815965,0.0134382081816988
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,28774,-0.00812345900904458,0.00329347084618715,-0.0145786618675714,-0.00166825615051776,0.0136485501087953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.00810273038921541,0.00329672991308367,-0.0145643210188594,-0.00164113975957142,0.0139855558948124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.00935728513673896,0.0038087372078777,-0.0168224100641792,-0.00189216020929867,0.0140241430770172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,24445,0.00497393410681812,0.00202558623456962,0.00100378508706166,0.00894408312657458,0.0140737195534808
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,24922,0.00514411986512402,0.00209520946354455,0.00103750931657671,0.00925073041367133,0.0140881255614281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,28931,-0.00867996996145272,0.00353764828827739,-0.0156137606064764,-0.00174617931642903,0.0141493206434675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.00982780001969947,0.00401110638691039,0.00196603150135511,0.0176895685380438,0.0142855929881149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.0151197602915426,0.00618566186859226,-0.0272436575539834,-0.00299586302910178,0.0145193235497561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,24445,0.00674848862531595,0.00276421970037986,0.00133061801257142,0.0121663592380605,0.0146386200388908
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,28745,-0.00969791453283473,0.00397240395856985,-0.0174838262916316,-0.00191200277403783,0.0146396195769743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,24229,0.00758049366087066,0.0031090313082997,0.00148679229660326,0.0136741950251381,0.0147670411346715
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00622947645490585,0.00256041080070325,0.00121107128552748,0.0112478816242842,0.014981333889168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.00608121086999885,0.00250314459616558,-0.0109873742784834,-0.00117504746151431,0.0151286946402256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,0.00803147475203191,0.00330626150927016,0.00155120219386239,0.0145117473102014,0.0151393372547084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,0.00544571407722339,0.00224191420634818,0.00105156223278096,0.00983986592166583,0.0151445252115267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.00679358069057606,0.00279694930569679,0.00131156005141036,0.0122756013297418,0.0151509114789464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,24229,0.00457894860913154,0.00189317474624501,0.000868326106491308,0.00828957111177177,0.0155850595688274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.00954096274586805,0.00395835043543923,-0.0172993295993289,-0.00178259589240716,0.0159438386242457
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.00464368654373216,0.00192822244905992,-0.00842300254388961,-0.00086437054357471,0.0160342667966645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.0144989600407046,0.00603110305478011,-0.0263199220280736,-0.0026779980533356,0.016221549734105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.0123431943689596,0.0051415440115818,-0.0224206206316599,-0.00226576810625929,0.0163708932396713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,29478,0.0136661627174447,0.00569362431872562,0.0025066590527425,0.0248256663821469,0.016389720052824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.0110002887611845,0.00458702818002611,-0.0199908639940357,-0.00200971352833332,0.0164863585895231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,0.00458004198629163,0.00191289694757533,0.000830763969043978,0.00832932000353928,0.0166596623908672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0198215875512473,0.00837375765036116,-0.0362341525459552,-0.00340902255653946,0.0179341397654232
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.00716083812330301,0.00302902082983557,-0.0130977189497807,-0.00122395729682529,0.0180814845981756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,29349,-0.00690372976139571,0.00295353641272144,-0.0126926611303297,-0.00111479839246169,0.0194227311779412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,28931,-0.00811978118608117,0.00348824999044238,-0.0149567511673482,-0.0012828112048141,0.0199321347970664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,29676,0.00711640943322812,0.00305940001137685,0.0011199854109295,0.0131128334555267,0.0200209826527041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,24845,-0.0084682796175859,0.00364406862656423,-0.0156106541256518,-0.00132590510952001,0.020141405867728
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00671478951377568,0.00289029628626698,0.00104980879269241,0.012379770234859,0.0201757512710409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.0115890804064935,0.00499209093918047,-0.0213735786472872,-0.00180458216569977,0.0202686910981349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00759487788010011,0.00328074098884524,0.00116462554196344,0.0140251302182368,0.0206218762300833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.00845701438567716,0.00366329703778367,0.00127695219162118,0.0156370765797332,0.0209750620231052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.00991996568992082,0.0042989432807966,-0.0183458945202822,-0.00149403685955949,0.0210319233438173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.00981621381583366,0.00425404137013549,-0.0181541349012992,-0.0014782927303681,0.02103362563957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,29478,-0.0123606629386776,0.00537919625152865,-0.0229038875916738,-0.00181743828568146,0.0215764862295932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.00619095569826735,0.00269487245177085,-0.0114729057037382,-0.000909005692796491,0.0216096285204878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.0036871970988233,0.00160976312600744,-0.00684233282579789,-0.000532061371848716,0.0219994118546808
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00366569516326603,0.00160390925471356,0.00052203302402746,0.00680935730250461,0.0222919546427396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00527513862060374,0.00231387710686449,0.000739939491149334,0.00981033775005815,0.0226292363967922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.00442394697771628,0.00194183172975456,-0.00822993716803523,-0.000617956787397336,0.0227197769385048
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,29725,0.00960617586476095,0.00421732125358282,0.00134022620773862,0.0178721255217833,0.0227461106158907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0175962353004266,0.00774044821735935,0.00242495679440224,0.0327675138064509,0.0230175616359239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.0108027642778611,0.00476351035581588,-0.0201392445752602,-0.00146628398046199,0.0233476409647323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,24867,-0.00408722440234221,0.00180840976118355,-0.00763170753426196,-0.000542741270422459,0.0238223752313698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.013419153030858,0.00594545670861523,-0.0250722481797438,-0.0017660578819721,0.0240128054806768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,24307,-0.0133932963267235,0.00593693056858939,-0.0250296802411587,-0.00175691241228829,0.0240839069880671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,24867,-0.00794186907607171,0.00352093187359223,-0.0148428955483125,-0.00104084260383093,0.0241033701263513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.00622126626452778,0.00276159674500257,-0.0116339958847328,-0.00080853664432274,0.0242820209539322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.00553583727677023,0.00245908349006997,-0.0103556409173074,-0.000716033636233101,0.0243815706297591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,24111,0.0094412447956741,0.004196870258324,0.00121537908935907,0.0176671105019891,0.0244838591482679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,-0.00727608524526382,0.00324097591819663,-0.0136283980449292,-0.000923772445598416,0.024773621797777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,24016,0.00737499919040275,0.00329124444729823,0.000924160073698221,0.0138258383071073,0.0250485613257077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.00704658215086639,0.00315011313770063,-0.0132208039007596,-0.000872360400973158,0.0252997558213653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,0.00652411477912209,0.00291875560641079,0.000803353790556953,0.0122448757676872,0.0254091715882509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,0.00417382453569258,0.0018697167793193,0.000509179648226764,0.0078384694231584,0.0256020204578445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,28797,0.0136857435734143,0.00613507675120033,0.00166099314106168,0.025710494005767,0.0257062206960642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,24793,-0.0125005274391044,0.00560716633824071,-0.0234905734620562,-0.00151048141615265,0.025797287274709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,24111,0.00703264042032593,0.00315696422682947,0.000844990535740169,0.0132202903049117,0.0259124459422761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,24111,-0.00789189198082099,0.00356801813713176,-0.0148852075295992,-0.000898576432042743,0.0269869377298947
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0121717147520038,0.00550839120145158,0.0013752679971587,0.0229681615068489,0.0271375591342998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,29497,0.00462997738228976,0.00209769807043382,0.000518489164239477,0.00874146560034005,0.0273098218399528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00577616495581053,0.00263133917162294,0.000618740179429566,0.0109335897321915,0.028162866605776
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.0064146056716695,0.00292346588226695,0.000684612542426276,0.0121445988009127,0.0282321033219219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.0113292175243218,0.00516676984518605,-0.0214560864208865,-0.00120234862775717,0.0283379882334121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.00841292618974667,0.00384638242733638,-0.015951835747326,-0.000874016632167358,0.0287349372703469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,28931,0.0075306725855634,0.00345621520066334,0.000756490792263243,0.0143048543788635,0.0293487494508464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00457990572880096,0.00210259935031324,-0.00870100045541491,-0.000458811002187011,0.0293996532161846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,24793,-0.0081166802386572,0.00373437706326019,-0.0154360592826472,-0.000797301194667237,0.0297519078559118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,24016,0.00632079627714147,0.00291089776407507,0.000615436659554337,0.0120261558947286,0.0299088204767586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,24229,-0.00502063088604235,0.00231321072318957,-0.0095545239034939,-0.000486737868590786,0.0299849882118897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,24445,-0.00671194704855931,0.00309750053045516,-0.0127830480882514,-0.000640846008867194,0.0302527732001448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,24111,0.00774717373516988,0.00358555688681736,0.000719482237007853,0.0147748652333319,0.0307313412011283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.00572320876853736,0.00264953484266587,-0.0109162970601625,-0.000530120476912261,0.0307762122635314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.0171281058263953,0.00793310422320657,-0.0326769901038801,-0.00157922154891041,0.0308546755796406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,28722,-0.00549320992942341,0.00255340016312555,-0.0104978742491495,-0.000488545609697339,0.0314583690423518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.00575483490842432,0.00268629754632756,0.000489691717622309,0.0110199780992263,0.032178164094219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.00631513200136228,0.00294876921947769,0.000535544331185995,0.0120947196715386,0.0322343252901623
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,29123,0.00387395729895433,0.00181543563803761,0.000315703448400619,0.00743221114950805,0.0328593373813264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0258391457473601,0.0121191989278043,0.00208551584886364,0.0495927756458565,0.0330083428190686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,24706,0.0108508936653143,0.00509589447269294,0.000862940498836109,0.0208388468317925,0.0332359768731256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,28774,0.00776562734402819,0.00364953268357474,0.000612543284221686,0.0149187114038347,0.0333587019391063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,24867,-0.00562007810678947,0.00264833714536195,-0.0108108189116989,-0.000429337301880048,0.0338378778911206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0110871245349335,0.00522613767857298,-0.0213303543849365,-0.000843894684930442,0.0338916305622017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.00783818883004966,0.0037020637897485,-0.0150942338579567,-0.000582143802142607,0.0342489478292799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00827647821144857,0.00392197543906247,0.00058940635088613,0.015963550072011,0.0348439795871932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00509404854892204,0.00241880045272871,0.000353199661573776,0.0098348974362703,0.0352127045853153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00620781210449378,0.00296806637575903,0.000390402008006088,0.0120252222009815,0.036490336085401
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,24445,0.00524554991062739,0.00250964731956997,0.000326641164270242,0.0101644586569845,0.0366142612925672
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00764597606795068,0.00366070039150405,-0.0148209488352986,-0.000471003300602737,0.0367483386709499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0144790744703163,0.00693638750878626,0.000883754953095259,0.0280743939875374,0.0368597658087815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,24845,0.00390801957162545,0.00187588298529684,0.00023128892044365,0.00758475022280725,0.0372344522341772
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00917879130030341,0.00440709495271828,-0.0178166974076312,-0.000540885192975588,0.0372863519923015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.00878909543144871,0.00422087254614067,-0.0170620056218844,-0.000516185241012988,0.0373258730434463
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.00757627073561757,0.00364165203017737,-0.0147139087147652,-0.000438632756469913,0.0374946326338986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.0116225952696401,0.00559595731337136,-0.022590671603848,-0.000654518935432283,0.0378138394603134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,29426,0.00961532316170126,0.00468105931042604,0.000440446913266224,0.0187901994101363,0.0399756751980492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,24756,0.00852598388295103,0.00415909385126453,0.00037415993447255,0.0166778078314295,0.0403786666473269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,24101,0.00685999112093553,0.00336888131309349,0.000256983747272298,0.0134629984945988,0.0417329997026353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,29121,-0.00822262601591554,0.00403855722479899,-0.0161381981765216,-0.00030705385530953,0.0417563195139592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.00643975814652837,0.00316700066388863,-0.0126470794477501,-0.000232436845306654,0.0420234310538699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00425675722049712,0.00210595272262844,0.000129089884145388,0.00838442455684886,0.0432596331379702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,0.00469475450295863,0.00232354599622935,0.000140604350349105,0.00924890465556816,0.0433412648910262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,24867,-0.0098227601996583,0.00487008436533123,-0.0193681255557075,-0.000277394843609091,0.0437105301915764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00475674232998579,0.00236235434108179,0.000126527821465485,0.0093869568385061,0.0440667857807404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.0077099386944252,0.0038309794837096,0.000201218906354392,0.015218658482496,0.0441758185081983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,24016,0.00902226891412946,0.00448378207373699,0.000234056049604969,0.017810481778654,0.0442099473413495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,24195,-0.010662199406417,0.00533906452412626,-0.0211267658737045,-0.000197632939129565,0.0458345890550773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,24016,0.00522959809848236,0.0026207221573909,9.29826699961941e-05,0.0103662135269685,0.0460018591651364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,24229,0.00801974746202124,0.0040298819378143,0.000121178863905207,0.0159183160601373,0.0465944418013121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,-0.00930811681576483,0.00468835296231095,-0.0184972886218943,-0.000118945009635366,0.0471146022737633
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00648379238613662,0.00327021370449261,7.4173525331101e-05,0.0128934112469421,0.0474143532551675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.0121276094452102,0.00612572115415389,-0.0241340229073518,-0.000121195983068574,0.0477391226443251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00512360305390009,0.00258857603911354,-0.0101972120905626,-4.99940172375467e-05,0.0477920474172262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.0152712421481494,0.00771677906001595,-0.0303961291057807,-0.000146355190518166,0.0478291739441324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,24195,-0.00681920621443305,0.00345285840206036,-0.0135868086824713,-5.16037463947558e-05,0.048285720665876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.00933853570499681,0.00472894464984045,-0.0186072672186841,-6.980419130952e-05,0.0483063546611688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,24195,-0.0128386689213263,0.00650301430311718,-0.0255845769554359,-9.27608872166082e-05,0.0483630604793804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.00559880500355983,0.00283784829498205,-0.0111609876617246,-3.66223453950191e-05,0.0485174172471507
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.0052445349391279,0.00265894982188374,3.29932882357767e-05,0.01045607659002,0.0485744197818842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.00542764806648357,0.00275436759705905,2.90875762478243e-05,0.0108262085567193,0.0487835534037931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,0.0118516234609263,0.00604219221218825,8.92672503737153e-06,0.0236943201968153,0.049833084828167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,24938,-0.0060089536818115,0.00307257905359541,-0.0120312086268585,1.33012632355092e-05,0.0505150819551475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.00588931941933328,0.00301547575485419,-0.0117996518988475,2.101306018093e-05,0.0508272254849031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,24111,0.00716695771954203,0.00366981833352871,-2.58862141742549e-05,0.0143598016532583,0.0508375310978869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,24149,-0.00939686529673828,0.00481439788458734,-0.0188330851505295,3.9354557052897e-05,0.0509704564218842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,24195,0.00520481088111726,0.00266976839438887,-2.79351718849149e-05,0.0104375569341194,0.0512429340582045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,29694,-0.0104140638153619,0.00534232753225714,-0.0208850257785859,5.68981478621042e-05,0.0512630998243445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.0106826383405452,0.00548533574699285,-0.0214338964046512,6.86197235607953e-05,0.051487223292001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.00820496164598678,0.004216293395477,-0.0164688967011217,5.89734091481463e-05,0.0516647904253453
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.0071986880906765,0.00370807784222904,-0.0144665206614454,6.91444800924217e-05,0.0522267954910852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,24229,-0.0056126021815016,0.0028911254029307,-0.0112792079712458,5.40036082425661e-05,0.0522309514793584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00807976789957869,0.00420021671508857,-0.000152656861994916,0.0163121926611523,0.0544074995674986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.0106660572654705,0.00554600256952747,-0.0215362223017444,0.00020410777080331,0.0544651353588863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.00992553534251878,0.00516770556152586,-0.0200542382431095,0.000203167558071893,0.0547809722939087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.0075921407490573,0.00396599853022892,-0.015365497868306,0.000181216370191373,0.0555927532019761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,28830,-0.00658070573434843,0.00344063415581089,-0.0133243486797378,0.000162937211040907,0.0558036395995354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00768880028528826,0.00402463657286005,-0.000199487397517435,0.0155770879680939,0.0560893321856798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,29443,-0.00324437866857965,0.00170518050101071,-0.00658653245056063,9.77751134013331e-05,0.0570946798449359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,24240,-0.00985099638160512,0.00517792129366284,-0.0199997221171843,0.000297729353974055,0.0571176362044229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,28774,-0.00904693996598291,0.00476455409877183,-0.0183854659995757,0.000291586067609867,0.0576006475023906
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.00418375871742996,0.00220808658862439,-0.00851160843113376,0.000144090996273839,0.0581382327201164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,29820,0.00423861491541207,0.00224165336774022,-0.000155025685358766,0.00863225551618291,0.0586549743995243
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00708829057795738,0.00374963438133623,-0.0144375739653764,0.000260992809461626,0.0587169889734818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.0103753154751438,0.00550103812105379,-0.0211573501924093,0.000406719242121602,0.059298169343665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,24229,0.0137834660055876,0.00731476786855095,-0.000553479016772258,0.0281204110279474,0.0595317749712237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,24966,-0.00344155345911439,0.00183019355810892,-0.00702873283300788,0.000145625914779097,0.0600609435559591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,24016,0.0063353576651512,0.00337919158768225,-0.000287857846706019,0.0129585731770084,0.0608303699121876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.00564296606632802,0.00302902863835427,-0.0115798621975024,0.000293930064846357,0.0624793923106433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,24016,0.00622948654111165,0.00334585145187187,-0.000328382304557204,0.0127873553867805,0.0626359005911352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00635604721330809,0.0034225891128812,-0.000352227447939056,0.0130643218745552,0.0633108498541093
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,29349,-0.0247697975393565,0.0133418146139499,-0.0509197541826982,0.0013801591039852,0.0633846704640147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,28931,-0.00659271774944705,0.00355887291910336,-0.0135681086708896,0.000382673171995532,0.0639680433129847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.00838000036807571,0.00455950272584318,-0.0173166257107283,0.00055662497457693,0.0660864659168448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,29434,-0.00718425570815609,0.00393489443252383,-0.0148966487959028,0.000528137379590618,0.0678933795036852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.00427803469608084,0.00234825445922301,-0.00888061343615795,0.00032454404399626,0.0684986500870297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.00628697696671538,0.00345458623460971,-0.0130579659865504,0.000484012053119646,0.0687873397266831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.00806409367221395,0.00445018052842242,-0.0167864475079219,0.000658260163494002,0.0699838380537378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.00438368109943117,0.00242153540151765,-0.00912989048640577,0.000362528287543431,0.0702629434991886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,24922,0.00481930793818344,0.00266252166285395,-0.000399234521010293,0.0100378503973772,0.0702994628466888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,29694,-0.00373476303360368,0.00206432035071469,-0.00778083092100448,0.000311304853797111,0.0704304530061425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00519357708738354,0.00287212331944846,-0.000435784618735433,0.0108229387935025,0.0705744729558032
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00451468620017388,0.00250252052401588,-0.000390254026897238,0.00941962642724501,0.0712350105863376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.00357488625859819,0.00198380145560382,-0.00746313711158167,0.00031336459438529,0.0715514534586969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0101684739587255,0.00565079379193372,-0.0212440297909156,0.000907081873464553,0.0719557997008717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,24101,-0.00789387141076533,0.00438923765139925,-0.0164967772075079,0.000709034385977199,0.0721165467906538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.00923061013918955,0.00513808331410935,-0.0193012534348439,0.000840033156464779,0.0724257865531178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,24229,0.00689354891245562,0.00385383274853065,-0.000659963274664463,0.0144470610995757,0.0736673490472972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,29218,0.00707802680094704,0.00396204790174774,-0.000687587086478527,0.0148436406883726,0.0740357211721736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,24229,0.00733865796778189,0.00412331141109011,-0.000743032397954715,0.0154203483335185,0.075121698889474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,24195,0.00434418539929129,0.00245067340353337,-0.000459134471634105,0.00914750527021669,0.0762993630768661
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00431170125021577,0.00243737174246461,-0.000465547365014865,0.0090889498654464,0.0769071902279532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,29478,-0.00501359574808859,0.00283677171079284,-0.0105736683012425,0.000546476805065374,0.0771783717847558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.00318166610559046,0.00180146408263813,-0.000349203496380279,0.00671253570756119,0.0773824362126758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,28845,-0.00549573980526184,0.00311209520402846,-0.0115954464051576,0.000603966794633935,0.077418308809501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00501839452229586,0.00284467178521279,-0.000557162176721211,0.0105939512213129,0.0777213615113325
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.00413122899271332,0.00234274009435142,-0.0087229995776421,0.000460541592215461,0.077840471119356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.00753040117839785,0.00427062658665805,-0.0159008292882476,0.000840026931451922,0.0778602606289354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,29218,-0.00532568585357772,0.00302631256714484,-0.0112572584851816,0.000605886778026177,0.0784532563547913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,24805,-0.00379166388123286,0.00217897512768639,-0.00806245513149818,0.000479127369032465,0.0818515115367216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00545993424289259,0.0031407937559247,-0.000696021518719814,0.011615890004505,0.082154279512636
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,29478,0.00565352323380517,0.0032661168312223,-0.000748065755390531,0.0120551122230009,0.0834690597138043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.00603560525818966,0.0034919222173659,-0.0128797728042268,0.000808562287847502,0.0839204300812021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,24229,0.00341772484088399,0.00197779803431649,-0.00045875930637632,0.0072942089881443,0.0839928299187163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.00942816818675635,0.00546160843601831,-0.00127658434783954,0.0201329207213522,0.0843130757319504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00382681925814461,0.00221690599682898,-0.00817195501192941,0.000518316495640189,0.0843245256962806
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00356924027243214,0.00207828826052627,-0.000504204718199344,0.00764268526306362,0.0859199508191673
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.00487796044129257,0.00285140730040534,-0.000710797867501905,0.010466718750087,0.087145555154374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00534844930442672,0.00312684698388876,-0.000780170783995246,0.0114770693928487,0.0871876524228031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,0.00839759106180744,0.00491643014825611,-0.00123861202877453,0.0180337941523894,0.0876368298511459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.0101513401535454,0.00594724451882425,-0.021807939410441,0.0015052591033501,0.0878517953537209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,24922,-0.0117891799846707,0.00691905871937695,-0.0253505350746495,0.00177217510530816,0.0884177580640113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,29434,0.0046655976712935,0.00273922904940192,-0.000703291265534262,0.0100344866081213,0.0885314595163839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,24111,-0.00889064290435017,0.00523326034799187,-0.0191478331864142,0.00136654737771389,0.0893560887046964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,24381,0.00412383544186091,0.00242929602731319,-0.000637584771672947,0.00888525565539476,0.0896067423246415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00546321314508302,0.00323005352826883,-0.0117941180604899,0.000867691770323899,0.0907792416306526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,0.00232564643372617,0.0013752185520287,-0.000369781928250078,0.00502107479570241,0.0908282023948511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.00384872844336832,0.00227720402981672,-0.00831204834180909,0.000614591455072456,0.0910195880778016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.00338197706483156,0.00200591890529872,-0.00731357811921705,0.000549623989553934,0.0918085214643804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.00661847177130308,0.0039295122787431,-0.0010833722950334,0.0143203158376396,0.0921365767426312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,24938,0.00563881224917787,0.00335069372217111,-0.000928547446277515,0.0122061719446332,0.0924110338492885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.00681796232946256,0.0040588385501676,-0.00113736122886594,0.014773285887791,0.0930103066525171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,29114,-0.0123638091754382,0.00736381355710439,-0.0267968837473628,0.00206926539648644,0.093163674024731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,24966,-0.00232018951363222,0.00138348418166444,-0.00503181850969453,0.000391439482430091,0.0935427761712057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.0045454908600494,0.00271480451817257,-0.00986650771566764,0.000775525995568835,0.0940776904989296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,-0.00388834922501234,0.00234125674912908,-0.00847721245330533,0.000700514003280657,0.0967653696982646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.0081140837985303,0.00489177734829864,-0.0177019674011956,0.00147379980413504,0.0971850683397902
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,24016,0.00711236298275618,0.00429049926615071,-0.0012970155788992,0.0155217415444116,0.0973909915615964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,24195,-0.00708763745719224,0.00428203990213238,-0.0154804356653717,0.00130516075098723,0.0978966749411162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,24195,-0.00813095152562034,0.00491709445946508,-0.0177684566661719,0.00150655361493122,0.098219968493143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,29439,0.00688355364620628,0.00416331202557172,-0.00127653792391428,0.0150436452163268,0.0982633969302581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00439168431572648,0.00265744171745661,-0.000816901450488473,0.00960027008194144,0.0984234506775383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.0071934726368028,0.00436681537530073,-0.0157524307723922,0.00136548549878662,0.0995082464294819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.005823094813528,0.00353529562360455,-0.00110608460873691,0.0127522742357929,0.0995441732427243
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.00850734959232752,0.00519685580877638,-0.00167848779287418,0.0186931869775292,0.101639647838354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,24195,-0.00585969653916875,0.00358879853435822,-0.0128937416665109,0.00117434858817337,0.102529580692409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.00840836861606802,0.00516481424448581,-0.00171466730312417,0.0185314045352602,0.103535864195962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,24867,-0.0041184589295421,0.00253016459964633,-0.0090775815448489,0.000840663685764706,0.103591965538822
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.00312960510246102,0.00192534837548961,-0.00690328791842065,0.000644077713498616,0.104072350281498
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,29694,-0.0146978236981938,0.00904888885263032,-0.0324336458493492,0.00303799845296163,0.104329169397746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.00375475202625828,0.00231420522173052,-0.0082905942608501,0.000781090208333537,0.104711317538651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,29293,-0.00640681558565455,0.0039536338863834,-0.014155938002966,0.00134230683165691,0.105138295962222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,24016,0.00352994029715733,0.00218046587327027,-0.00074377281445239,0.00780365340876706,0.105483489303893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00529032474819572,0.00327179688820811,-0.0117030466490836,0.00112239715269217,0.105900509832955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.0040250322071538,0.00250059844765655,-0.000876140750253046,0.00892620516456064,0.10749015171474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.0027582944889166,0.00171399654029956,-0.00611772770790373,0.000601138730070539,0.107566607272007
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00600939616781594,0.00374847833075503,-0.00133762136046391,0.0133564136960958,0.108913127543362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00381429534530934,0.0023861149641299,-0.000862489984385254,0.00849108067500393,0.109936415483529
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.00376292856498685,0.0023566465822992,-0.00838195586629328,0.000856098736319578,0.110336566865049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.00459944627057459,0.00288193904241754,-0.010248046793713,0.00104915425256378,0.110509722542862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,28916,-0.00547721250881935,0.00343573152164637,-0.0122112462912462,0.00125682127360755,0.110904180758918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,-0.00330437400773312,0.00207747915443926,-0.00737623315043408,0.000767485134967836,0.111719768371294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.004946605298724,0.00311164775954658,-0.0110454349074353,0.00115222430998729,0.111914131915532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.0129935167797883,0.00817705395565827,-0.0290205425328785,0.00303350897330187,0.112068197164537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00305151902068148,0.00192838522233875,-0.000728116015102481,0.00683115405646543,0.113563988206611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.00372843998022753,0.0023593735666713,-0.00835281217090328,0.00089593221044822,0.114058815074312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.00639863971789355,0.00405900231125679,-0.0143542842479569,0.00155700481216976,0.114942977436892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,24793,0.00302389277658418,0.00192047800164422,-0.000740244106638479,0.00678802965980684,0.115372620570496
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,29674,-0.00343254360248493,0.0021807814432821,-0.00770687523131784,0.000841788026347991,0.115498792694777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.004356402550183,0.00276897398853926,-0.00107078646735395,0.00978359156771995,0.115662394219347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,24101,-0.0123331073106293,0.00785689772018967,-0.027732626842201,0.00306641222094247,0.116494058578917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.00278282165365127,0.00177541217369082,-0.00626262951408528,0.000696986206782743,0.117028865707566
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.00534860031920317,0.00341511782307348,-0.0120422312524272,0.00134503061402086,0.117323519250783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00558361128659395,0.0035733948316533,-0.00142024258344652,0.0125874651566344,0.118171398173436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00289289209107481,0.00185578484504285,-0.000744446205209168,0.00653023038735879,0.119044830672708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.0049059953803082,0.00315502933790127,-0.0110898528825947,0.00127786212197828,0.119964817697866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.00960772868874214,0.00618517964877497,-0.0025152234228568,0.0217306808003411,0.120351096710693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,29216,-0.00566365562622587,0.00365046594246828,-0.0128185688734637,0.00149125762101196,0.12079551786758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,0.00629464322370444,0.00406292755869274,-0.00166869479133332,0.0142579812387422,0.121325740854317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,24445,0.00376821564268944,0.00243568094009492,-0.00100571899989661,0.00854215028527548,0.121854693882864
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0157258527185749,0.0101731854310052,-0.035665296163345,0.00421359072619524,0.122162672815004
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,29820,0.00213135921291876,0.00138001972112319,-0.00057347944048269,0.00483619786632021,0.122492119825803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.00713854394289243,0.00462382403564229,-0.00192415116696646,0.0162012390527513,0.122632889558375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,0.00437878565107873,0.00283959106473052,-0.00118681283579309,0.00994438413795055,0.123074678881965
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.00290244308364184,0.00188345410898791,-0.00078912696997447,0.00659401313725815,0.123322310419005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,28954,0.00450522160417033,0.00292399545633792,-0.001225809490252,0.0102362526985926,0.123382280814988
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00325307260656535,0.00211430813654229,-0.000890971341057531,0.00739711655418823,0.123913138765744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.00492693509422969,0.00320432262337685,-0.0112074074360483,0.00135353724758894,0.124159580937343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00548384590974595,0.00357369951703035,-0.00152060514363354,0.0124882969631254,0.12491939320024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.00981791923832664,0.00640034630033556,-0.0223625979869843,0.00272675951033106,0.125050929598956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.0112573451982571,0.00736390920677064,-0.0256906072435276,0.00317591684701335,0.126344946560262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.00912437696103611,0.00597904959285614,-0.0208433141630341,0.00259456024096192,0.127008478603615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00732405812019284,0.00481079433027671,-0.0167532150075352,0.00210509876714951,0.127914422609357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,0.00345516859151007,0.00226981523136317,-0.000993669261961741,0.00790400644498188,0.127963797756381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,24845,0.010191253465952,0.00669985665142174,-0.00294046557083466,0.0233229725027386,0.128243676023246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.00574261458000891,0.00377676680472703,-0.0131450775172739,0.00165984835725606,0.128393433309207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,0.00709069213724531,0.00466885981172677,-0.00206027309373915,0.0162416573682298,0.128846087780451
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,24826,0.00256104206504323,0.00168768249612462,-0.000746815627361021,0.00586889975744747,0.129155643917974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,24229,-0.00282613559959772,0.00186781835925342,-0.00648705958373443,0.000834788384538985,0.130275517800044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,28774,-0.0041375514299135,0.00273703247665147,-0.00950213508415038,0.00122703222432339,0.130623098162965
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00277895534239624,0.00183914130394805,-0.000825761613341928,0.00638367229813442,0.130797450421712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,24229,-0.00487672808423931,0.00323565130419234,-0.0112186046404563,0.00146514847197768,0.131776053607811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,0.00533890054269503,0.00354419155242713,-0.00160771490006214,0.0122855159854522,0.131982673381862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00399792916814296,0.00266632209175338,-0.00122806213169368,0.00922392046797959,0.133778393064557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,24203,0.00737464360847193,0.00493950412649883,-0.00230678447946577,0.0170560716964096,0.13545213996255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,24111,0.00363041663689896,0.0024372964354538,-0.0011466843765905,0.00840751765038842,0.136361975113076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,24240,-0.00312133544019745,0.00210671428216533,-0.00725049543324149,0.00100782455284659,0.138456282286411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,28114,-0.00293761815947379,0.00198471671378784,-0.00682766291849796,0.000952426599550379,0.138852535920078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,24938,0.00929320952595792,0.00628361074504187,-0.00302266753432414,0.02160908658624,0.139163618910017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,29478,-0.00298730281645966,0.00202153996086543,-0.0069495211397559,0.000974915506836582,0.139489085002436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.0030732531246901,0.00208236042526178,-0.0071546795582032,0.001008173308823,0.139996974985308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00553041656900862,0.00376167873150843,-0.0129033068827651,0.0018424737447479,0.141520724593227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,29694,-0.00279014205911465,0.00189826808945834,-0.00651074751445299,0.000930463396223691,0.141616878501357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00329593909349591,0.00224778916111484,-0.00110972766228918,0.00770160584928101,0.142578870872241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00509628695518973,0.00348171443000886,-0.00172787332762764,0.0119204472380071,0.1432810128516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00673387371593343,0.0046079075365983,-0.00229762505579923,0.0157653724876661,0.143926028558915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,24101,0.00555968458875359,0.00380761022323976,-0.00190323144879634,0.0130226006263035,0.144261713765449
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00872763877355981,0.00601993069464447,-0.020526702935063,0.00307142538794335,0.147129874152363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.00996431805797904,0.00687365611250865,-0.023436684038496,0.00350804792253791,0.147171948072098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,24016,0.00567461653124274,0.0039289206523089,-0.0020260679472827,0.0133753010097682,0.148662189093527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,24195,-0.00845213955166237,0.00585986060936786,-0.0199374663460234,0.00303318724269864,0.149208452654831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0034350967869422,0.00238623758909817,-0.0012419288876902,0.0081121224615746,0.150008689774132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00492012915101099,0.00342218874790994,-0.0116276190969145,0.0017873607948925,0.150528164904345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.00880304916049213,0.00612523971606682,-0.0208085190039831,0.00320242068299885,0.150680720758146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,28931,0.0047774206121733,0.00332736043137382,-0.00174420583331939,0.011299047057666,0.15107037567399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,29322,0.00365172679314983,0.00254865466354372,-0.00134363634739586,0.00864708993369553,0.151924053332687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.00618895558950887,0.00431983221312427,-0.0146558267272324,0.00227791554821471,0.151960706810228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.0046404386017832,0.00324985516342963,-0.0110101547221053,0.00172927751853888,0.153336223778204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,24445,-0.00726080383689522,0.00508919077976237,-0.0172356177652295,0.00271401009143902,0.153676028358355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.00406620364191621,0.00286706395546744,-0.0096856489946324,0.00155324171079998,0.156131719573216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00439991463707985,0.00310811607189575,-0.0104918221379955,0.00169199286383581,0.156899404800723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,24111,0.00665990637414234,0.0047186913572235,-0.00258872868601571,0.0159085414343004,0.158143024454102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00216577871007752,0.00153555687581629,-0.00517547018667744,0.000843912766522407,0.158428821081716
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,24101,0.00906732687827016,0.0064534915384397,-0.00358151653707164,0.021716170293612,0.160026283063617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00459349569236533,0.00327025079782798,-0.00181619587137751,0.0110031872561082,0.160143919020441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,24016,-0.00718674975382895,0.00511884725083265,-0.0172196903654609,0.00284619085780304,0.160338291123599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.0040553052102109,0.0028894798530595,-0.00160807530178572,0.00971868572220751,0.160488954893049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.00630465844980786,0.00449308789319517,-0.0151111107204704,0.00250179382085467,0.160572768407235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,24195,0.00585219111632944,0.00419603106555547,-0.00237202977215929,0.0140764120048182,0.163120100679279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00692964688279389,0.00497241493029706,-0.00281628638058834,0.0166755801461761,0.16344585193664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.0115073975662864,0.00832516373427803,-0.0278247184854714,0.00480992335289851,0.166907840894323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.0101127948992051,0.00733507389051003,-0.0244895397246048,0.00426394992619455,0.168003028707751
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,0.00558894327252932,0.00405906956511613,-0.00236683307509829,0.0135447196201569,0.168555098979099
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.0069513800730672,0.00506790304902535,-0.00298170990302249,0.0168844700491569,0.170185578730905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0088750336590845,0.00647103633404237,-0.00380819755563855,0.0215582648738075,0.170231566279845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,0.00473575586976271,0.0034565590997803,-0.00203909996580667,0.0115106117053321,0.170673214621044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.0050648070204236,0.00371006814092301,-0.0022069265357855,0.0123365405766327,0.172218094283374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.00506490436643384,0.00371041495990551,-0.0123373176878486,0.00220750895498096,0.172247799494351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,0.00432819345616535,0.00317420441196108,-0.00189324719127837,0.0105496341036091,0.172718958058843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,24657,0.00286911762328504,0.00211316904267812,-0.00127269370036407,0.00701092894693416,0.174561112008271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00616026368334525,0.00453827197847336,-0.015055276761153,0.00273474939446253,0.174665789060254
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,24101,0.00905185545412883,0.00667732168597332,-0.00403569505037888,0.0221394059586365,0.175235454720739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,24229,-0.00473379347749495,0.00349664230281742,-0.0115872123910171,0.00211962543602719,0.175809257735716
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0036205976427465,0.00267841971016719,-0.0088703002746742,0.00162910498918119,0.176462373196168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.0020778798546413,0.0015404117502777,-0.00509708688518559,0.000941327175902988,0.177375577490763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,28931,-0.00370609497184007,0.00274982384528301,-0.00909574970859476,0.00168355976491463,0.177747036358012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,24938,0.00842803160127537,0.00625726018127603,-0.00383619835402566,0.0206922615565764,0.178018105865373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.00401867412446612,0.00299609325811549,-0.00989101691037249,0.00185366866144025,0.179832061740017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00535092761525877,0.00398976669136307,-0.00246901509981285,0.0131708703303304,0.179880170020665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.00704342273170647,0.00525195242809421,-0.00325040402735819,0.0173372494907711,0.179898819918617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.00596230965785395,0.00445716238291226,-0.014698347928362,0.00277372861265407,0.181009499436538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.00532894621948849,0.00399536410541932,-0.0131598598661104,0.00250196742713338,0.182287795473942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00316273654646123,0.0023766142812673,-0.00149542744482267,0.00782090053774513,0.18327592619563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,24867,0.00206425139937867,0.00155216436166718,-0.000977990749489015,0.00510649354824635,0.183557478776174
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,24454,-0.00236143273282248,0.00177671635267058,-0.00584379678405682,0.00112093131841186,0.18382756780399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,28916,0.00303863323806427,0.00231386988701776,-0.00149655174049054,0.00757381821661907,0.189117355878679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00328573365545305,0.00250232689718818,-0.00161882706303579,0.00819029437394188,0.189171424169453
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,24381,0.00481225419368114,0.00367331342156938,-0.00238744011259485,0.0120119484999571,0.19018851345963
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.00533916461364256,0.00407612591931898,-0.00265004218822264,0.0133283714155078,0.1902527987052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00520796809526851,0.00397766093421161,-0.00258824733578625,0.0130041835263233,0.190443822911185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00356576785542573,0.00272573051000539,-0.00177666394418483,0.0089081996550363,0.190822008497724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,24195,-0.00556798849766624,0.00426793448429346,-0.0139331400868814,0.00279716309154893,0.19203821794187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.00413221529438428,0.00316747257057784,-0.0103404615327168,0.00207603094394829,0.19204703077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00723835398163771,0.00555900826127492,-0.0181340101737366,0.00365730221046114,0.192896584382096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00461960273291378,0.00356084642107393,-0.0115988617182187,0.00235965625239112,0.194529092296927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,24016,-0.00673981758639054,0.00519611293235908,-0.0169241989338143,0.00344456376103325,0.194613254916193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.00245904103185025,0.00191111830308854,-0.0062048329059038,0.00128675084220329,0.198209935890018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.00789488004385957,0.00615409181478174,-0.0199569000008318,0.00416713991311264,0.199551026414656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,24016,0.0039856154888179,0.00310989840574198,-0.00210978538643638,0.0100810163640722,0.199998800935679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00261708427313806,0.00205176131716522,-0.00140436790850577,0.0066385364547819,0.202133765985079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,0.00483391002876528,0.00379023455606164,-0.00259494970111554,0.0122627697586461,0.202192498101406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00232386853033461,0.00182883108296095,-0.00126064039226884,0.00590837745293807,0.203853011411062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,24966,0.00174206806154601,0.00137197269210336,-0.000946998414976584,0.00443113453806861,0.204184048077405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00400485308029684,0.00315736572441167,-0.00218358373955003,0.0101932899001437,0.20466136098117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,28774,-0.00532508756036044,0.00421232162067764,-0.0135812379368886,0.00293106281616774,0.206179522316622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,24240,-0.0062905640587373,0.00500325244910428,-0.0160969388589817,0.00351581074150709,0.208658970905481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.00390059365070881,0.0031065352316553,-0.00998940270475319,0.00218821540333557,0.209267729236889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00611381301970656,0.00487469302893438,-0.00344058531700482,0.0156682113564179,0.209783330471365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,28916,0.00471256838900028,0.00376126474223315,-0.00265951050577669,0.0120846472837773,0.210244517063012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,-0.00800234020797995,0.00646196406314791,-0.0206677897717499,0.00466310935578996,0.215586613945842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,23801,0.0034132192399399,0.00277452300465446,-0.00202484584918285,0.00885128432906265,0.21863424547118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,29757,-0.00259188995681539,0.00211618046439927,-0.00673960366703797,0.00155582375340719,0.220661687546618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,0.00400329300643373,0.00327871240439323,-0.00242298330617701,0.0104295693190445,0.222097419036136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.00317202195858885,0.00260635871482822,-0.00828048503965216,0.00193644112247446,0.223603631959893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,24111,-0.009542724134796,0.00786777034871809,-0.0249635540182835,0.00587810574869145,0.225184539322471
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,24229,0.00592847993104165,0.0049071678050975,-0.00368956896694945,0.0155465288290328,0.227010369766791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.00525209393752076,0.00436966726891017,-0.00331245390954316,0.0138166417845847,0.22939716779887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0021615471507315,0.00181270162197415,-0.00139134802833782,0.00571444232980083,0.233098182081198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,28931,0.00239945297533765,0.00201731866551656,-0.00155449160907482,0.00635339755975011,0.234281508523807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,24229,0.00142533122718313,0.0012010535883474,-0.000928733805977775,0.00377939626034403,0.23534416965881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.00465217083438886,0.0039288836095423,-0.0123527827090918,0.00304844104031405,0.236385305890744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,28626,0.0056100852837801,0.00473861939585447,-0.00367760873209467,0.0148977792996549,0.236459663276472
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.00567572800014136,0.00482730952178014,-0.0151372546628304,0.00378579866254771,0.239704495459009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,-0.00247162137261437,0.00210597996645835,-0.00659934210687274,0.001656099361644,0.240558604427493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.00420874653545959,0.00362968187026714,-0.002905429930264,0.0113229230011832,0.246249335279492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,0.00577629685126643,0.00501050364960566,-0.00404429030196066,0.0155968840044935,0.248988496174378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,29632,-0.00499263112050044,0.00433871608838227,-0.0134965146537297,0.0035112524127288,0.249858277814973
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.00218962859713229,0.00190775001266306,-0.00154956142768731,0.00592881862195189,0.251080987342652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.00352267762119569,0.00307427298826146,-0.00954825267818814,0.00250289743579676,0.25186375455503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00244037777165142,0.00213254028979283,-0.00173940119634253,0.00662015673964536,0.252488858055501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00275132830730114,0.00241045533857735,-0.00197316415631047,0.00747582077091275,0.253708924389504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.00462658442420333,0.00405981272247246,-0.0125838173602493,0.00333064851184268,0.254462115036078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.00745357201717075,0.00655402806970403,-0.0202994670337907,0.00539232299944914,0.25544491395487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,28774,0.00358527249193176,0.00316059705588988,-0.00260949773761241,0.00978004272147592,0.256650688217886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,24111,0.0048752096101085,0.00430062716251004,-0.00355401962841117,0.0133044388486282,0.256971830116067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,29579,-0.0121779166493975,0.0107465140144232,-0.033241084117667,0.00888525081887195,0.257140753917656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.00558664107377888,0.00493943401948149,-0.00409464960440483,0.0152679317519626,0.258052160244259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.00199649622928126,0.001766327222738,-0.00146550512728521,0.00545849758584774,0.258357073454952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.00425842871284769,0.00378535566842432,-0.0116777258229594,0.00316086839726397,0.260610879509931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,24922,0.00839009450321338,0.00749236563860772,-0.00629494214845774,0.0230751311548845,0.262801635822674
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.0036457775712864,0.00325584715478632,-0.0100272379946676,0.00273568285209477,0.262824062459978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.00426017164722763,0.00381860222166028,-0.0117446320016818,0.00322428870722653,0.264587074126969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00494939299858882,0.00443974462724306,-0.00375250647080758,0.0136512924679852,0.264950507841907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,29341,-0.00565847524332859,0.00507976214422568,-0.0156148090460109,0.00429785855935375,0.265320391358821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,29497,-0.00188583632109316,0.00169950470813923,-0.00521686554904605,0.00144519290685973,0.267163766246384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.00849588098455597,0.00767108848836716,-0.0235312144217556,0.00653945245264366,0.268080395087347
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,28931,0.0111090792247255,0.0100308404870952,-0.00855136812998108,0.0307695265794321,0.268090324756253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.0059214741700903,0.00536119609660672,-0.0164294185194395,0.00458647017925887,0.269384321339334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.00401973622964916,0.00364184711129978,-0.0031182841084984,0.0111577565677967,0.269706964569117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,24101,0.00375878342322063,0.00341060130069959,-0.00292599512615056,0.0104435619725918,0.270434343861666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00263928886105496,0.00239493101680332,-0.00205477593187954,0.00733335365398946,0.27045908566574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,24195,-0.0017805576482355,0.00162030127297432,-0.00495634814326516,0.00139523284679416,0.271820317805257
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00449294902453728,0.00409069421628473,-0.00352481163938079,0.0125107096884553,0.272069539532469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00673643071213864,0.00614785879133635,-0.0187862339431579,0.0053133725188806,0.273204936563197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.00461448466253295,0.00421825088250451,-0.0128822563922418,0.00365328706717589,0.273995257164146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,28334,0.00367658415405583,0.0033815350396037,-0.00295122452356742,0.0103043928316791,0.276934262066066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00299430387376295,0.00276046317826401,-0.00840481170316042,0.00241620395563451,0.27806063325491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,0.00281504361173181,0.00259654806069494,-0.00227419058723027,0.00790427781069389,0.278309783398321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,24195,-0.00268150084243942,0.00250028932478623,-0.00758206791902043,0.00221906623414158,0.283516892565756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,0.00325861368135267,0.0030532407722626,-0.00272573823228202,0.00924296559498736,0.285861532765109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00326508592792108,0.00307269160966421,-0.00275738962702077,0.00928756148286293,0.287967565345964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00285023574019488,0.00268726384470902,-0.0024168013954348,0.00811727287582456,0.28886142841849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,0.0017011811434347,0.00160416546461944,-0.00144298316721941,0.0048453454540888,0.288937793841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0110423680706304,0.0104225043993112,-0.00938574055201951,0.0314704766932802,0.28939447649615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,24229,0.00195624637867882,0.00185423451746059,-0.00167805327554394,0.00559054603290158,0.291428707085287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.00599367359657039,0.00568446541919852,-0.00514787862505871,0.0171352258181995,0.291712588704516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00408887421199187,0.00388671867692695,-0.00352909439478495,0.0117068428187687,0.292802939159309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.00459353062297545,0.00437622377426093,-0.0131709292205269,0.00398386797457598,0.293886717837887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,24951,-0.00391933753927295,0.00373676879656082,-0.0112434043805322,0.00340472930198626,0.294253927497511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,28931,0.00252544465865067,0.00240865317420613,-0.00219551556279334,0.00724640488009468,0.294422455540007
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00517288191201182,0.00493542555485632,-0.0148463159995302,0.00450055217550658,0.294597081406868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,24101,-0.00544210673435477,0.00520838080720133,-0.0156505331164694,0.00476631964775984,0.296091245632168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,0.00246705461456735,0.002364089208567,-0.00216656023422396,0.00710066946335867,0.296700539531915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,24229,0.00750380721095792,0.00720911261034887,-0.00662605350532587,0.0216336679272417,0.297942533625432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00272313722096647,0.00262733823574684,-0.00787272016303027,0.00242644572109733,0.299995151924482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,29434,-0.00253379663884518,0.00244780823459608,-0.00733150077865349,0.00226390750096314,0.300617303351891
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00436099419690242,0.00422246779441351,-0.0126370310739529,0.00391504268014805,0.301704607675677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,29434,0.00407859197797935,0.00394937246081566,-0.00366217804521935,0.0118193620011781,0.301743908501056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,24229,0.00300274939048483,0.00291583961603447,-0.00271229625694272,0.00871779503791239,0.303111327647991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00580873177824765,0.00565157730250228,-0.00526835973465682,0.0168858232911521,0.304050911479313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,0.0056171187755727,0.00547711297678371,-0.00511802265892336,0.0163522602100688,0.305108399946944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,29478,0.00843048570972843,0.00824202985944642,-0.00772389281478655,0.0245848642342434,0.30637997243023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00198946886090082,0.00194672275353654,-0.00580504545783244,0.0018261077360308,0.306810712169389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00267509499046029,0.0026177747490426,-0.00780593349858379,0.00245574351766321,0.306840163900489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.00295342766461482,0.00289753943566838,-0.00272574962929521,0.00863260495852484,0.308076452970217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,24914,0.00106477376795124,0.00104523237309639,-0.000983881683317682,0.00311342921922017,0.308357332196684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,24966,0.00165201599276845,0.00162863145645497,-0.00154010166188329,0.0048441336474202,0.31042160402694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.00220218255209751,0.00217502271924715,-0.00646522708182193,0.0020608619776269,0.311313664029423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.00476602771289838,0.00470923043513997,-0.0139961193657727,0.00446406393997596,0.311517220192143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,24111,-0.00480950896961997,0.00475939066088469,-0.014137914664954,0.00451889672571402,0.312251386758031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,28931,0.00465478257601232,0.00460769783617774,-0.00437630518289605,0.0136858703349207,0.312398968698338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,29725,0.00446257189557962,0.0044379658166011,-0.00423584110495853,0.0131609848961178,0.314642946231793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.0034632511578437,0.00345250049399766,-0.00330364981039171,0.0102301521260791,0.315815992284287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,24016,0.00314303818902725,0.00314251281397397,-0.00301628692636174,0.00930236330441624,0.317239690645068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.00306610591550839,0.00307574007690748,-0.00909455646624704,0.00296234463523027,0.318837080757146
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.00321292389030337,0.00322397906401634,-0.0095319228557754,0.00310607507516865,0.318982680834926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,0.00268023180960917,0.00269432411514906,-0.002600643456083,0.00796110707530134,0.319858254616882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,29713,-0.00148714743374489,0.00149623742588787,-0.00441977278848511,0.00144547792099534,0.320267593733798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.00244753353423773,0.00246731934661568,-0.00728347945360446,0.002388412385129,0.321214930748779
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,24966,0.00509362622885268,0.00513968714876675,-0.00498016058273014,0.0151674130404355,0.321676544548324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00167022514521099,0.00168677178019216,-0.00497629783438761,0.00163584754396563,0.322090726708598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,24016,0.00237675236189869,0.0024009339636168,-0.00232907820679024,0.00708258293058762,0.322219168408553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,28797,-0.00274701922302174,0.00278477827576477,-0.00820518464352068,0.0027111461974772,0.323925088971211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.00328649456617451,0.00334311746904855,-0.00983900480550966,0.00326601567316064,0.325584653911218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,24445,-0.00596355270317773,0.00606690851001377,-0.0178546933828047,0.00592758797644926,0.325634887247864
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,24195,0.00190173868830825,0.00193533666438129,-0.00189152117387909,0.00569499855049558,0.325794616950192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,24016,0.0048096683666585,0.00490096615568307,-0.00479622529848031,0.0144155620317973,0.326419481045984
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0028345337245697,0.00288876751207808,-0.00282745059910334,0.00849651804824273,0.326490896697537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,29725,0.00219429986001892,0.00223901185350106,-0.00219416337284316,0.00658276309288101,0.32707905356742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00385129357498394,0.00394645603432546,-0.00388376025229396,0.0115863474022618,0.329130496779527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00301659027449984,0.00309356789558408,-0.00907998334984465,0.00304680280084496,0.329511941132423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0017329245415685,0.00177795849873174,-0.00175187411594572,0.00521772319908272,0.329731503709143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.00433864958758813,0.00446436884333605,-0.00441151334535054,0.0130888125205268,0.331140067354433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00249315671304977,0.00257001278276295,-0.00254406834116561,0.00753038176726515,0.332008812534976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00592170906170684,0.00611788551224175,-0.00606934654228699,0.0179127646657007,0.333087074361569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.00415900176927878,0.00429965800019145,-0.00426832791109645,0.012586331449654,0.333410417670191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,24229,0.0037683447959965,0.00389711841127923,-0.00387000729011079,0.0114066968821038,0.33357533231637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.00701702860479817,0.00726407196089235,-0.0212546096481472,0.00722055243855084,0.334058075375277
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00243276035968952,0.00253367782712854,-0.00739876890086145,0.00253324818148242,0.336977765706474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.00345003125975811,0.00360824946696707,-0.00362213769549734,0.0105222002150136,0.33900399915618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,24445,0.011409520183088,0.0119335773385356,-0.0119802914004417,0.0347993317666177,0.339038503194367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,24445,0.00384795479596401,0.00402509378358193,-0.00404122901985658,0.0117371386117846,0.339086069457759
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00384930318753897,0.00404108448444846,-0.0117698287770579,0.00407122240198001,0.34082991553958
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,0.00241636758259856,0.00253927057210805,-0.00256060273873322,0.00739333790393034,0.341309593934135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,29413,-0.00857688903628699,0.00902872361488707,-0.0262731873214656,0.00911940924889166,0.342142483109535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,24101,0.00517064899807037,0.00547192689680223,-0.005554327719662,0.0158956257158027,0.344698390352742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,29434,0.00400367181364505,0.00425718896269431,-0.0043404185532358,0.0123477621805259,0.346994693004001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,24229,-0.00196366349397079,0.00209270690740459,-0.00606536903248378,0.00213804204454219,0.34808081290989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.00176070984000509,0.00187884299044918,-0.00544324210128549,0.0019218224212753,0.348703937817435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,24793,-0.00727644756302198,0.00777723989216846,-0.0225198377516722,0.0079669426256282,0.34948419158652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.00322159176461897,0.00344612290514935,-0.0099759926587117,0.00353280912947375,0.349875846050443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.00143011140130496,0.00153563377799311,-0.00443995360617144,0.00157973080356153,0.351714261385316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.00412462550483805,0.00443602506785367,-0.00456998362815515,0.0128192346378312,0.35248286350639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.00392935062273823,0.0042284476782175,-0.0122171080720445,0.00435840682656806,0.352759257351783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,24240,-0.0056408777917593,0.00608646933375386,-0.0175703576859169,0.00628860210239826,0.354044906356414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,27585,0.00319335019027897,0.00345795691767077,-0.00358424536835574,0.00997094574891368,0.355765781923613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.00387724617485513,0.00420354777532686,-0.0121161998144958,0.00436170746478551,0.356342426203319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,0.00265711736029799,0.002901663319513,-0.00303014274594748,0.00834437746654347,0.359821708782795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,28797,-0.00668371677673147,0.0073021370248995,-0.0209959053455345,0.00762847179207155,0.360036741492045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,28797,0.00589550694274373,0.00644819076633108,-0.00674294695926519,0.0185339608447527,0.360572907744422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,24195,-0.00270699017248588,0.00296329421753664,-0.0085150468388577,0.00310106649388594,0.360985033020039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.00291310967783688,0.00319660443257195,-0.0091784543656779,0.00335223501000414,0.362137662928419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00320664785063257,0.00351937537143984,-0.00369132787738951,0.0101046235786547,0.362230102242418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.00240763540760195,0.00265231544352372,-0.00760617367690844,0.00279090286170454,0.364018537819688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,24101,0.00223281662349881,0.00246010596769516,-0.0025889910731837,0.00705462432018132,0.364093422057376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.00307944550675728,0.00339562926797007,-0.00973487887197862,0.00357598785846406,0.364475172036206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.00662747554124552,0.00730922067678553,-0.0209535480677452,0.00769859698525413,0.364559652060286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,24966,0.00134035660501615,0.00147862560929266,-0.00155774958919747,0.00423846279922977,0.36468628343367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,24938,0.00281561379276584,0.00310760484533879,-0.00327529170409819,0.00890651928962986,0.36492352502417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00266271228552368,0.00294242398337221,-0.00310443872188584,0.00842986329293321,0.365507135231387
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.00185082772990812,0.00205353785569549,-0.00587576192707128,0.00217410646725504,0.367442830583256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,24805,-0.00388015953232154,0.00432524296288205,-0.0123576357395703,0.00459731667492728,0.369676235239063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,0.000859173324309711,0.000962329641979038,-0.0010269927739692,0.00274533942258863,0.371970038375286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,24016,0.00589159460044318,0.00661196547485906,-0.00706785773028058,0.0188510469311669,0.372911054500455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00298659552108068,0.00335899581933634,-0.00957022732697991,0.00359703628481856,0.373940242584266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.00273510833928637,0.00308996296203027,-0.00879143574486571,0.00332121906629296,0.37607830873805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.00445827569288632,0.00505271080910011,-0.0143615888787225,0.00544503749294991,0.377594591403284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00254503209714547,0.00289151363705187,-0.00821239882576714,0.00312233463147621,0.378774400829542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,24195,-0.00359796004508681,0.004093521666294,-0.0116212625110231,0.00442534242084942,0.379442527947535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.00136259214084656,0.0015503064821527,-0.00167600856417272,0.00440119284586585,0.37945450559805
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00416681193437666,0.00475018663361186,-0.0051435538675026,0.0134771777362559,0.380392561376475
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,24229,0.00186334628483214,0.00212585644801568,-0.00230333235327858,0.00603002492294287,0.380758508642363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.00354576780334165,0.00406346066733525,-0.0115101507113187,0.00441861510463545,0.382889495597664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,24195,0.00417490950148593,0.00484968517976735,-0.00533047345085808,0.0136802924538299,0.389322608961381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.00223082084314968,0.0026095222217673,-0.00734548439781359,0.00288384271151423,0.39262767705927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.00202529083944585,0.00236983932949127,-0.00261959424635705,0.00667017592524875,0.39277504693669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00302851390259496,0.00355015897018716,-0.00392979767897187,0.00998682548416179,0.393632345328267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,24229,0.00452437253383509,0.00531340259096646,-0.00588989654445917,0.0149386416121293,0.394499014987804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00215156464575478,0.0025280660416891,-0.00280344479595586,0.00710657408746543,0.394738132156853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00226675212390374,0.00266849648196754,-0.00296350098075263,0.00749700522856012,0.395639811943556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00284640860685446,0.00335173627712483,-0.00372299449631021,0.00941581171001913,0.395759504370921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.004496062866206,0.00531185901646819,-0.0149073065384837,0.00591518080607164,0.397326982451268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,-0.00424346218326809,0.00501681622984185,-0.0140764219937581,0.00558949762722194,0.397644562532969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,24229,0.0034406308689469,0.00407799494760808,-0.00455223922836493,0.0114335009662587,0.398841765397206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,24195,0.00282584424430566,0.00336268185202097,-0.00376501218565543,0.00941670067426676,0.400718058307462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.00179643873813702,0.00214139080156556,-0.00599356470920552,0.00240068723293148,0.401525343167587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00259873232508612,0.00310999543817412,-0.00349685873373515,0.00869432338390739,0.40338449670415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,-0.00173939650044512,0.00210051616773393,-0.00585640818920362,0.00237761518831338,0.407631587035692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,-0.00215700871975747,0.00261335399853766,-0.00727918255689129,0.00296516511737635,0.409164271070668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.00155999276375319,0.00190397979563567,-0.00529179316319911,0.00217180763569273,0.412603317195333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.00172276766396889,0.00211313800268991,-0.00586451814924111,0.00241898282130334,0.414927332739873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.00171879133570039,0.0021135792362123,-0.00586140663867649,0.00242382396727572,0.416102140922844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.00304754820479548,0.00376128548230641,-0.010419667750116,0.00432457134052508,0.41780997650036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.00168176582496345,0.00207850146793957,-0.00575562870212501,0.00239209705219811,0.418450327945943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,29599,0.00639477811605086,0.0079153287423472,-0.00911926621894966,0.0219088224510514,0.419155808905778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,24101,-0.00327016295098241,0.00408314848430691,-0.011273133980224,0.00473280807825913,0.423201788569934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00200092292993856,0.00251145781028563,-0.00292153437822127,0.00692338023809838,0.425622734784279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,29523,-0.0030765346086457,0.00390007953450539,-0.0107206904962763,0.00456762127898487,0.430212484029898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,24445,-0.00231599766029546,0.0029417614589943,-0.00808185011992429,0.00344985479933337,0.431124080455844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.00363306987210317,0.00464528446124703,-0.0127378274161473,0.005471687671941,0.434164352852912
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,29589,0.00188551553746462,0.00241196438268972,-0.00284193465260723,0.00661296572753648,0.434376936695175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,29820,0.00144670118241858,0.00185778928859042,-0.00219456582321865,0.00508796818805581,0.436149741678012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00469278606909701,0.0060329061846296,-0.016517282190971,0.007131710052777,0.436656185124235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,24793,0.00230273338644754,0.00296445443393338,-0.00350759730406189,0.00811306407695697,0.437295103318211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,24016,0.00436142409869751,0.00562600987899638,-0.00666555526413539,0.0153884034615304,0.438214293403527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,29218,-0.00332246114096279,0.00429782451301583,-0.0117461971864738,0.00510127490454824,0.439495205153587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.00335298620708418,0.00434605854815276,-0.0118712609614636,0.00516528854729523,0.440416648871296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,0.00494603537447843,0.00641749444704567,-0.00763225374173108,0.017524324490688,0.4408856024919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,24229,0.00255337229987893,0.00331469129241003,-0.00394342263324473,0.00905016723300259,0.441117735096914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.00419033759767369,0.00545113049088317,-0.0148745533598047,0.00649387816445732,0.442073095050006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00358203504995522,0.00466375529898298,-0.0127229954359619,0.00555892533605142,0.442460166428391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,28916,0.00581027147074358,0.00757662627396874,-0.00903991602623515,0.0206604589677223,0.443166325284834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,24754,0.00280638573882381,0.00366134460471083,-0.00436984968640942,0.00998262116405705,0.443391834990958
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.00292456589588546,0.00381899284694589,-0.0104097918758994,0.00456066008412848,0.443805722603677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,29454,0.00125143306012629,0.00164107862074327,-0.00196508103653051,0.0044679471567831,0.445727541295269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,24101,0.00285256886890658,0.0037432593050516,-0.00448421936899456,0.0101893571068077,0.446034736300122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,29392,-0.00421825806410889,0.00556272860335562,-0.0151212061266859,0.00668468999846814,0.448273082868866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0011841725955325,0.00157708127266725,-0.0019069066988953,0.0042752518899603,0.452740964622261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00293594204461416,0.00394239700219754,-0.0106630401689213,0.00479115607969301,0.456454355337162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.00321042338637354,0.00431182596580096,-0.0116616022793434,0.00524075550659635,0.45654237358158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,29454,0.00188847635656468,0.00253652476701925,-0.00308311218679305,0.00686006489992241,0.456571956958173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,28931,0.00151471616022999,0.00203608885851798,-0.00247601800246525,0.00550545032292523,0.456922321311851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.00248203941823451,0.00334672608538488,-0.00904162254558886,0.00407754370911985,0.45831633419075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.00166388153997241,0.0022514939499067,-0.00607680968178954,0.00274904660184472,0.459906740761518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,0.00178489085229651,0.00242016921881751,-0.0029586408165858,0.00652842252117882,0.46082029817661
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00473215199296448,0.00642353731123501,-0.00785798113705614,0.0173222851229851,0.461318377611959
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,24381,-0.00437811667214465,0.00595615239909844,-0.0160521753743776,0.00729594203008831,0.46231132749893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00310610841569243,0.00426318266796856,-0.0114619464449108,0.00524972961352594,0.466260032667749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.00251799822537067,0.00347125290516242,-0.00932165391948902,0.00428565746874768,0.46822101639436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00245968838845811,0.00339353503532656,-0.00419164028078195,0.00911101705769816,0.468571974826008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,24111,0.00219206341482414,0.00303710036419993,-0.00376065329900773,0.008144780128656,0.470447863566775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.00198202054348624,0.00274867145699052,-0.00736941659918767,0.00340537551221519,0.470865286298985
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,24229,0.00192767213401279,0.00267778390430535,-0.00332078431842569,0.00717612858645127,0.471608347316154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,0.00310891891293976,0.00432313744090774,-0.0053644304712394,0.0115822682971189,0.47206479324193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,24111,0.0024437871074164,0.00346529077631069,-0.00434818281415255,0.00923575702898536,0.480681096662768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00488447342914267,0.00695675333618453,-0.0185197099680643,0.008750763109779,0.482611311485074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.0029295109895892,0.00421613712856375,-0.0111931397615741,0.00533411778239574,0.487166664264689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00295881679891049,0.00432233309837406,-0.00551295607390268,0.0114305896717236,0.493639815869513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,0.00207690703737386,0.00304776696759908,-0.00389671621912033,0.00805053029386805,0.495592051284211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.00179948261699257,0.00264281658805435,-0.00338043789559396,0.0069794031295791,0.495943991888339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00155709044727921,0.00229887808203838,-0.00606289148807444,0.00294871059351602,0.498204434045774
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.000967946323249408,0.00143362757238214,-0.00184196371861959,0.00377785636511841,0.499571315500699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,0.00198530737627001,0.00295370672847571,-0.00380395781154238,0.00777457256408241,0.501500410849094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.00213380119044666,0.00317775655948288,-0.00836220404703311,0.00409460166613979,0.501920812212151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,-0.00320477998071875,0.00478301609927318,-0.0125794915352942,0.00616993157385668,0.502841769960413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.00185687754010953,0.00277666936152943,-0.00729914948870721,0.00358539440848815,0.503665990138462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00320163605380123,0.00478859354548836,-0.00618400729535595,0.0125872794029584,0.503759446337581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,28931,-0.00210897502029807,0.00315859258666076,-0.00829981649015316,0.00408186644955702,0.504333925304308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,29313,-0.00326384326064334,0.00490635778543457,-0.0128803045200951,0.00635261799880842,0.505910342655545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,29466,0.00186379404536871,0.00281825769069784,-0.00365999102839905,0.00738757911913648,0.508406861009677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,28797,0.00771274687709138,0.011679529383757,-0.0151791307150722,0.030604624469255,0.509025216120816
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.00140193401180074,0.00213378522032447,-0.00558415304363671,0.00278028502003522,0.511174987555763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,0.00105631455292722,0.00162003137096715,-0.0021189469341684,0.00423157604002285,0.514384738722748
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.00495710653300639,0.0076656136796236,-0.0199817093450686,0.0100674962790559,0.517853169361671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00341818898387115,0.0053346802088619,-0.0138741621932405,0.00703778422549817,0.521692082995562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.00313337963646297,0.00491592429450129,-0.00650183198075957,0.0127685912536855,0.523874404595095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.00350752081554864,0.00554156152345898,-0.00735393977043096,0.0143689814015282,0.526773523703813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,28931,0.00182730679764396,0.00290424549754191,-0.00386501437753819,0.00751962797282611,0.529233122320797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,28931,-0.00211240109341492,0.00336095689026952,-0.00869987659834318,0.00447507441151333,0.529673677588735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,24374,0.00143996036815661,0.00229825962014544,-0.00306462848732845,0.00594454922364166,0.530964173543118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.00132741132474941,0.00211990639369513,-0.00282760520689304,0.00548242785639186,0.531211587188877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,28872,-0.00248398209931288,0.0039700202029305,-0.0102652216970567,0.0052972574984309,0.531526520465778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00113061167879301,0.00181723672336208,-0.00469239565658269,0.00243117229899667,0.533842493864765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.00217218820206479,0.00350136084372487,-0.00469047905163596,0.00903485545576553,0.535010902100875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.00517152075765651,0.00839267640626673,-0.0216211665139393,0.0112781249986263,0.537772003312921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00154755650346746,0.00251422109294402,-0.00647542984563773,0.00338031683870282,0.538216389170618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00234272085080505,0.00382812960429541,-0.00984585487522405,0.00516041317361396,0.540559779543881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,24240,0.000777819948147846,0.00127521800425961,-0.00172160734020099,0.00327724723649668,0.541900273127195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,24867,-0.00129921850796505,0.0021477753468872,-0.00550885818786397,0.00291042117193387,0.545241931815362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,24016,0.00179448201762978,0.0029781912571348,-0.00404277284635442,0.00763173688161399,0.546819844158729
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,0.0016767245770654,0.00278846659848747,-0.00378866995597004,0.00714211911010085,0.54764097826605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0026839206637548,0.00451646585999974,-0.0115361937493543,0.00616835242184468,0.552348703089485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.00155999987128458,0.00263379870037834,-0.00672224532402612,0.00360224558145696,0.553654891330628
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.00260607960527314,0.0044118210955872,-0.0112532489526241,0.00604108974207778,0.554724270745635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00660221916442309,0.0112197941998021,-0.0285930157960353,0.0153885774671891,0.55623974351255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,28916,0.00159430458535977,0.00272056654345376,-0.0037380058398096,0.00692661501052915,0.557867100631424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,0.00167299691135832,0.00286767435312866,-0.00394764482077384,0.00729363864349049,0.559630550085916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.0022401467707513,0.00385251591351193,-0.00531078441973208,0.00979107796123468,0.560924915479457
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,24101,-0.00181116788964088,0.00311980179708928,-0.00792597941193586,0.0043036436326541,0.561556350338202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00124561863257218,0.00214834190732646,-0.00545636877093204,0.00296513150578769,0.562051604174594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.00137392448680252,0.0023722253179827,-0.00602348611004862,0.00327563713644357,0.562479103073278
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.0025325389389679,0.00438446966064148,-0.0111260994738252,0.00606102159588941,0.563528909670746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.00169513348348936,0.00293758528815323,-0.00406253368129098,0.0074528006482697,0.563911076047219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00301504901877394,0.00528617611144717,-0.0133759541972104,0.00734585615966251,0.568435588330074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00198079270174046,0.00349575021589685,-0.00487087772141736,0.00883246312489828,0.57097161840234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,0.00306672333523826,0.00542307194712855,-0.00756249768113369,0.0136959443516102,0.571741982158201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.00209717484296071,0.00375885098724873,-0.00946452277796822,0.0052701730920468,0.576897550007822
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,28931,-0.00124339381676096,0.00225838907111844,-0.00566983639615311,0.00318304876263119,0.581934995058965
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.00390834716743872,0.00711762987585138,-0.0178589017241074,0.01004220738923,0.582936391455642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.00167933756311219,0.00306727351844761,-0.0076911936592695,0.00433251853304512,0.584039012223762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00274416073115254,0.00502065904619164,-0.00709633099938307,0.0125846524616882,0.584676630689476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.00261812725133118,0.00480709205151769,-0.0120400276723058,0.0068037731696435,0.586006414889336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00293382528542914,0.00541665236998268,-0.0135504639305952,0.00768281335973691,0.588077784851515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,0.00378197437000306,0.00698286782749939,-0.00990444657189575,0.0174683953119019,0.588093854190318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.00297904412702377,0.00551416301429514,-0.0137868036350422,0.0078287153809947,0.589026602204149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,-0.00149248931550668,0.0027682553428535,-0.00691826978749953,0.00393329115648618,0.589792067575752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,29497,0.00124628332396186,0.00231689464002349,-0.00329483017048418,0.00578739681840789,0.590642491193251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.000911840762356966,0.00170631835896736,-0.00243254322121907,0.004256224745933,0.593075261196082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00352767910299157,0.00662644277496166,-0.00946014873593328,0.0165155069419164,0.594478891599139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00251819790074476,0.00474939765696553,-0.0118270173083972,0.00679062150690767,0.595968338344149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,0.00102831465236772,0.00194729595311569,-0.00278838541573903,0.00484501472047447,0.597453289934276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00189662638207136,0.00363559824909671,-0.00522914618615819,0.0090223989503009,0.60189651264618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00105900566341846,0.00206107563833156,-0.0029807025877114,0.00509871391454832,0.607387405162426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00155773653089442,0.00308304357107454,-0.00448502886841167,0.00760050193020052,0.613381195152053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.00173391789665393,0.00344521346284304,-0.00848653628382629,0.00501870049051843,0.614769809103393
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00164244924538159,0.00331488908528051,-0.00485473336176821,0.00813963185253139,0.62026755904548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.00146057330440745,0.00295713542745723,-0.00725655874222362,0.00433541213340872,0.621370754241024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,28931,-0.00169786629265211,0.00343957834260539,-0.00843943984415867,0.00504370725885444,0.6215738801393
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.00194464015189618,0.00394289678704884,-0.0096727178545119,0.00578343755071954,0.621875029258889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.00189354393570077,0.00385681466542729,-0.00945290067993827,0.00566581280853672,0.62345878958024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.0021676584475228,0.0044626043614482,-0.00657904610091567,0.0109143629959613,0.6271563314502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,24845,0.000772459459451532,0.00159613772869278,-0.00235597048878631,0.00390088940768938,0.628421795835122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,-0.00160241979504913,0.00332122942455099,-0.00811202946716908,0.00490718987707081,0.629470877392237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00117288894589118,0.00243791785659193,-0.003605430053029,0.00595120794481136,0.63044703421695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,28797,-0.00105329611935078,0.00219695870674849,-0.00535933518457782,0.00325274294587627,0.631633741294865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.000974902343413713,0.00205890736586612,-0.00501036078051131,0.00306055609368388,0.63585670095367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,29443,-0.00174122454844952,0.0036787177741255,-0.00895151138573549,0.00546906228883646,0.635985720276927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.00212051931585257,0.00451666139968912,-0.0067321370275381,0.0109731756592433,0.638724310917744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,24111,0.00169604945261653,0.00361473614604702,-0.00538883339363564,0.0087809322988687,0.638927914706315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.00277051337694054,0.00594955730691895,-0.0144316456985017,0.00889061894462059,0.641457965656981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.00179525302809838,0.00392862522485449,-0.00590485241261643,0.00949535846881319,0.647698024778944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,24195,0.00194893947673181,0.004265000990619,-0.00641046246488144,0.0103083414183451,0.647703122075191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.00200868557109112,0.00443521192918751,-0.00668432981011641,0.0107017009522986,0.650628387818365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,0.00250415984606328,0.00553769921147325,-0.0083497306084243,0.0133580503005509,0.651127327907321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.00170447958925154,0.00379269335516599,-0.00913815856537687,0.00572919938687379,0.653138300888199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,0.00172585513913447,0.0038518558640228,-0.00582378235435022,0.00927549263261916,0.654115261214987
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,29461,0.00592262177395769,0.0132294991721312,-0.0200071966034195,0.0318524401513348,0.654385291179233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,0.00226933268858095,0.00520748912627796,-0.00793734599892386,0.0124760113760858,0.662998384000533
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.0011804092338355,0.00272345075865434,-0.006518372720798,0.004157554253127,0.664709848373262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00201909877690519,0.00466522705881998,-0.0111629438121923,0.00712474625838197,0.665165736793999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,24016,-0.00194453581107038,0.00450298377395688,-0.0107703840080259,0.0068813123858851,0.665866862779606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00224867519063795,0.00522438736685603,-0.00799112404839986,0.0124884744296758,0.66689478268334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,24445,-0.00069696866829879,0.00163123720162763,-0.00389419358348895,0.00250025624689137,0.669190933740986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.00169507570328382,0.00401994449901292,-0.0061840155147815,0.00957416692134914,0.67327226174577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.000835646827669963,0.00198316664301027,-0.00472265344797009,0.00305135979263016,0.673488014988525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,0.00158905174624797,0.00377640661844891,-0.0058127052259119,0.00899080871840784,0.673916519260006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.00100195782351519,0.00239556328541334,-0.00569726186292534,0.00369334621589497,0.675763842623378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.00781923861911836,0.0186984967159223,-0.044468292182326,0.0288298149440893,0.675823084426584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000956391350519194,0.0023069843391929,-0.00356529795429888,0.00547808065533727,0.678465211133457
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,24381,-0.00128585714988041,0.00313441213421507,-0.00742930493294194,0.00485759063318112,0.681634463512888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,29820,-0.00209474520548731,0.00511684216757587,-0.012123755853936,0.0079342654429614,0.682261984061883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00158447741199188,0.00389999423218348,-0.00922846610707151,0.00605951128308775,0.684542807618585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.00121114842582955,0.00299551897960532,-0.00708236562585598,0.00466006877419688,0.685980379647076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,28931,0.00135895240927111,0.00339966734726018,-0.00530439559135884,0.00802230040990107,0.689357613300088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00126070094638359,0.00316706678148105,-0.00494674994531927,0.00746815183808646,0.690585167572971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00132011080527295,0.00335478845634536,-0.00525527456916395,0.00789549617970985,0.69395335266133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.000705173840678399,0.00179578840559522,-0.00281457143428822,0.00422491911564502,0.694557701125573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,24793,0.000958486201296583,0.00247005253676119,-0.00388281677075535,0.00579978917334851,0.697987664382439
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,24111,0.00229429911333417,0.00593137357110243,-0.0093311930860266,0.0139197913126949,0.69890222361442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.00500959914181121,0.0130832029162217,-0.0206334785739833,0.0306526768576057,0.701794376871635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,24195,0.00175184771842238,0.00463699838828632,-0.0073366691226188,0.0108403645594636,0.705584135567479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00075040237580513,0.00198830408448826,-0.00314667362979185,0.00464747838140211,0.705873540334117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,-0.00134898722219764,0.0036187965481312,-0.00844182845653479,0.00574385401213951,0.709321189715709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00169871333446199,0.00457496253246318,-0.0106656398980898,0.00726821322916585,0.710412475477964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.00142841741828663,0.00385549075117117,-0.00612834445400887,0.00898517929058213,0.711021314049333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.000759516282324106,0.0020846277100542,-0.00332635402938213,0.00484538659403034,0.715605667953983
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00125587948701528,0.0034719586782974,-0.00806091849647818,0.00554915952244761,0.717563882085452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,24445,-0.000785839164318522,0.00217430310107111,-0.00504747324241791,0.00347579491378086,0.717787752264083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00154947590885366,0.00429918661549588,-0.00997588167522558,0.00687692985751825,0.718542129207049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.00115446443627244,0.00321428671981164,-0.00745446640710326,0.00514553753455838,0.719473520686922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,0.00124482935294768,0.00347361333696265,-0.00556345278749911,0.00805311149339447,0.720071628507911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,24805,-0.00171469055164024,0.00486406013997797,-0.0112482484259971,0.00781886732271658,0.724449458058464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,24229,0.00152149836972219,0.00434396002687214,-0.0069926632829472,0.0100356600223916,0.726149576700901
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,28931,-0.00226321312559522,0.00647869436529332,-0.0149614540815701,0.0104350278303797,0.726842868348567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.000885751328002757,0.00258681730166759,-0.00418441058326573,0.00595591323927124,0.732045487623596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,23902,-0.00106241823665878,0.00310980056966919,-0.00715762735321038,0.00503279087989283,0.732628231577525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.0015081899227499,0.00449086448543661,-0.0103102843142056,0.00729390446870585,0.736998155478417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.0019784076056965,0.00591042942727323,-0.00960603407175904,0.013562849283152,0.737830421799059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.000615900320194847,0.00185196849121637,-0.00424575856297893,0.00301395792258924,0.739465373519527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,24793,0.000890354202374698,0.00268482834024098,-0.00437190934449762,0.00615261774924702,0.740175805657793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.00116867910693529,0.00360251626771859,-0.00589225277779316,0.00822961099166373,0.745633238445701
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,29693,0.000725537678695384,0.00227046611854979,-0.0037245759136622,0.00517565127105297,0.749308315527755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.000526863331934588,0.00165209159114501,-0.00271123618670963,0.0037649628505788,0.749799897370878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,24111,-0.00107454825220305,0.00337220672517529,-0.00768407343354661,0.00553497692914051,0.749995914546415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.000939676386243272,0.00297362283456048,-0.0067679771419818,0.00488862436949526,0.752002277058181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,24805,0.00255344735265841,0.00808483799917009,-0.013292835125715,0.0183997298310318,0.752132987248702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,24229,0.000941067918846578,0.00304409801297967,-0.00502536418659357,0.00690750002428673,0.757213829653489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,28916,0.0015436890981615,0.00503912320785874,-0.00833299238924163,0.0114203705855646,0.759347374615789
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,24938,0.00197793300832202,0.00646512193886172,-0.0106937059918469,0.014649572008491,0.759653638284043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,24966,0.000325986752306924,0.00107195851469737,-0.00177505193649992,0.00242702544111377,0.761051280552592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00371016980084561,0.012205894530212,-0.0276337230800612,0.02021338347837,0.761156790840524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00117659621424132,0.00387817223568098,-0.00877781379617603,0.00642462136769339,0.761595694912796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,24101,0.00137662643864442,0.00459646361703657,-0.00763244225074725,0.0103856951280361,0.764563548614204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.00288951235494899,0.00974478759928206,-0.0219892960495418,0.0162102713396439,0.766836411547856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.00113646756620349,0.00384949966935626,-0.00868148691814177,0.00640855178573479,0.767824743191844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,29786,-0.00085779549096915,0.00294842087927846,-0.00663670041435493,0.00492110943241663,0.771103924802216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,28797,0.00177807717398661,0.00613404942555394,-0.0102446597000991,0.0138008140480723,0.771917748003623
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,24016,0.000832521419541451,0.00290308463745179,-0.00485752446986406,0.00652256730894696,0.774289898062882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.00127021715262783,0.00452097598995409,-0.0101313300929379,0.0075908957876822,0.778742867409458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,29519,0.000597537279305833,0.00215905209742949,-0.00363420483165598,0.00482927939026764,0.781967039797667
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.000921248694308184,0.00334360172661256,-0.0074747080784688,0.00563221068985243,0.78291424960346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.00100989446032026,0.00370487702023177,-0.00827145341997452,0.006251664499334,0.785174431692375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.000723301237238817,0.00267844513406704,-0.00597305370001021,0.00452645122553257,0.787127789011748
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000756678868181448,0.00284701017244395,-0.0048234610698087,0.00633681880617159,0.790410785276949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.000922507720739328,0.00348410541482494,-0.00775135433379621,0.00590633889231756,0.791184242174847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,28774,0.00070746749706384,0.00269871976252885,-0.00458202323749271,0.00599695823162039,0.793208216866722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.000761722669952464,0.00290980000273776,-0.00494148533541355,0.00646493067531848,0.793494531228888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,-0.00158986801041825,0.00628415629320241,-0.013906814345095,0.0107270783242585,0.800272868400919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,24229,0.00116116371890823,0.00470640926793991,-0.00806339844625399,0.0103857258840705,0.80512727773708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,24111,-0.00065496699120251,0.00268705486372157,-0.00592159452409679,0.00461166054169177,0.807427280242709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,-0.000993752281580225,0.00408741651440982,-0.00900508864982348,0.00701758408666303,0.807910805264903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,24111,0.00112265640397663,0.0046246004425467,-0.0079415604634149,0.0101868732713682,0.808195333382271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,24867,-0.000640808339356783,0.00264562772310238,-0.00582623867663745,0.00454462199792388,0.808616268211251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.000984756223060762,0.00406694484783767,-0.00698645567870107,0.0089559681248226,0.808676383074656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.000680712979249128,0.0028241219181567,-0.00621599193883627,0.00485456598033801,0.809529501654818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00143240459847124,0.0059456295462542,-0.0130858385091295,0.010221029312187,0.80962132587511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,24833,-0.00043872807875691,0.00182749512506931,-0.00402061852389275,0.00314316236637893,0.810277411743077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.000577097317461612,0.00242926321677765,-0.00533845322234581,0.00418425858742259,0.812223526758479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,0.000950227375086459,0.00400419752863014,-0.00689799978102861,0.00879845453120153,0.812420016297697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.000728138203966922,0.00313242840655428,-0.00541142147287947,0.00686769788081331,0.816189148180821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.000767956119114618,0.00338852228212152,-0.00740945979207279,0.00587354755384356,0.82070986098448
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,24111,-0.000639950087173334,0.00283806376005918,-0.00620255505688932,0.00492265488254265,0.821601361886271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.000554059978392543,0.0024868723677214,-0.00432020986234141,0.00542832981912649,0.823697756914931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.000765352426784309,0.00356939485009622,-0.00776136633297289,0.00623066147940427,0.830220752969323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,24229,-0.000533306639353802,0.00248756010591241,-0.00540892444694213,0.00434231116823453,0.830245174448432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,29349,0.00129344589291187,0.00606485430942489,-0.0105936685535609,0.0131805603393847,0.831118572154217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,24101,-0.000721159051905945,0.00338206218429443,-0.00735000093312304,0.00590768282931115,0.831148928655727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,24195,0.00100665261629741,0.00473692536113556,-0.00827772109152829,0.0102910263241231,0.831709550832239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.000437911358988748,0.00206169956730099,-0.00447884251089869,0.0036030197929212,0.831794048679345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.000934851843282958,0.00447130098474036,-0.00969860177337406,0.00782889808680814,0.834388886459443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.000627706935546579,0.0030070579239482,-0.0052661265953919,0.00652154046648505,0.834649423106237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000575541092321683,0.00285564631851969,-0.0050215256919769,0.00617260787662027,0.84027414322669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.000903392259737929,0.00448940318660116,-0.00789583798600034,0.00970262250547619,0.840522241271548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.000822037406200149,0.00409867174475477,-0.0088554340259195,0.00721135921351921,0.841042842771715
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,29218,0.000494874708797671,0.00247285491673486,-0.00435192092800266,0.005341670345598,0.841385917043183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,24229,0.00122114007867314,0.00618857173014291,-0.010908460512407,0.0133507406697533,0.843577381301959
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,24833,-0.000658966475247257,0.0033450846336488,-0.00721533235719891,0.0058973994067044,0.843832706203099
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.000940248485906196,0.00492674698843542,-0.00871617561142723,0.0105966725832396,0.848648084117589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.000750226640759448,0.00395081808630935,-0.00699337680840688,0.00849383008992578,0.849395757057513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,24101,0.000980702116700964,0.00519194674472272,-0.00919551350295557,0.0111569177363575,0.850181332838925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.000530632386248943,0.00283141661832649,-0.00608020895816886,0.00501894418567098,0.851341702547327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,24229,-0.000398193262068856,0.00213748406688914,-0.00458766203317158,0.00379127550903387,0.852218412363096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,0.000336203859512292,0.00184260483037811,-0.0032753016080288,0.00394770932705338,0.855222074274293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.000839281843896679,0.00460072750674306,-0.00985670775711307,0.00817814406931971,0.855251488063271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,0.000694207100277146,0.00383094920426377,-0.00681445334007984,0.00820286754063414,0.856204112885621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,0.000510017987284629,0.00282515165186467,-0.00502727925037013,0.00604731522493939,0.856739604539046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,24016,0.000643257282968596,0.00379280337453146,-0.00679063733111307,0.00807715189705027,0.86532660169833
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.000503517425463074,0.00297344982349952,-0.00532444422859599,0.00633147907952214,0.86553233437305
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,24229,0.00038698121518585,0.00229022279026906,-0.00410185545374151,0.00487581788411321,0.86582087020126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,28797,0.00165204849071701,0.00978115347561372,-0.0175190123214859,0.0208231093029199,0.865875547671607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,24229,0.000322984153872225,0.00192841213511942,-0.00345670363096184,0.00410267193870629,0.86698819640207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,0.000940086583694077,0.00563956859353809,-0.0101134678596406,0.0119936410270287,0.867611601238315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.000343045567605882,0.0020633854916022,-0.0043872811311462,0.00370118999593444,0.867958652704897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-0.000567759719978328,0.00343179628553694,-0.00729408043963073,0.00615856099967408,0.868598301145558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,0.00101726461047134,0.00618363896211416,-0.0111026677552724,0.0131371969762151,0.869331803229342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,24195,-0.000476406912548087,0.00295037774450932,-0.00625914729178635,0.00530633346669018,0.871722072840984
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,0.000362560095956606,0.00225071341532234,-0.00404883819807518,0.00477395838998839,0.872026211136339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0013829013738732,0.00870561475642933,-0.0156801035487283,0.0184459062964747,0.873786859533365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,24793,0.000385200065915134,0.00243604965831767,-0.0043894572643875,0.00515985739621777,0.874359682407073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,28931,-0.000568173777148129,0.00369207361622779,-0.0078046380649546,0.00666829051065834,0.877697421531131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,-0.000448301110580191,0.0029183305914542,-0.00616822906983043,0.00527162684867005,0.877914116232425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,29725,0.000318571434136268,0.00207726337855552,-0.00375286478783255,0.00439000765610508,0.878114546956759
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,0.000347531842450532,0.00227715226574195,-0.0041156865984037,0.00481075028330476,0.878701658334081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,-0.000379433577085563,0.002569207746154,-0.0054150807595474,0.00465621360537627,0.882592359475933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.000264807663567875,0.00179534186513493,-0.00378367771923233,0.00325406239209658,0.882740691556008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.000378409144055701,0.00256987518435457,-0.00541536450539067,0.00465854621727926,0.88293745253217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,24867,-0.000448050914933302,0.00319992586234825,-0.00671990560513587,0.00582380377526927,0.888645990717482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.000478016367090719,0.0034645730620713,-0.00726857956875047,0.00631254683456903,0.890263170874148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.000753472732577213,0.00546733693833207,-0.00996250766655365,0.0114694531317081,0.890388975459391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,24101,0.00048212931403752,0.00349966004550395,-0.00637720437515022,0.00734146300322526,0.890427603393923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.000324698340170479,0.00235704084449155,-0.00429510171503296,0.00494449839537392,0.890433608472489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.000539722886041043,0.0039216624825795,-0.00822618135189687,0.00714673557981479,0.890536935406784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,24445,0.000723650451823514,0.0052838049807876,-0.00963260731052018,0.0110799082141672,0.89106645489326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.00120424086611016,0.00882689714377083,-0.018504959267901,0.0160964775356807,0.891483451326527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.000457546238750508,0.00335615362180967,-0.00612051485999644,0.00703560733749745,0.891560935302078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,24445,0.000495744665953477,0.00373631830204006,-0.00682743920604504,0.00781892853795199,0.894445446452656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,28774,0.000486573411882567,0.00373869291545906,-0.00684126470241719,0.00781441152618232,0.896452359519337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.000696015115956949,0.00542407330480039,-0.00993516856145181,0.0113271987933657,0.897897067091134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,24421,-0.000890370141913479,0.00698705970119342,-0.0145850071562526,0.0128042668724256,0.898600089515493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,28931,-0.000282875016763566,0.00222827442873285,-0.00465029289707994,0.00408454286355281,0.898982425810001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.000228811855882881,0.00184233741973161,-0.00383979319855684,0.00338216948679108,0.901160701781792
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000520467617723597,0.00425601961356017,-0.00886226606030153,0.00782133082485434,0.902670561548581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.000381544843027397,0.00313540596695061,-0.00576385085219579,0.00652694053825059,0.903146236242504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.000675992927499503,0.00559176745738038,-0.011635857143965,0.010283871288966,0.903778395603258
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.000726018033619906,0.0060163023313707,-0.0125179706031065,0.0110659345358667,0.903949205645982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,24229,0.000378639108243207,0.00337418478530371,-0.00623476307095207,0.00699204128743848,0.910652700034788
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.000309102094418982,0.00281177214142628,-0.00582017549161449,0.00520197130277652,0.912464682197942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,28719,0.000252658022954807,0.00245296675130089,-0.00455515680959495,0.00506047285550456,0.917962898554725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.000505876022671354,0.00494265041310381,-0.00918171878701212,0.0101934708323548,0.918480398505916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,0.000290051609215741,0.00284541987909742,-0.00528697135381521,0.00586707457224669,0.918808063646002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,28774,-0.000339287278240931,0.00334750572179133,-0.00690039849295194,0.00622182393647008,0.919269165604575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,28931,0.000432101759794436,0.00440473026501024,-0.00820116955962564,0.00906537307921451,0.921853978332298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,24793,0.000297811269721433,0.00314256888024317,-0.00586162373555517,0.00645724627499804,0.924500805697282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,24101,0.000645279952927637,0.00685272310750529,-0.0127860573377827,0.014076617243638,0.924979649176446
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,24445,-0.000267965780959856,0.00293297376684994,-0.00601659436398573,0.00548066280206602,0.92720477441429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,0.000543741733784672,0.00600483280929148,-0.0112257305724266,0.012313214039996,0.927850370196711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.000213397448155996,0.0023920421992953,-0.00490180015877478,0.00447500526246279,0.928914509495711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,28852,-0.000445249737533506,0.00517338091453713,-0.0105850763300263,0.00969457685495927,0.931414927529485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,24793,-0.000282914392913598,0.00339606350429044,-0.00693919886132286,0.00637337007549566,0.933608451419407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,29349,0.000109871988450281,0.00134860943458212,-0.00253340250333067,0.00275314648023123,0.935068279231798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,24922,0.000282232323114211,0.00348260656883182,-0.00654367655179616,0.00710814119802458,0.935410361964029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,24101,-0.000363527817302413,0.00449044590560687,-0.00916480179229188,0.00843774615768706,0.935477744878208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,24195,-0.000267871328334249,0.00342459159622568,-0.00698007085693658,0.00644432820026808,0.937653752831935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000175504866480271,0.00225937724789233,-0.00460388427234923,0.00425287453938869,0.938084503950976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,28931,0.000379231041662466,0.00540883595552416,-0.0102220874311649,0.0109805495144898,0.944104009320212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.000127614366239717,0.00188050866587077,-0.00381341135134643,0.00355818261886699,0.945896335054379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-0.000401998999409318,0.00595263637290364,-0.0120691662903005,0.0112651682914818,0.946158004833499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,23913,-0.000165316165651248,0.00245036709543,-0.00496803567269405,0.00463740334139155,0.946211390501545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,29434,-0.000390161405886181,0.0062822122439944,-0.0127032974041152,0.0119229745923428,0.950479052214237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.000224975865078744,0.00363550364128405,-0.00735056300199548,0.00690061127183799,0.950656518512927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.000214729975612649,0.00356016033713501,-0.00676318428517197,0.00719264423639727,0.95190550079683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,24016,0.000496718579969974,0.00826626570769525,-0.0157051622071127,0.0166985993670527,0.9520845824931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.000209525006704257,0.00355750347664446,-0.00718223182092741,0.00676318180751889,0.953034919829631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,24445,0.000238141204671813,0.00425738882091438,-0.00810634088432037,0.008582623293664,0.955393267309924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,28916,-0.000104291876594208,0.00193792173875965,-0.00390261848456311,0.0036940347313747,0.957081854102334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00016347345964612,0.00346000434930648,-0.00661813506499458,0.00694508198428682,0.962317076439181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-8.30538785733973e-05,0.00184659959169322,-0.00370238907829211,0.00353628132114531,0.964126274350737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,24016,0.000179096555963481,0.0042821589624354,-0.0082139350104099,0.00857212812233687,0.966639436125442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,0.00019110890787336,0.00469470240487335,-0.00901050780567841,0.00939272562142513,0.967529532271197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,0.000252976284904903,0.00655014188793646,-0.0125853018154506,0.0130912543852604,0.969192481375134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,0.000127715997419344,0.00349222802217197,-0.00671705092603772,0.0069724829208764,0.970826974405814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,28931,0.000139917047840811,0.00392703402681848,-0.00755706964472341,0.00783690374040503,0.971578277473767
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,29349,5.97237490062695e-05,0.00200422100428925,-0.00386854941940067,0.00398799691741321,0.976227572025844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.000105131451112519,0.0035386455054434,-0.00683061373955655,0.00704087664178159,0.976298927430663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.000210378532169745,0.00803288471646237,-0.015954832576436,0.0155340755120965,0.979106278793213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,24059,-0.000142630322583256,0.00604062002278554,-0.0119822455672429,0.0116969849220764,0.981162401432083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,24101,-5.55048115314908e-05,0.00266411371970173,-0.00527716770214688,0.0051661580790839,0.983378048605054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,24805,0.000198822366036831,0.0183556675966003,-0.0357782861232998,0.0361759308553735,0.991357841191373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,24229,4.69076721727337e-05,0.00442463139887898,-0.00862536986963007,0.00871918521397554,0.991541482996429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,24111,3.43374778668414e-05,0.00339128978119205,-0.00661259049326957,0.00668126544900326,0.991921483317296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,24867,2.11993333130437e-05,0.00231502803969294,-0.00451625562448512,0.00455865429111121,0.992693732467904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,2.5492561313316e-05,0.00333842319463489,-0.00651781690017108,0.00656880202279771,0.993907389138396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,24445,2.9336122725434e-05,0.00420845566637212,-0.00821923698336391,0.00827790922881478,0.994438242394158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,1.68132858554262e-05,0.00289070966035194,-0.00564897764843438,0.00568260422014524,0.995359323959068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-3.21648661973612e-05,0.00750745539520321,-0.0147467774407957,0.0146824477084009,0.996581597183745
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,24445,-9.31572288880513e-06,0.00379551334308176,-0.00744852187532905,0.00742989042955144,0.998041690998966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,29590,-5.2873184969611e-06,0.00290118280848303,-0.0056916056231237,0.00568103098612978,0.998545892458191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,1.0917929825091e-06,0.00132129848521335,-0.00258865323803565,0.00259083682400067,0.999340712225897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,24111,1.10277022001995e-06,0.00339331340447064,-0.00664979150254244,0.00665199704298248,0.999740703529621
